<SEC-DOCUMENT>0001213900-24-011840.txt : 20240209
<SEC-HEADER>0001213900-24-011840.hdr.sgml : 20240209
<ACCEPTANCE-DATETIME>20240209090011
ACCESSION NUMBER:		0001213900-24-011840
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		20
CONFORMED PERIOD OF REPORT:	20240206
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240209
DATE AS OF CHANGE:		20240209

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Peraso Inc.
		CENTRAL INDEX KEY:			0000890394
		STANDARD INDUSTRIAL CLASSIFICATION:	SEMICONDUCTORS & RELATED DEVICES [3674]
		ORGANIZATION NAME:           	04 Manufacturing
		IRS NUMBER:				770291941
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-32929
		FILM NUMBER:		24611575

	BUSINESS ADDRESS:	
		STREET 1:		2309 BERING DRIVE
		CITY:			SAN JOSE
		STATE:			CA
		ZIP:			95131
		BUSINESS PHONE:		408 418 7500

	MAIL ADDRESS:	
		STREET 1:		2309 BERING DRIVE
		CITY:			SAN JOSE
		STATE:			CA
		ZIP:			95131

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MoSys, Inc.
		DATE OF NAME CHANGE:	20060530

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MONOLITHIC SYSTEM TECHNOLOGY INC
		DATE OF NAME CHANGE:	19960613
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea193205-8k_perasoinc.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:PRSO="http://perasoinc.com/20240206">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_036_PRSO_perasoinc.com_20240206 -->
<!-- Field: Set; Name: xdx; ID: xdx_042_20240206_20240206 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_058_edei%2D%2DEntityCentralIndexKey_0000890394 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2024-02-06" name="dei:AmendmentFlag" id="ixv-344">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-02-06" name="dei:EntityCentralIndexKey" id="ixv-345">0000890394</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="prso-20240206.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2024-02-06">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000890394</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-02-06</xbrli:startDate>
        <xbrli:endDate>2024-02-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_900_edei--DocumentType_c20240206__20240206_zS1yooEDctD9"><ix:nonNumeric contextRef="AsOf2024-02-06" name="dei:DocumentType" id="ixv-365">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event Reported):
<span id="xdx_90B_edei--DocumentPeriodEndDate_c20240206__20240206_zzLvi9aPIuGg"><ix:nonNumeric contextRef="AsOf2024-02-06" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="ixv-366">February 6, 2024</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_906_edei--EntityRegistrantName_c20240206__20240206_zCDMRfyszygd"><ix:nonNumeric contextRef="AsOf2024-02-06" name="dei:EntityRegistrantName" id="ixv-367">PERASO INC.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact Name of Registrant as Specified in Charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90C_edei--EntityFileNumber_c20240206__20240206_zBIRkGDXyfze"><ix:nonNumeric contextRef="AsOf2024-02-06" name="dei:EntityFileNumber" id="ixv-368">000-32929</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Commission File Number)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--EntityIncorporationStateCountryCode_c20240206__20240206_zCmOyHeVNKZf"><ix:nonNumeric contextRef="AsOf2024-02-06" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="ixv-369">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90F_edei--EntityTaxIdentificationNumber_c20240206__20240206_zOAfKmW7GrE5"><ix:nonNumeric contextRef="AsOf2024-02-06" name="dei:EntityTaxIdentificationNumber" id="ixv-370">77-0291941</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or Other&#160;Jurisdiction<br/> of Incorporation)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S. Employer <br/>
Identification&#160;Number)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90A_edei--EntityAddressAddressLine1_c20240206__20240206_zEBq7CFumTP2"><ix:nonNumeric contextRef="AsOf2024-02-06" name="dei:EntityAddressAddressLine1" id="ixv-371">2309 Bering Dr.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90A_edei--EntityAddressCityOrTown_c20240206__20240206_zONnC8V0Yxe3"><ix:nonNumeric contextRef="AsOf2024-02-06" name="dei:EntityAddressCityOrTown" id="ixv-372">San Jose</ix:nonNumeric></span>, <span id="xdx_90B_edei--EntityAddressStateOrProvince_c20240206__20240206_z2vWBlXCugpg"><ix:nonNumeric contextRef="AsOf2024-02-06" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="ixv-373">California</ix:nonNumeric></span> <span id="xdx_903_edei--EntityAddressPostalZipCode_c20240206__20240206_zG1lxqvcIEja"><ix:nonNumeric contextRef="AsOf2024-02-06" name="dei:EntityAddressPostalZipCode" id="ixv-374">95131</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices, with zip
code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(<span id="xdx_906_edei--CityAreaCode_c20240206__20240206_zAQ3zDLlACY9"><ix:nonNumeric contextRef="AsOf2024-02-06" name="dei:CityAreaCode" id="ixv-375">408</ix:nonNumeric></span>) <span id="xdx_905_edei--LocalPhoneNumber_c20240206__20240206_zQ6Psnyvwljk"><ix:nonNumeric contextRef="AsOf2024-02-06" name="dei:LocalPhoneNumber" id="ixv-376">418-7500</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant&#8217;s telephone number, including
area code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--WrittenCommunications_c20240206__20240206_zCPvsa81TP98"><ix:nonNumeric contextRef="AsOf2024-02-06" format="ixt:booleanfalse" name="dei:WrittenCommunications" id="ixv-377">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written&#160;communications&#160;pursuant&#160;to&#160;Rule&#160;425&#160;under&#160;the&#160;Securities&#160;Act&#160;(17&#160;CFR&#160;230.425)</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--SolicitingMaterial_c20240206__20240206_zSDnC2WQthri"><ix:nonNumeric contextRef="AsOf2024-02-06" format="ixt:booleanfalse" name="dei:SolicitingMaterial" id="ixv-378">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting&#160;material&#160;pursuant&#160;to&#160;Rule&#160;14a-12&#160;under&#160;the&#160;Exchange&#160;Act&#160;(17&#160;CFR&#160;240.14a-12)</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--PreCommencementTenderOffer_c20240206__20240206_zWpe28N9nZE3"><ix:nonNumeric contextRef="AsOf2024-02-06" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer" id="ixv-379">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement&#160;communications&#160;pursuant&#160;to&#160;Rule&#160;14d-2(b)&#160;under&#160;the&#160;Exchange&#160;Act&#160;(17&#160;CFR&#160;240.14d-2(b))</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--PreCommencementIssuerTenderOffer_c20240206__20240206_z87kNNP1yxhb"><ix:nonNumeric contextRef="AsOf2024-02-06" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer" id="ixv-380">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement&#160;communications&#160;pursuant&#160;to&#160;Rule&#160;13e-4(c)&#160;under&#160;the&#160;Exchange&#160;Act&#160;(17&#160;CFR&#160;240.13e-4(c))</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title of each class</span></td>
    <td style="vertical-align: top; width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading Symbol(s)</span></td>
    <td style="vertical-align: top; width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: top; width: 32%; padding-left: 11.65pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of each exchange on which registered</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--Security12bTitle_c20240206__20240206_zSIR81sybKK9"><ix:nonNumeric contextRef="AsOf2024-02-06" name="dei:Security12bTitle" id="ixv-381">Common Stock, par value $0.001 per share</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--TradingSymbol_c20240206__20240206_zJfkWSsq3Hz7"><ix:nonNumeric contextRef="AsOf2024-02-06" name="dei:TradingSymbol" id="ixv-382">PRSO</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The <span id="xdx_901_edei--SecurityExchangeName_c20240206__20240206_z19vyWuld3ml"><ix:nonNumeric contextRef="AsOf2024-02-06" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="ixv-383">Nasdaq</ix:nonNumeric></span> Stock Market LLC</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR&#167;230.405) or Rule 12b-2 of the Securities
Exchange Act of 1934 (17 CFR &#167;240.12b-2).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Emerging growth company <span id="xdx_900_edei--EntityEmergingGrowthCompany_c20240206__20240206_zkUzagSNjZa5"><ix:nonNumeric contextRef="AsOf2024-02-06" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany" id="ixv-384">&#9744;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>Item 1.01</b> <b>Entry
into a Material Definitive Agreement.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><span style="background-color: white">On
February 6, 2024, Peraso Inc. (the &#8220;Company&#8221;) entered into an underwriting agreement (the &#8220;Underwriting Agreement&#8221;)
with Ladenburg Thalmann &amp; Co. Inc., as the sole underwriter (the &#8220;Underwriter&#8221;), relating to the issuance and sale in
a public offering (the &#8220;Offering&#8221;) of: (i) 480,000 shares of the Company&#8217;s common stock, par value $0.001 per share
(the &#8220;Common Stock&#8221;), (ii) pre-funded warrants to purchase up to 1,424,760 shares of Common Stock, (iii) Series A warrants
to purchase up to 3,809,520 shares of Common Stock, (iv) Series B warrants to purchase up to 3,809,520 shares of Common Stock, and (v)
up to 285,714 additional shares of Common Stock, Series A warrants to purchase up to 571,428 shares of Common Stock and&#160;Series B
warrants to purchase up to 571,428 shares of Common Stock that may be purchased pursuant to a&#160;45-day&#160;option to purchase additional
securities granted to the Underwriter by the Company. The Underwriter partially exercised this option on February 7, 2024 for 82,500 shares
of Common Stock, Series A warrants to purchase up to 165,000 shares of Common Stock and Series B warrants to purchase up to 165,000 shares
of Common Stock. The combined public offering price of each share of Common Stock, together with the accompanying Series A warrants and
Series B warrants, was $2.10, less underwriting discounts and commissions. The combined public offering price of each pre-funded warrant,
together with the accompanying Series A warrants and Series B warrants, was $2.099, less underwriting discounts and commissions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">The
Offering, including the additional shares of Common Stock, Series A warrants and Series B warrants sold pursuant to the partial exercise
of the Underwriter&#8217;s option, closed on February 8, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><span style="background-color: white">The
net proceeds from the Offering, including the additional shares of Common Stock, Series A warrants and Series B warrants sold pursuant
to the partial exercise of the Underwriter&#8217;s option, after deducting underwriting discounts and commissions and other estimated
Offering expenses payable by the Company and excluding any net proceeds from the exercise of the Series A warrants, Series B warrants
and pre-funded warrants, were approximately $3.4 million. The Company intends to use the net proceeds from the Offering to fund operations
and for working capital and other general corporate purposes.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">The
Series A warrants and Series B warrants each have an exercise price of $2.25 per share and are immediately exercisable upon issuance.
The Series A warrants expire on the five-year anniversary of the date of issuance and the Series B warrants expire on the six-month anniversary
of the date of issuance.&#160; The pre-funded warrants have an exercise price of $0.001 per share, are exercisable immediately and may
be exercised at any time until all of the pre-funded warrants are exercised in full. The exercise price and number of shares of Common
Stock issuable upon exercise of the warrants is subject to appropriate adjustment in the event of stock dividends, stock splits, reorganizations
or similar events affecting the Common Stock and the exercise price. Subject to limited exceptions, a holder may not exercise any portion
of its warrants to the extent that the holder would beneficially own more than 4.99% (or, at the election of the holder prior to the date
of issuance, 9.99%) of the Company&#8217;s outstanding Common Stock after exercise.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">There
is no trading market available for the warrants on any securities exchange or nationally recognized trading system. The Company does not
intend to list the warrants on any securities exchange or nationally recognized trading system.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><span style="background-color: white">In
connection with the&#160;Offering, the Company and Equiniti Trust Company, LLC (&#8220;Equiniti&#8221;) entered into a Warrant Agency
Agreement (&#8220;Warrant Agreement&#8221;) pursuant to which Equiniti agreed to act as warrant agent with respect to the Series A warrants,
the Series B warrants and the pre-funded warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">The
Underwriting Agreement contains customary representations, warranties, covenants and closing conditions and customary indemnification
rights and obligations of the parties. Pursuant to the Underwriting Agreement, the Company has also agreed to be subject to a&#160;lock-up&#160;period
of 90 days following the date of the Underwriting Agreement in respect of certain equity issuances, subject to certain exceptions set
forth in the Underwriting Agreement, and a lock-up period of one year following the closing of the Offering with respect to entering or
effecting any issuance of the Company&#8217;s securities involving a variable rate transaction, as such term is defined in the Underwriting
Agreement; provided, however, that the Company is able to, at its sole discretion, after 90 days following the closing of the Offering,
enter into or issue shares of Common Stock in an &#8220;at-the-market&#8221; offering with the Underwriter as sales agent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><span style="background-color: white">In
addition, pursuant to the terms of the Underwriting Agreement, the officers and directors of the Company have entered into agreements
providing that each such person may not, without the prior written consent of the Underwriter, subject to certain exceptions, offer,
issue, sell, transfer or otherwise dispose of the Company&#8217;s securities for a period of 90 days following the date of the Underwriting
Agreement (the &#8220;Lock-Up Agreements&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">All
securities issued in the Offering (including the shares of Common Stock issuable from time to time upon exercise of the warrants) were
offered pursuant to the Company&#8217;s registration statement on Form&#160;S-1, as amended&#160;(File&#160;No.&#160;333-276247), which
became effective on February 6, 2024, including a prospectus contained therein (as amended, the &#8220;Registration Statement&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">On
February 8, 2024, pursuant to the Underwriting Agreement, the Company issued warrants to the Underwriter to purchase up to 139,108 shares
of Common Stock at an exercise price of $2.625, subject to adjustments (the &#8220;Underwriter Warrants&#8221;). The Underwriter Warrants
are exercisable at any time and from time to time, in whole or in part, until February 8, 2029, and have substantially similar terms to
the Series A warrants. The Underwriter Warrants and the shares of Common Stock underlying the Underwriter Warrants were registered as
a part of the Registration Statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Immediately after the Offering, there are outstanding 1,346,334 shares
of Common Stock and 95,093 exchangeable shares, which can be converted to Common Stock at any time by their respective holders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">The
Underwriting Agreement, form of Series A Warrant, form of Series B Warrant, form of Pre-Funded Warrant, form of Underwriter Warrant, form
of Lock-Up Agreement and the Warrant Agreement are filed as Exhibits 1.1, 4.1, 4.2, 4.3, 4.4, 10.1 and 10.2 hereto, respectively, and
are incorporated by reference into this Current Report on Form&#160;8-K. The foregoing description of the terms of the Underwriting Agreement,
form of Series A Warrant, form of Series B Warrant, form of Pre-Funded Warrant, form of Underwriter Warrant, form of Lock-Up Agreement
and the Warrant Agreement are qualified in their entirety by reference to such exhibits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>Item 7.01</b> <b>Regulation
FD Disclosure.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><span style="background-color: white">On
February 6, 2024, the Company issued a press release announcing the pricing of the Offering, a copy of which is furnished as Exhibit 99.1
to this Current Report on Form 8-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">On
February 8, 2024, the Company issued a press release announcing the closing of the Offering and the partial exercise of the Underwriter&#8217;s
option, a copy of which is furnished as Exhibit 99.2 to this Current Report on Form 8-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">In
accordance with General Instruction B.2 of Form 8-K, the information furnished under Item 7.01 of this Current Report on Form 8-K, including
Exhibits 99.1 and 99.2, is deemed to be &#8220;furnished&#8221; and shall not be deemed &#8220;filed&#8221; for the purpose of Section
18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall such information and Exhibits be deemed incorporated
by reference into any filing under the Securities Act or the Exchange Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>Item 9.01 Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>(d) Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1*</span></td>
    <td style="width: 1%; text-align: justify">&#160;</td>
    <td style="width: 90%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea193205ex1-1_perasoinc.htm">Underwriting Agreement, dated February 6, 2024, by and between the Company and Ladenburg Thalmann &amp; Co. Inc.</a></span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/890394/000121390024009832/ea192642ex4-15_perasoinc.htm">Form of Series A Warrant (incorporated by reference to Exhibit 4.15 to the Company&#8217;s Form S-1/A, as filed with the Securities and Exchange Commission on February 5, 2024)</a>.</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/890394/000121390024009832/ea192642ex4-16_perasoinc.htm">Form of Series B Warrant (incorporated by reference to Exhibit 4.16 to the Company&#8217;s Form S-1/A, as filed with the Securities and Exchange Commission on February 5, 2024)</a>.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/890394/000121390024005461/ea1915161ex4-16_perasoinc.htm">Form of Pre-Funded Warrant (incorporated by reference to Exhibit 4.16 to the Company&#8217;s Form S-1, as filed with the Securities and Exchange Commission on January 23, 2024)</a>.</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/890394/000121390024005461/ea1915161ex4-17_perasoinc.htm">Form of Underwriter Warrant (incorporated by reference to Exhibit 4.17 to the Company&#8217;s Form S-1, as filed with the Securities and Exchange Commission on January 23, 2024)</a>.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/890394/000121390024005461/ea1915161ex10-30_perasoinc.htm">Form of Lock-Up Agreement (incorporated by reference to Exhibit 10.30 to the Company&#8217;s Form S-1, as filed with the Securities and Exchange Commission on January 23, 2024)</a>.</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea193205ex10-2_perasoinc.htm">Warrant Agency Agreement, dated February 8, 2024, by and between the Company and Equiniti Trust Company, LLC.</a> </span></td></tr>
  <tr style="vertical-align: top; background-color: transparent">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea193205ex99-1_perasoinc.htm">Press Release of Peraso Inc., dated February 6, 2024</a>.</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.2</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea193205ex99-2_perasoinc.htm">Press Release of Peraso Inc., dated February 8, 2024.</a></span></td></tr>
  <tr style="vertical-align: top; background-color: transparent">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left">*</td><td style="text-align: justify">Certain schedules, exhibits and similar attachments have been
omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company hereby undertakes to furnish copies of such omitted materials supplementally
upon request by the Securities and Exchange Commission.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PERASO INC.</b></span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: February 9, 2024</span></td>
    <td style="width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:&#160;</span></td>
    <td style="vertical-align: top; width: 36%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ James
    Sullivan&#160;</span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="border-top: black 1.5pt solid; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">James Sullivan<br/>
Chief Financial Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">4</p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>











</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ea193205ex1-1_perasoinc.htm
<DESCRIPTION>UNDERWRITING AGREEMENT, DATED FEBRUARY 6, 2024, BY AND BETWEEN THE COMPANY AND LADENBURG THALMANN & CO. INC
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 1.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>480,000 SHARES <FONT STYLE="text-transform: uppercase">of
Common Stock </FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>PRE-FUNDED
WARRANTS EXERCIsABLE INTO 1,424,760 SHARES OF COMMON STOCK </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Series
A WARRANTS EXERCIsABLE INTO 3,809,520 SHARES OF cOMMON sTOCK AND</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Series
B WARRANTS EXERCIsABLE INTO 3,809,520 SHARES OF cOMMON sTOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PERASO INC.</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">UNDERWRITING AGREEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><BR>
February 6, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladenburg Thalmann &amp; Co. Inc.,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As the Representative of the</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">several Underwriters, if any, named in <U>Schedule I</U> hereto</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">c/o Ladenburg Thalmann &amp; Co. Inc.,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">640 Fifth Avenue, 4<SUP>th</SUP> Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, NY 10019</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned, Peraso Inc.,
a company incorporated under the laws of Delaware (the &ldquo;<U>Company</U>&rdquo;), hereby confirms its agreement (this &ldquo;<U>Agreement</U>&rdquo;)
with the several underwriters (such underwriters, including the Representative (as defined below), the &ldquo;<U>Underwriters</U>&rdquo;
and each an &ldquo;<U>Underwriter</U>&rdquo;) named in <U>Schedule I</U> hereto for which Ladenburg Thalmann &amp; Co. Inc. is acting
as representative to the several Underwriters (the &ldquo;<U>Representative</U>&rdquo; and if there are no Underwriters other than the
Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same
meaning as Underwriter) on the terms and conditions set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">It is understood that the
several Underwriters are to make a public offering of the Public Securities as soon as the Representative deems it advisable to do so.
The Public Securities are to be initially offered to the public at the public offering price set forth in the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">It is further understood that
you will act as the Representative for the Underwriters in the offering and sale of the Closing Securities and, if any, the Option Securities
in accordance with this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE I.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DEFINITIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.1   <U>Definitions</U>.
In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the meanings
set forth in this Section 1.1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(k).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means with respect to any Person, any other Person that, directly or indirectly through one or more intermediaries, controls or is controlled
by or is under common control with such Person as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized
or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;&nbsp;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally
are open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Closing Securities pursuant to Section 2.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing
Date</U>&rdquo; means the hour and the date on the Trading Day on which all conditions precedent to (i) the Underwriters&rsquo; obligations
to pay the Closing Purchase Price and (ii) the Company&rsquo;s obligations to deliver the Closing Securities, in each case, have been
satisfied or waived, but in no event later than 10:00 a.m. (New York City time) on the second (2<SUP>nd</SUP>) Trading Day following the
date hereof or at such earlier time as shall be agreed upon by the Representative and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing
Purchase Price</U>&rdquo; shall have the meaning ascribed to such term in Section 2.1(b), which aggregate purchase price shall be net
of the underwriting discounts and commissions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing
Securities</U>&rdquo; shall have the meaning ascribed to such term in Section 2.1(a)(iii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing
Shares</U>&rdquo; shall have the meaning ascribed to such term in Section 2.1(a)(i).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing
A Warrants</U>&rdquo; shall have the meaning ascribed to such term in Section 2.1(a)(iii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing
B Warrants</U>&rdquo; shall have the meaning ascribed to such term in Section 2.1(a)(iv).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Company
Auditor</U>&rdquo; means Weinberg &amp; Company, P.A. with offices located at 1925 Century Park East, Suite 1120, Los Angeles, CA 90067.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Company
Counsel</U>&rdquo; means Mitchell Silberberg &amp; Knupp LLP, with offices located at 437 Madison Ave., 25<SUP>th</SUP> Floor, New York,
NY 10022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Disclosure
Schedules</U>&rdquo; means the Disclosure Schedules of the Company delivered concurrently herewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Effective
Date</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(f).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>EGS</U>&rdquo;
means Ellenoff Grossman &amp; Schole LLP, with offices located at 1345 Avenue of the Americas, New York, New York 10105.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Execution
Date</U>&rdquo; shall mean the date on which the parties execute and enter into this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exempt
Issuance</U>&rdquo; means the issuance of (a) shares of Common Stock, options, restricted stock units or other equity awards to employees,
officers, directors or consultants of the Company pursuant to any stock or option plan or arrangement duly adopted for such purpose by
a majority of the non-employee members of the Board of Directors or a majority of the members of a committee of non-employee directors
established for such purpose for services rendered to the Company, (b) warrants issued to the Representative (and/or its designees) and
the securities upon the exercise of the warrants issued to the Representative (and/or its designees), securities upon the exercise or
exchange of or conversion of any Securities issued hereunder and/or other securities exercisable or exchangeable for or convertible into
shares of Common Stock issued and outstanding on the date of this Agreement, provided that such securities have not been amended since
the date of this Agreement to increase the number of such securities or to decrease the exercise price, exchange price or conversion price
of such securities (other than in connection with stock splits or combinations) or to extend the term of such securities, (c) securities
issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested directors of the Company, provided
that such securities are issued as &ldquo;restricted securities&rdquo; (as defined in Rule 144) if issued during the prohibition period
in Section 4.20(a) herein and carry no registration rights that require or permit the filing of any registration statement in connection
therewith within ninety (90) days following the Closing Date, and provided that any such issuance shall only be to a Person (or to the
equity holders of a Person) which is, itself or through its subsidiaries, an operating company or an owner of an asset in a business synergistic
with the business of the Company and shall provide to the Company additional benefits in addition to the investment of funds, but shall
not include a transaction in which the Company is issuing securities primarily for the purpose of raising capital or to an entity whose
primary business is investing in securities, and (d) the filing of any registration statement on Form S-8 with respect to the registration
of securities to be issued pursuant to any stock or option plan described in clause (a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>FINRA</U>&rdquo;
means the Financial Industry Regulatory Authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(i).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Indebtedness</U>&rdquo;
means (a) any liabilities for borrowed money or amounts owed in excess of $50,000 (other than trade accounts payable incurred in the ordinary
course of business), (b) all guaranties, endorsements and other contingent obligations in respect of indebtedness of others, whether or
not the same are or should be reflected in the Company&rsquo;s consolidated balance sheet (or the notes thereto), except guaranties by
endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business; and (c) the
present value of any lease payments in excess of $50,000 due under leases required to be capitalized in accordance with GAAP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Lock-Up
Agreements</U>&rdquo; means the lock-up agreements that are delivered on the date hereof by each of the Company&rsquo;s officers and directors,
in the form of <U>Exhibit B</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material
Adverse Effect</U>&rdquo; means (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document,
(ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the
Company and the Subsidiaries, taken as a whole or (iii) a material adverse effect on the Company&rsquo;s ability to perform in any material
respect on a timely basis its obligations under any Transaction Document.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Offering</U>&rdquo;
shall have the meaning ascribed to such term in Section 2.1(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Option</U>&rdquo;
shall have the meaning ascribed to such term in Section 2.2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Option
Closing Date</U>&rdquo; shall have the meaning ascribed to such term in Section 2.2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Option
Closing Purchase Price</U>&rdquo; shall have the meaning ascribed to such term in Section 2.2(b), which aggregate purchase price shall
be net of the underwriting discounts and commissions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Option
Securities</U>&rdquo; shall have the meaning ascribed to such term in Section 2.2(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Option
Shares</U>&rdquo; shall have the meaning ascribed to such term in Section 2.2(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Option
Warrants</U>&rdquo; shall have the meaning ascribed to such term in Section 2.2(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&ldquo;<U>Pre-Funded Warrants</U>&rdquo;
means, collectively, the Pre-Funded Common Stock purchase warrants delivered to the Underwriters in accordance with Section 2.1(a)(ii)
and Section 2.2, which Pre-Funded Warrants shall be exercisable immediately and shall be exercisable until exercised in full, in the form
of <U>Exhibit A-3</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Preliminary
Prospectus</U>&rdquo; means any preliminary prospectus relating to the Securities included in the Registration Statement or filed with
the Commission pursuant to Rule 424(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or, to the Company&rsquo;s knowledge, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prospectus</U>&rdquo;
means the final prospectus filed for the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prospectus
Supplement</U>&rdquo; means, if any, any supplement to the Prospectus complying with Rule 424(b) of the Securities Act that is filed with
the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Public
Securities</U>&rdquo; means, collectively, the Closing Securities and, if any, the Option Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration
Statement</U>&rdquo; means, collectively, the various parts of the registration statement prepared by the Company on Form S-1 (File No.
333-276247) with respect to the Securities, each as amended as of the date hereof, including the Prospectus and Prospectus Supplement,
if any, the Preliminary Prospectus, and all exhibits filed with or incorporated by reference into such registration statement, and includes
any Rule 462(b) Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Required
Approvals</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 424</U>&rdquo;
means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 462(b)
Registration Statement</U>&rdquo; means any registration statement prepared by the Company registering additional Public Securities, which
was filed with the Commission on or prior to the date hereof and became automatically effective pursuant to Rule 462(b) promulgated by
the Commission pursuant to the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>SEC Reports</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(i).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities</U>&rdquo;
means the Closing Securities, the Option Securities and the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Series
A Warrants</U>&rdquo; means, collectively, the Series A Common Stock purchase warrants delivered to the Underwriters in accordance with
Section 2.1(a)(iii) and Section 2.2, which Series A Warrants shall be exercisable immediately and have a term of exercise equal to five
years, in the form of <U>Exhibit A-1</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Series
B Warrants</U>&rdquo; means, collectively, the Series B Common Stock purchase warrants delivered to the Underwriters in accordance with
Section 2.1(a)(iv) and Section 2.2, which Series B Warrants shall be exercisable immediately and have a term of exercise equal to six
months, in the form of <U>Exhibit A-2</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Share
Purchase Price</U>&rdquo; shall have the meaning ascribed to such term in Section 2.1(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Shares</U>&rdquo;
means, collectively, the shares of Common Stock delivered to the Underwriters in accordance with Section 2.1(a)(i) and Section 2.2(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any significant subsidiary of the Company (as such term is defined in Rule 1-02 of Regulation S-X promulgated by the Commission)
and shall, where applicable, also include any direct or indirect subsidiary of the Company formed or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange, OTCQX or OTCQB (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement, the Warrants, the Warrant Agency Agreement, the Lock-Up Agreements, and any other documents
or agreements executed in connection with the transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transfer
Agent</U>&rdquo; means Equiniti Trust Company, LLC, the current transfer agent of the Company, with offices located at 1110 Centre Pointe
Curve, Suite 101, Mendota Heights, MN 55120-4101, and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrant
Agency Agreement</U>&rdquo; means the warrant agency agreement dated on or about the Closing Date, among the Company and the Transfer
Agent in the form of <U>Exhibit C</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrant
Purchase Price</U>&rdquo; shall have the meaning ascribed to such term in Section 2.1(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrant
Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrants</U>&rdquo;
means, collectively, the Series A Warrants, the Series B Warrants and the Pre-Funded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE II.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURCHASE AND SALE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.1   <U>Closing</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)   Upon
the terms and subject to the conditions set forth herein, the Company agrees to sell (i) in the aggregate 480,000 shares of Common Stock,
(ii) Pre-Funded Warrants exercisable for an aggregate of 1,424,760 shares of Common Stock, (iii) Series A Warrants exercisable for an
aggregate of 3,809,520 shares of Common Stock and (iv) Series B Warrants exercisable for an aggregate of 3,809,520 shares of Common Stock,
and each Underwriter agrees to purchase, severally and not jointly, at the Closing, the following securities of the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)   the
number of shares of Common Stock (the &ldquo;<U>Closing Shares</U>&rdquo;) set forth opposite the name of such Underwriter on <U>Schedule
I</U> hereof;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)   Pre-Funded
Warrants to purchase up to the number of shares of Common Stock set forth opposite the name of such Underwriter on <U>Schedule I</U> hereof
(the &ldquo;<U>Pre-Funded Warrants</U>&rdquo;), which Pre-Funded Warrants shall have an exercise price of $0.001, subject to adjustment
as provided therein;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii)   Series
A Warrants to purchase up to 200% of the sum of the number of Closing Shares and Pre-Funded Warrants, if any, set forth opposite the name
of such Underwriter on <U>Schedule I</U> hereof (the &ldquo;<U>Closing A Warrants</U>&rdquo;), which Series A Warrants shall have an exercise
price of $2.25, subject to adjustment as provided therein; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iv)   Series
B Warrants to purchase up to 200% of the sum of the number of Closing Shares and Pre-Funded Warrants, if any, set forth opposite the name
of such Underwriter on <U>Schedule I</U> hereof (the &ldquo;<U>Closing B Warrants</U>&rdquo; and, collectively with the Closing Shares,
the Closing A Warrants and Pre-Funded Warrants, the &ldquo;<U>Closing Securities</U>&rdquo;), which Series B Warrants shall have an exercise
price of $2.25, subject to adjustment as provided therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)   The
aggregate purchase price for the Closing Securities shall equal the amount set forth opposite the name of such Underwriter on <U>Schedule
I</U> hereto (the &ldquo;<U>Closing Purchase Price</U>&rdquo;). The combined purchase price for one Share, one Series A Warrant and one
Series B Warrant shall be $1.932, which shall be allocated as $1.93199816 per Share (the &ldquo;<U>Share Purchase Price</U>&rdquo;), $0.00000092
per Series A Warrant and $0.00000092 per Series B Warrant (each, the &ldquo;<U>Warrant Purchase Price</U>&rdquo;). The combined purchase
price for one Pre-Funded Warrant, one Series A Warrant and one Series B Warrant shall be $1.93108, which shall be allocated as $1.93107816
per Pre-Funded Warrant, $0.00000092 per Series A Warrant and $0.00000092 per Series B Warrant; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)
On the Closing Date, each Underwriter shall deliver or cause to be delivered to the Company, via wire transfer, immediately available
funds equal to such Underwriter&rsquo;s Closing Purchase Price and the Company shall deliver to, or as directed by, such Underwriter its
respective Closing Securities and the Company shall deliver the other items required pursuant to Section 2.3 deliverable at the Closing.
Upon satisfaction of the covenants and conditions set forth in Sections 2.3 and 2.4, the Closing shall occur at such location as the Company
and Representative shall mutually agree. The Public Securities are to be offered initially to the public at the offering price set forth
on the cover page of the Prospectus (the &ldquo;<U>Offering</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)   The
Company acknowledges and agrees that, with respect to any Notice(s) of Exercise (as defined in the Pre-Funded Warrants) delivered by a
Holder (as defined in the Pre-Funded Warrants) on or prior to 12:00 p.m. (New York City time) on the Closing Date, which Notice(s) of
Exercise may be delivered at any time after the time of execution of this Agreement, the Company shall deliver the Warrant Shares (as
defined in the Pre-Funded Warrants) subject to such notice(s) to the Holder by 4:00 p.m. (New York City time) on the Closing Date and
the Closing Date shall be the Warrant Share Delivery Date (as defined in the Pre-Funded Warrants). The Company acknowledges and agrees
that the Holders are third-party beneficiaries of this covenant of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.2   <U>Option
to Purchase Additional Securities</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)   For
the purposes of covering any over-allotments in connection with the distribution and sale of the Closing Securities, the Representative
is hereby granted an option (the &ldquo;<U>Option</U>&rdquo;) to purchase, in the aggregate, up to 285,714 shares of Common Stock (the
&ldquo;<U>Option Shares</U>&rdquo;), Series A Warrants to purchase up to 571,428 shares of Common Stock and/or Series B Warrants to purchase
up to 571,428 shares of Common Stock (the &ldquo;<U>Option Warrants</U>&rdquo; and, collectively with the Option Shares, the &ldquo;<U>Option
Securities</U>&rdquo;) which may be purchased in any combination of Option Shares and/or Option Warrants at the Share Purchase Price and/or
Warrant Purchase Price, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)   In
connection with an exercise of the Option, (a) the purchase price to be paid for the Option Shares is equal to the product of the Share
Purchase Price multiplied by the number of Option Shares to be purchased and (b) the purchase price to be paid for the Option Warrants
is equal to the product of the Warrant Purchase Price multiplied by the number of Option Warrants to be purchased (the aggregate purchase
price to be paid on an Option Closing Date, the &ldquo;<U>Option Closing Purchase Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)   The
Option granted pursuant to this Section 2.2 may be exercised by the Representative as to all (at any time) or any part (from time to time)
of the Option Securities within 45 days after the Execution Date. An Underwriter will not be under any obligation to purchase any Option
Securities prior to the exercise of the Option by the Representative. The Option granted hereby may be exercised by the giving of oral
notice to the Company from the Representative, which must be confirmed in writing by overnight mail or electronic transmission setting
forth the number of Option Shares and/or Option Warrants to be purchased and the date and time for delivery of and payment for the Option
Securities (each, an &ldquo;<U>Option Closing Date</U>&rdquo;), which will not be later than two (2) full Business Days after the date
of the notice or such other time as shall be agreed upon by the Company and the Representative at such place (including remotely by other
electronic transmission) as shall be agreed upon by the Company and the Representative. If such delivery and payment for the Option Securities
does not occur on the Closing Date, each Option Closing Date will be as set forth in the notice. Upon exercise of the Option, the Company
will become obligated to convey to the Underwriters, and, subject to the terms and conditions set forth herein, the Underwriters will
become obligated to purchase, the number of Option Shares and/or Option Warrants specified in such notice. The Representative may cancel
the Option at any time prior to the expiration of the Option by written notice to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.3   <U>Deliveries</U>.
The Company shall deliver or cause to be delivered to each Underwriter (if applicable) the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)   At
the Closing Date, the Closing Shares and, as to each Option Closing Date, if any, the applicable Option Shares, which shares shall be
delivered via The Depository Trust Company Deposit or Withdrawal at Custodian system for the accounts of the several Underwriters;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)   At
the Closing Date, the Pre-Funded Warrants via The Depository Trust Company Deposit or Withdrawal at Custodian system for the accounts
of the several Underwriters;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iii)   At
the Closing Date, the Closing A Warrants and, as to each Option Closing Date, if any, the applicable Option Warrants via The Depository
Trust Company Deposit or Withdrawal at Custodian system for the accounts of the several Underwriters;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iv)   At
the Closing Date, the Closing B Warrants and, as to each Option Closing Date, if any, the applicable Option Warrants via The Depository
Trust Company Deposit or Withdrawal at Custodian system for the accounts of the several Underwriters;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(v)   At
the Closing Date, and each Option Closing Date, if any, to the Representative only, a warrant to purchase up to a number of shares of
Common Stock equal to 7.0% of the Closing Shares, Pre-Funded Warrants and Option Shares issued on such Closing Date and Option Closing
Date, as applicable, for the account of the Representative (or its designees), which warrant shall have an exercise price of $2.625, subject
to adjustment as provided therein, and registered in the name of the Representative, otherwise on substantially the same terms as the
Series A Warrants;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(vi)   At
the Closing Date, the Warrant Agency Agreement duly executed by the parties thereto;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(vii)   At
the Closing Date, a legal opinion of Company Counsel addressed to the Underwriters, including, without limitation, a negative assurance
letter, in form and substance reasonably satisfactory to the Representative and as to each Option Closing Date, if any, a bring-down opinion
from Company Counsel, including, without limitation, a negative assurance letter, addressed to the Underwriters and in form and substance
reasonably satisfactory to the Representative;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(viii)   Contemporaneously
herewith, a cold comfort letter, addressed to the Underwriters and in form and substance reasonably satisfactory in all respects to the
Representative from the Company Auditor dated, respectively, as of the date of this Agreement and a bring-down letter dated as of the
Closing Date and each Option Closing Date, if any;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ix)   On
the Closing Date and on each Option Closing Date, the duly executed and delivered Officers&rsquo; Certificate, in form and substance reasonably
satisfactory to the Representative;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(x)   On
the Closing Date and on each Option Closing Date, the duly executed and delivered Secretary&rsquo;s Certificate, in form and substance
reasonably satisfactory to the Representative; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(xi)   Contemporaneously
herewith, the duly executed and delivered Lock-Up Agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.4   <U>Closing
Conditions</U>. The respective obligations of each Underwriter hereunder in connection with the Closing and each Option Closing Date are
subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)   the
accuracy in all material respects when made and on the date in question (other than representations and warranties of the Company already
qualified by materiality, which shall be true and correct in all respects) of the representations and warranties of the Company contained
herein (unless as of a specific date therein);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)   all
obligations, covenants and agreements of the Company required to be performed at or prior to the date in question shall have been performed
in all material respects;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iii)   the
delivery by the Company of the items set forth in Section 2.3 of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iv)   the
Registration Statement shall be effective on the date of this Agreement and at each of the Closing Date and each Option Closing Date,
if any, no stop order suspending the effectiveness of the Registration Statement shall have been issued and no proceedings for that purpose
shall have been instituted or shall, to the Company&rsquo;s knowledge, be pending or contemplated by the Commission and any request on
the part of the Commission for additional information shall have been complied with to the reasonable satisfaction of the Representative;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(v)   by
the Execution Date, if required by FINRA, the Underwriters shall have received clearance from FINRA as to the amount of compensation allowable
or payable to the Underwriters as described in the Registration Statement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(vi)   the
Closing Shares, the Option Shares and the Warrant Shares have been approved for listing on the Trading Market; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(vii)   prior
to and on each of the Closing Date and each Option Closing Date, if any: (i)&nbsp;there shall have been no material adverse change or
development involving a prospective material adverse change in the condition or prospects or the business activities, financial or otherwise,
of the Company from the latest dates as of which such condition is set forth in the Registration Statement and Prospectus; (ii)&nbsp;no
action suit or proceeding, at law or in equity, shall have been pending or, to the Company&rsquo;s knowledge, threatened against the Company
or any Affiliate of the Company before or by any court or federal or state commission, board or other administrative agency wherein an
unfavorable decision, ruling or finding may materially adversely affect the business, operations, prospects or financial condition or
income of the Company, except as set forth in the Registration Statement and Prospectus; (iii)&nbsp;no stop order shall have been issued
under the Securities Act and no proceedings therefor shall have been initiated or, to the Company&rsquo;s knowledge, threatened by the
Commission; and (iv)&nbsp;the Registration Statement and the Prospectus and any amendments or supplements thereto shall contain all material
statements which are required to be stated therein in accordance with the Securities Act and the rules and regulations thereunder and
shall conform in all material respects to the requirements of the Securities Act and the rules and regulations thereunder, and neither
the Registration Statement nor the Prospectus nor any amendment or supplement thereto shall contain any untrue statement of a material
fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances
under which they were made, not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE III.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REPRESENTATIONS AND WARRANTIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.1   <U>Representations
and Warranties of the Company</U>. Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall be deemed a part
hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure contained in the corresponding section
of the Disclosure Schedules, the Company represents and warrants to the Underwriters as of the Execution Date, as of the Closing Date
and as of each Option Closing Date, if any, as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)   <U>Subsidiaries</U>.
All of the direct and indirect Subsidiaries of the Company are set forth in the SEC Reports. Except as set forth on <U>Schedule 3.1(a)</U>,
the Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any
Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable
and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no Subsidiaries, all other references
to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)   <U>Organization
and Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing
and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to
own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary is in
violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational
or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign
corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification
necessary, except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected
to result in a Material Adverse Effect and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing
or seeking to revoke, limit or curtail such power and authority or qualification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)   <U>Authorization;
Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated
by this Agreement and each of the other Transaction Documents to which the Company is a party and otherwise to carry out its obligations
hereunder and thereunder. The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and
the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part
of the Company and no further action is required by the Company, the Board of Directors or the Company&rsquo;s stockholders in connection
herewith or therewith other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which
the Company is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with
the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance
with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium
and other laws of general application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to
the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution
provisions may be limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)   <U>No
Conflicts</U>. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which it
is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby do
not and will not (i) conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or articles of
incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that with
notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets
of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments, acceleration
or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing
a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property
or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in
a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority
to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any property
or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could not
have or reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)   <U>Filings,
Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to,
or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection
with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filing with the Commission
of the Prospectus, (ii) the submission of the Listing of Additional Shares Notification Form with the Trading Market with respect to the
Offering, (iii) the notices, forms and authorizations of The Depository Trust &amp; Clearing Corporation related to the account and transfer
of the Warrants and (iv) such filings as are required to be made under applicable state securities laws or blue sky laws or the rules
of FINRA (collectively, the &ldquo;<U>Required Approvals</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f)   <U>Registration
Statement</U>. The Company has filed with the Commission the Registration Statement, including any related Prospectus or Prospectuses,
for the registration of the Securities under the Securities Act, which Registration Statement has been prepared by the Company in all
material respects in conformity with the requirements of the Securities Act and the rules and regulations of the Commission under the
Securities Act. The Registration Statement has been declared effective by the Commission on February 6, 2024 (the &ldquo;<U>Effective
Date</U>&rdquo;). Any reference in this Agreement to the Registration Statement, the Preliminary Prospectus, the Prospectus or any Prospectus
Supplement shall be deemed to refer to and include the documents incorporated by reference therein, if any, which were filed under the
Exchange Act, on or before the date of this Agreement, or the issue date of the Preliminary Prospectus, the Prospectus or the Prospectus
Supplement, if any, as the case may be; and any reference in this Agreement to the terms &ldquo;amend,&rdquo; &ldquo;amendment&rdquo;
or &ldquo;supplement&rdquo; with respect to the Registration Statement, the Prospectus or the Prospectus Supplement shall be deemed to
refer to and include the filing of any document under the Exchange Act after the date of this Agreement, or the issue date of the Preliminary
Prospectus, the Prospectus or the Prospectus Supplement, as the case may be, deemed to be incorporated therein by reference. All references
in this Agreement to financial statements and schedules and other information which is &ldquo;contained,&rdquo; &ldquo;included,&rdquo;
&ldquo;described,&rdquo; &ldquo;referenced,&rdquo; &ldquo;set forth&rdquo; or &ldquo;stated&rdquo; in the Registration Statement, the
Preliminary Prospectus, the Prospectus or the Prospectus Supplement (and all other references of like import) shall be deemed to mean
and include all such financial statements and schedules and other information which is or is deemed to be incorporated by reference in
the Registration Statement, the Preliminary Prospectus, the Prospectus or the Prospectus Supplement, as the case may be. No stop order
suspending the effectiveness of the Registration Statement or the use of the Prospectus or any Prospectus Supplement has been issued,
and no proceeding for any such purpose is pending or has been initiated or, to the Company&rsquo;s knowledge, is threatened by the Commission.
For purposes of this Agreement, &ldquo;<U>free writing prospectus</U>&rdquo; has the meaning set forth in Rule 405 under the Securities
Act. The Company will not, without the prior consent of the Representative, prepare, use or refer to, any free writing prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g)   <U>Issuance
of Securities</U>. The Securities are duly authorized and, when issued and paid for in accordance with the applicable Transaction Documents,
will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company. The Warrant Shares,
when issued in accordance with the terms of the Warrants and the shares of Common Stock underlying the warrants to be issued to the Representative,
will be validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company. The Company has reserved from
its duly authorized capital stock the maximum number of shares of Common Stock issuable pursuant to this Agreement and the Warrants. The
holder of the Securities will not be subject to personal liability by reason of being such holders. The Securities are not and will not
be subject to the preemptive rights of any holders of any security of the Company or similar contractual rights granted by the Company.
All corporate action required to be taken for the authorization, issuance and sale of the Securities has been duly and validly taken.
The Securities conform in all material respects to all statements with respect thereto contained in the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(h)   <U>Capitalization</U>.
The capitalization of the Company is as set forth in the Prospectus. The Company has not issued any capital stock since its most recently
filed periodic report under the Exchange Act that is not described in the Prospectus, other than pursuant to the Company&rsquo;s equity
incentive plans, the issuance of shares of Common Stock to employees pursuant to the Company&rsquo;s employee stock purchase plans, pursuant
to the conversion and/or exercise of Common Stock Equivalents outstanding as of the date of the most recently filed periodic report under
the Exchange Act, and in connection with the rounding of fractional shares as a result of the 1-for-40 reverse stock split of the Company&rsquo;s
issued and outstanding Common Stock effected on January 2, 2024. No Person has any right of first refusal, preemptive right, right of
participation, or any similar right to participate in the transactions contemplated by the Transaction Documents. Except as a result of
the purchase and sale of the Securities, or as set forth on <U>Schedule 3.1(h)</U>, there are no outstanding options, warrants, scrip
rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible
into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire, any shares of Common Stock or the
capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or
may become bound to issue additional shares of Common Stock or Common Stock Equivalents or the capital stock of any Subsidiary. The issuance
and sale of the Securities will not obligate the Company or any Subsidiary to issue shares of Common Stock or other securities to any
Person (other than the Underwriters). Except as a result of the purchase and sale of the Securities, or as described on <U>Schedule 3.1(h)</U>,
there are no outstanding securities or instruments of the Company or any Subsidiary with any provision that adjusts the exercise, conversion,
exchange or reset price of such security or instrument upon an issuance of securities by the Company or any Subsidiary. Except as a result
of the purchase and sale of the Securities, or as described on <U>Schedule 3.1(h)</U>, there are no outstanding securities or instruments
of the Company or any Subsidiary that contain any redemption or similar provisions, and there are no contracts, commitments, understandings
or arrangements by which the Company or any Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary.
The Company does not have any stock appreciation rights or &ldquo;phantom stock&rdquo; plans or agreements or any similar plan or agreement.
All of the outstanding shares of capital stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have
been issued in compliance with all federal and state securities laws, and none of such outstanding shares was issued in violation of any
preemptive rights or similar rights to subscribe for or purchase securities. The authorized shares of the Company conform in all material
respects to all statements relating thereto contained in the Registration Statement and the Prospectus. The offers and sales of the Company&rsquo;s
securities were at all relevant times either registered under the Securities Act and the applicable state securities or Blue Sky laws
or, based in part on the representations and warranties of the purchasers, exempt from such registration requirements. No further approval
or authorization of any stockholder, the Board of Directors or others is required for the issuance and sale of the Securities. There are
no stockholders agreements, voting agreements or other similar agreements with respect to the Company&rsquo;s capital stock to which the
Company is a party or, to the knowledge of the Company, between or among any of the Company&rsquo;s stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)   <U>SEC
Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required to be
filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the twelve
months preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the
foregoing materials, including the exhibits thereto and documents incorporated by reference therein, together with the Prospectus and
the Prospectus Supplement, being collectively referred to herein as the &ldquo;<U>SEC Reports</U>&rdquo;) on a timely basis or has received
a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their
respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act,
as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material
fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which
they were made, not misleading. The Company has never been an issuer subject to Rule 144(i) under the Securities Act. The financial statements
of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations
of the Commission with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance
with United States generally accepted accounting principles applied on a consistent basis during the periods involved (&ldquo;<U>GAAP</U>&rdquo;),
except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements
may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and
its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended,
subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments. The agreements and documents described
in the Registration Statement, the Prospectus, the Prospectus Supplement and the SEC Reports conform to the descriptions thereof contained
therein and there are no agreements or other documents required by the Securities Act and the rules and regulations thereunder to be described
in the Registration Statement, the Prospectus, the Prospectus Supplement or the SEC Reports or to be filed with the Commission as exhibits
to the Registration Statement, that have not been so described or filed. Each agreement or other instrument (however characterized or
described) to which the Company is a party or by which it is or may be bound or affected and (i)&nbsp;that is referred to in the Registration
Statement, the Prospectus, the Prospectus Supplement or the SEC Reports, or (ii)&nbsp;is material to the Company&rsquo;s business, has
been duly authorized and validly executed by the Company, is in full force and effect in all material respects and is enforceable against
the Company and, to the Company&rsquo;s knowledge, the other parties thereto, in accordance with its terms, except (x)&nbsp;as such enforceability
may be limited by bankruptcy, insolvency, reorganization or similar laws affecting creditors&rsquo; rights generally, (y)&nbsp;as enforceability
of any indemnification or contribution provision may be limited under the federal and state securities laws, and (z)&nbsp;that the remedy
of specific performance and injunctive and other forms of equitable relief may be subject to the equitable defenses and to the discretion
of the court before which any proceeding therefore may be brought. None of such agreements or instruments has been assigned by the Company,
and neither the Company nor, to the best of the Company&rsquo;s knowledge, any other party is in default thereunder and, to the best of
the Company&rsquo;s knowledge, no event has occurred that, with the lapse of time or the giving of notice, or both, would constitute a
default thereunder. To the best of the Company&rsquo;s knowledge, performance by the Company of the material provisions of such agreements
or instruments will not result in a violation of any existing applicable law, rule, regulation, judgment, order or decree of any governmental
agency or court, domestic or foreign, having jurisdiction over the Company or any of its assets or businesses, including, without limitation,
those relating to environmental laws and regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(j)   <U>Material
Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included within
the SEC Reports, except as specifically disclosed in a subsequent SEC Report filed prior to the date hereof, (i) there has been no event,
occurrence or development that has had or that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has
not incurred any liabilities (contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course
of business consistent with past practice and (B) liabilities not required to be reflected in the Company&rsquo;s financial statements
pursuant to GAAP or disclosed in filings made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the
Company has not declared or made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or
made any agreements to purchase or redeem any shares of its capital stock, (v) the Company has not issued any equity securities to any
officer, director or Affiliate, except pursuant to existing Company equity incentive plans and (vi) no officer or director of the Company
has resigned from any position with the Company. The Company does not have pending before the Commission any request for confidential
treatment of information. Except for the issuance of the Securities contemplated by this Agreement, no event, liability, fact, circumstance,
occurrence or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries
or their respective businesses, prospects, properties, operations, assets or financial condition that would be required to be disclosed
by the Company under applicable securities laws at the time this representation is made or deemed made that has not been publicly disclosed
at least 1 Trading Day prior to the date that this representation is made. Unless otherwise disclosed in an SEC Report filed prior to
the date hereof, the Company has not: (i)&nbsp;issued any securities or incurred any liability or obligation, direct or contingent, for
borrowed money; or (ii)&nbsp;declared or paid any dividend or made any other distribution on or in respect to its capital stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(k)   <U>Litigation</U>.
There is no action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of the Company, threatened
against or affecting the Company, any Subsidiary or any of their respective properties before or by any court, arbitrator, governmental
or administrative agency or regulatory authority (federal, state, county, local or foreign) (collectively, an &ldquo;<U>Action</U>&rdquo;)
which (i) adversely affects or challenges the legality, validity or enforceability of any of the Transaction Documents or the Securities
or (ii) could, if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the
Company nor any Subsidiary, nor, to the Company&rsquo;s knowledge, any current director or officer thereof, is or has been the subject
of any Action involving a claim of violation of or liability under federal or state securities laws or a claim of breach of fiduciary
duty. There has not been, and to the knowledge of the Company, there is not pending or contemplated, any investigation by the Commission
involving the Company or any current or former director or officer of the Company. The Commission has not issued any stop order or other
order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary under the Exchange Act or the
Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(l)   <U>Labor
Relations</U>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company,
which could reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo; employees
is a member of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither the Company
nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their relationships
with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary, is, or is now expected
to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement
or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third party, and the continued
employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability with respect to any
of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal, state, local and foreign laws and
regulations relating to employment and employment practices, terms and conditions of employment and wages and hours, except where the
failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(m)   <U>Compliance</U>.
Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that has not been waived
that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or
any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement
or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default
or violation has been waived), (ii) is in violation of any judgment, decree or order of any court, arbitrator or other governmental authority
or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation
all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality
and safety and employment and labor matters, except in each case as could not have or reasonably be expected to result in a Material Adverse
Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(n)   <U>Regulatory
Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal,
state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports, except
where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (each, a &ldquo;<U>Material
Permit</U>&rdquo;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or modification
of any Material Permit. The disclosures in the Registration Statement concerning the effects of Federal, State, local and all foreign
regulation on the Company&rsquo;s business as currently contemplated are correct in all material respects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(o)   <U>Title
to Assets</U>. The Company and the Subsidiaries have good and marketable title in fee simple to, or have valid and marketable rights to
lease or otherwise use, all real property and all personal property that is material to the business of the Company and the Subsidiaries,
in each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially
interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii) Liens for the payment
of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP, and the payment of which
is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries
are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance, except
where failure to be in compliance could not reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(p) <U>Intellectual
Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications,
service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights
necessary or required for use in connection with their respective businesses as described in the SEC Reports and which the failure to
do so could have a Material Adverse Effect (collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;). None of, and neither
the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights has expired,
terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this Agreement,
except for Intellectual Property Rights that are within two years of the end of their term or the abandonment of which would not have
a Material Adverse Effect. Neither the Company nor any Subsidiary has received, since the date of the latest unaudited financial statements
included within the SEC Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate
or infringe upon the rights of any Person, except as could not have or reasonably be expected to have a Material Adverse Effect. To the
knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person
of any of the Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy,
confidentiality and value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(q)   <U>Insurance</U>.
The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such
amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including, but not limited
to, directors and officers insurance coverage. Neither the Company nor any Subsidiary has any reason to believe that it will not be able
to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may
be necessary to continue its business without a significant increase in cost.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(r)   <U>Transactions
With Affiliates and Employees</U>. Except as set forth in the SEC Reports, none of the officers or directors of the Company or any Subsidiary
and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to any transaction with
the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract, agreement or other
arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from, providing
for the borrowing of money from or lending of money to or otherwise requiring payments to or from, any officer, director or such employee
or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial interest or is
an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for (i) payment of salary,
bonus or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee
benefits, including equity awards under any equity incentive plan of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(s)   <U>Sarbanes-Oxley;
Internal Accounting Controls</U>. The Company and the Subsidiaries are in compliance in all material respects with any and all applicable
requirements of the Sarbanes-Oxley Act of 2002 that are effective as of the date hereof, and any and all applicable rules and regulations
promulgated by the Commission thereunder that are effective as of the date hereof and as of the Closing Date. The Company and the Subsidiaries
maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance
with management&rsquo;s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial
statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management&rsquo;s
general or specific authorization, and (iv) the recorded accountability for assets is compared with the existing assets at reasonable
intervals and appropriate action is taken with respect to any differences. The Company and the Subsidiaries have established disclosure
controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such
disclosure controls and procedures to ensure that information required to be disclosed by the Company in the reports it files or submits
under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&rsquo;s rules
and forms. The Company&rsquo;s certifying officers have evaluated the effectiveness of the disclosure controls and procedures of the Company
and the Subsidiaries as of the end of the period covered by the most recently filed periodic report under the Exchange Act (such date,
the &ldquo;<U>Evaluation Date</U>&rdquo;). The Company presented in its most recently filed periodic report under the Exchange Act the
conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations as
of the Evaluation Date. Since the Evaluation Date, there have been no changes in the internal control over financial reporting (as such
term is defined in the Exchange Act) of the Company and its Subsidiaries that have materially affected, or is reasonably likely to materially
affect, the internal control over financial reporting of the Company and its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(t)   <U>Certain Fees</U>.
Except as set forth in the Prospectus, no brokerage or finder&rsquo;s fees or commissions are or will be payable by the Company, any
Subsidiary or Affiliate of the Company to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank
or other Person with respect to the transactions contemplated by the Transaction Documents. To the Company&rsquo;s knowledge, there are
no other arrangements, agreements or understandings of the Company or, to the Company&rsquo;s knowledge, any of its stockholders that
may affect the Underwriters&rsquo; compensation, as determined by FINRA. Other than as set forth in <U>Schedule 3.1(t)</U>, or in connection
with the August 2023 engagement of the investment bank to assist with the exploration of strategic alternatives, the Company has not
made any direct or indirect payments (in cash, securities or otherwise) to: (i) any person, as a finder&rsquo;s fee, consulting fee or
otherwise, in consideration of such person raising capital for the Company or introducing to the Company persons who raised or provided
capital to the Company; (ii) any FINRA member; or (iii) any person or entity that has any direct or indirect affiliation or association
with any FINRA member, within the twelve months prior to the Execution Date. None of the net proceeds of the Offering will be paid by
the Company to any participating FINRA member or its affiliates, except as specifically authorized herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(u)   <U>Investment Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment
for the Securities will not be or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company
Act of 1940, as amended. The Company shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo;
subject to registration under the Investment Company Act of 1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(v)   <U>Registration
Rights</U>. Except as set forth on <U>Schedule 3.1(v)</U>, no Person has any right to cause the Company or any Subsidiary to effect the
registration under the Securities Act of any securities of the Company or any Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(w)   <U>Listing
and Maintenance Requirements</U>. The Common Stock is registered pursuant to Section 12(b) of the Exchange Act, and the Company has taken
no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under
the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating such registration. Except
as disclosed in the SEC Reports, the Company has not, in the 12 months preceding the date hereof, received notice from any Trading Market
on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance
requirements of such Trading Market. The Company is, and has no reason to believe that it will not in the foreseeable future continue
to be, in compliance with all such listing and maintenance requirements. The Common Stock is currently eligible for electronic transfer
through the Depository Trust Company or another established clearing corporation and the Company is current in payment of the fees of
the Depository Trust Company (or such other established clearing corporation) in connection with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(x)   <U>Application
of Takeover Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order to render inapplicable
any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar
anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents) or the laws of its state
of incorporation that is or could become applicable as a result of the Underwriters and the Company fulfilling their obligations or exercising
their rights under the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(y)   <U>Disclosure; 10b-5.</U> The Registration Statement (and any further documents to be filed with the Commission
in connection with the Offering) contains all exhibits and schedules as required by the Securities Act. Each of the Registration Statement
and any post-effective amendment thereto, if any, at the time it became effective, complied in all material respects with the Securities
Act and the Exchange Act and the applicable rules and regulations under the Securities Act and did not and, as amended or supplemented,
if applicable, will not, contain any untrue statement of a material fact or omit to state a material fact required to be stated therein
or necessary to make the statements therein not misleading. The Preliminary Prospectus, Prospectus and the Prospectus Supplement, each
as of its respective date, comply in all material respects with the Securities Act and the Exchange Act and the applicable rules and
regulations. Each of the Preliminary Prospectus, Prospectus and the Prospectus Supplement, as amended or supplemented, did not and will
not contain as of the date thereof any untrue statement of a material fact or omit to state a material fact necessary in order to make
the statements therein, in light of the circumstances under which they were made, not misleading. The SEC Reports, when they were filed
with the Commission, conformed in all material respects to the requirements of the Exchange Act and the applicable rules and regulations,
and none of such documents, when they were filed with the Commission, contained any untrue statement of a material fact or omitted to
state a material fact necessary to make the statements therein (with respect to the SEC Reports incorporated by reference in the Preliminary
Prospectus, Prospectus or Prospectus Supplement), in light of the circumstances under which they were made not misleading; and any further
documents so filed and incorporated by reference in the Preliminary Prospectus, Prospectus or Prospectus Supplement, when such documents
are filed with the Commission, will conform in all material respects to the requirements of the Exchange Act and the applicable rules
and regulations, as applicable, and will not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements therein, in light of the circumstances under which they were made not misleading. No post-effective amendment
to the Registration Statement reflecting any facts or events arising after the date thereof which represent, individually or in the aggregate,
a fundamental change in the information set forth therein is required to be filed with the Commission. There are no documents required
to be filed with the Commission in connection with the transaction contemplated hereby that (x) have not been filed as required pursuant
to the Securities Act or (y) will not be filed within the requisite time period. There are no contracts or other documents required to
be described in the Preliminary Prospectus, Prospectus or Prospectus Supplement, or to be filed as exhibits or schedules to the Registration
Statement, which have not been described or filed as required. The press releases disseminated by the Company during the twelve months
preceding the date of this Agreement taken as a whole do not contain any untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they
were made and when made, not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(z)   <U>No
Integrated Offering</U>. Neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or
indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause
this offering of the Securities to be integrated with prior offerings by the Company for purposes of any applicable shareholder approval
provisions of any Trading Market on which any of the securities of the Company are listed or designated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(aa) <U>Solvency</U>.
Based on the consolidated financial condition of the Company as of the Closing Date and as of the Option Closing Date, after giving
effect to the receipt by the Company of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the
Company&rsquo;s assets exceeds the amount that will be required to be paid on or in respect of the Company&rsquo;s existing debts
and other liabilities (including known contingent liabilities) as they mature, (ii) the Company&rsquo;s assets do not constitute
unreasonably small capital to carry on its business as now conducted and as proposed to be conducted including its capital needs
taking into account the particular capital requirements of the business conducted by the Company, consolidated and projected capital
requirements and capital availability thereof, and (iii) the current cash flow of the Company, together with the proceeds the
Company would receive, were it to liquidate all of its assets, after taking into account all anticipated uses of the cash, may be
insufficient to pay all amounts on or in respect of its liabilities when such amounts are required to be paid. The Company does not
intend to incur debts beyond its ability to pay such debts as they mature (taking into account the timing and amounts of cash to be
payable on or in respect of its debt). The Company has no knowledge of any facts or circumstances which lead it to believe that it
will file for reorganization or liquidation under the bankruptcy or reorganization laws of any jurisdiction within six months from
the Closing Date or the Option Closing Date, as applicable. The SEC Reports sets forth as of the date hereof all outstanding secured
and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments. Neither the
Company nor any Subsidiary is in default with respect to any Indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(bb) <U>Tax Status</U>.
Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect,
the Company and its Subsidiaries each (i) has made or filed, or secured all extensions for the filing of, all applicable United States
federal, state and local income and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction
to which it is subject, (ii) has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined
to be due on such returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment
of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid
taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any
Subsidiary know of no basis for any such claim. The provisions for taxes payable, if any, shown on the financial statements filed with
or as part of the Registration Statement are sufficient for all material accrued and unpaid taxes, whether or not disputed, and for all
periods to and including the dates of such consolidated financial statements. The term &ldquo;taxes&rdquo; mean all federal, state, local,
foreign, and other net income, gross income, gross receipts, sales, use, ad valorem, transfer, franchise, profits, license, lease, service,
service use, withholding, payroll, employment, excise, severance, stamp, occupation, premium, property, windfall profits, customs, duties
or other taxes, fees, assessments, or charges of any kind whatsoever, together with any interest and any penalties, additions to tax,
or additional amounts with respect thereto. The term &ldquo;returns&rdquo; means all returns, declarations, reports, statements, and other
documents required to be filed in respect to taxes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(cc) <U>Foreign
Corrupt Practices</U>. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or other
person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful contributions, gifts,
entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign
or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii)
failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf of which the
Company is aware) which is in violation of law, or (iv) violated in any material respect any provision of FCPA. The Company has taken
reasonable steps to ensure that its accounting controls and procedures are sufficient to cause the Company to comply in all material respects
with the FCPA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(dd) <U>Accountants</U>.
To the knowledge and belief of the Company, the Company Auditor (i) is an independent registered public accounting firm as required by
the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company&rsquo;s Annual
Report for the fiscal year ended December 31, 2023. Except as set forth in the SEC Reports, the Company Auditor has not, during the periods
covered by the financial statements included in the Prospectus, provided to the Company any non-audit services, as such term is used in
Section 10A(g) of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ee) <U>Reserved</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ff) <U>Stock
Option Plans</U>. Each stock option granted by the Company under the Company&rsquo;s equity incentive plans was granted (i) in accordance
with the terms of the Company&rsquo;s equity incentive plans and (ii) with an exercise price at least equal to the fair market value of
the Common Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted under
the Company&rsquo;s equity incentive plans has been backdated. The Company has not knowingly granted, and there is no and has been no
Company policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with,
the release or other public announcement of material information regarding the Company or its Subsidiaries or their financial results
or prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(gg) <U>Office
of Foreign Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any director, officer, agent, employee
or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets
Control of the U.S. Treasury Department.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(hh) <U>U.S.
Real Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within the meaning
of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon the Representative&rsquo;s request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)   <U>Bank
Holding Company Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act of 1956,
as amended (the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the &ldquo;<U>Federal
Reserve</U>&rdquo;). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly, five percent
(5%) or more of the outstanding shares of any class of voting securities or twenty-five percent (25%) or more of the total equity of a
bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries
or Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and
to regulation by the Federal Reserve.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(jj) <U>Money
Laundering</U>. The operations of the Company and its Subsidiaries are and have been conducted at all times in material compliance with
applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended,
applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the &ldquo;<U>Money Laundering Laws</U>&rdquo;),
and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or
any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(kk) <U>D&amp;O
Questionnaires</U>. To the Company&rsquo;s knowledge, all information contained in the questionnaires completed by each of the Company&rsquo;s
directors and officers immediately prior to the Offering and in the Lock-Up Agreement provided to the Underwriters is true and correct
in all material respects and the Company has not become aware of any information which would cause the information disclosed in such questionnaires
to become inaccurate and incorrect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ll) <U>FINRA
Affiliation</U>. To the Company&rsquo;s knowledge, no officer, director or any beneficial owner of 5% or more of the Company&rsquo;s unregistered
securities has any direct or indirect affiliation or association with any FINRA member (as determined in accordance with the rules and
regulations of FINRA) that is participating in the Offering. The Company will advise the Representative and EGS if it learns that any
officer, director or owner of 5% or more of the Company&rsquo;s outstanding shares of Common Stock or Common Stock Equivalents is or becomes
an affiliate or associated person of a FINRA member firm.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(mm) <U>Officers&rsquo;
Certificate</U>. Any certificate signed by any duly authorized officer of the Company and delivered to the Representative or EGS shall
be deemed a representation and warranty by the Company to the Underwriters as to the matters covered thereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(nn) <U>Board
of Directors</U>. The Board of Directors is comprised of the persons set forth under the heading of the Prospectus captioned &ldquo;Management.&rdquo;
The qualifications of the persons serving as board members and the overall composition of the Board of Directors comply with the Sarbanes-Oxley
Act of 2002 and the rules promulgated thereunder applicable to the Company and the rules of the Trading Market. At least one member of
the Board of Directors qualifies as a &ldquo;financial expert&rdquo; as such term is defined under the Sarbanes-Oxley Act of 2002 and
the rules promulgated thereunder and the rules of the Trading Market. In addition, at least a majority of the persons serving on the Board
of Directors qualify as &ldquo;independent&rdquo; as defined under the rules of the Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(oo)   <U>Cybersecurity</U>.&nbsp;
(i)(x) There has been no material security breach or other compromise of or relating to any of the Company&rsquo;s or any Subsidiary&rsquo;s
information technology and computer systems, networks, hardware, software, data (including the data of its respective customers, employees,
suppliers, vendors and any third party data maintained by or on behalf of it), equipment or technology (collectively, &ldquo;<U>IT Systems
and Data</U>&rdquo;) and (y) the Company and the Subsidiaries have not been notified of, and has no knowledge of any event or condition
that would reasonably be expected to result in, any material security breach or other compromise to its IT Systems and Data; (ii) the
Company and the Subsidiaries are presently in compliance in all material respects with all applicable laws or statutes and all judgments,
orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations
relating to the privacy and security of IT Systems and Data and to the protection of such IT Systems and Data from unauthorized use, access,
misappropriation or modification, except as would not, individually or in the aggregate, have a Material Adverse Effect; (iii)&nbsp;the
Company and the Subsidiaries have implemented and maintained commercially reasonable safeguards to maintain and protect its material confidential
information and the integrity, continuous operation, redundancy and security of all IT Systems and Data; and (iv) the Company and the
Subsidiaries have implemented backup and disaster recovery technology consistent with industry standards and practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(pp) <U>Compliance
with Data Privacy Laws</U>. (i) To the Company&rsquo;s knowledge, the Company and the Subsidiaries are, and at all times during the last
three (3) years were, in compliance with all applicable state, federal and foreign data privacy and security laws and regulations, including,
without limitation, the European Union General Data Protection Regulation (&ldquo;GDPR&rdquo;) (EU 2016/679) (collectively, &ldquo;Privacy
Laws&rdquo;); (ii) the Company and the Subsidiaries have in place, comply with, and take appropriate steps reasonably designed to ensure
compliance with their policies and procedures relating to data privacy and security and the collection, storage, use, disclosure, handling
and analysis of Personal Data (as defined below) (the &ldquo;Policies&rdquo;); (iii) the Company provides accurate notice of its applicable
Policies to its customers, employees, third party vendors and representatives as required by the Privacy Laws; and (iv) applicable Policies
provide accurate and sufficient notice of the Company&rsquo;s then-current privacy practices relating to its subject matter, and do not
contain any material omissions of the Company&rsquo;s then-current privacy practices, as required by Privacy Laws. &ldquo;Personal Data&rdquo;
means (i) a natural person&rsquo;s name, street address, telephone number, email address, photograph, social security number, bank information,
or customer or account number; (ii) any information which would qualify as &ldquo;personally identifying information&rdquo; under the
Federal Trade Commission Act, as amended; (iii) &ldquo;personal data&rdquo; as defined by GDPR; and (iv) any other piece of information
that allows the identification of such natural person, or his or her family, or permits the collection or analysis of any identifiable
data related to an identified person&rsquo;s health or sexual orientation. (i) None of such disclosures made or contained in any of the
Policies have been inaccurate, misleading, or deceptive in violation of any Privacy Laws and (ii) the execution, delivery and performance
of the Transaction Documents will not result in a breach of any Privacy Laws or Policies. Neither the Company nor the Subsidiaries (i)
to the knowledge of the Company, has received written notice of any actual or potential liability of the Company or the Subsidiaries under,
or actual or potential violation by the Company or the Subsidiaries of, any of the Privacy Laws; (ii) is currently conducting or paying
for, in whole or in part, any investigation, remediation or other corrective action pursuant to any regulatory request or demand pursuant
to any Privacy Law; or (iii) is a party to any order, decree, or agreement by or with any court or arbitrator or governmental or regulatory
authority that imposed any obligation or liability under any Privacy Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(qq) <U>Environmental
Laws</U>. The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating to pollution
or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata),
including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or
hazardous substances or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;) into the environment, or otherwise relating to
the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well as
all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders, permits,
plans or regulations, issued, entered, promulgated or approved thereunder (&ldquo;<U>Environmental Laws</U>&rdquo;); (ii) have received
all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses; and
(iii) are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i), (ii) and (iii),
the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-underline-style: double">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE IV.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OTHER AGREEMENTS OF THE PARTIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.1   <U>Amendments
to Registration Statement</U>. The Company has delivered, or will as promptly as practicable deliver, to the Underwriters complete conformed
copies of the Registration Statement and of each consent and certificate of experts, as applicable, filed as a part thereof, and conformed
copies of the Registration Statement (without exhibits), the Prospectus, as amended or supplemented, in such quantities and at such places
as an Underwriter reasonably requests. Neither the Company nor any of its directors and officers has distributed and none of them will
distribute, prior to the Closing Date, any offering material in connection with the offering and sale of the Securities other than the
Preliminary Prospectus, the Prospectus or any Prospectus Supplement, the Registration Statement, and copies of the documents incorporated
by reference therein. The Company shall not file any such amendment or supplement to which the Representative shall reasonably object
in writing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.2   <U>Federal
Securities Laws</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)   <U>Compliance</U>.
During the time when a Prospectus is required to be delivered under the Securities Act, the Company will use its reasonable best efforts
to comply with all requirements imposed upon it by the Securities Act and the rules and regulations thereunder and the Exchange Act and
the rules and regulations thereunder, as from time to time in force, so far as necessary to permit the continuance of sales of or dealings
in the Securities in accordance with the provisions hereof and the Prospectus. If at any time when a Prospectus relating to the Securities
is required to be delivered under the Securities Act, any event shall have occurred as a result of which, in the opinion of counsel for
the Company or counsel for the Underwriters, the Prospectus, as then amended or supplemented, includes an untrue statement of a material
fact or omits to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances
under which they were made, not misleading, or if it is necessary at any time to amend the Prospectus to comply with the Securities Act,
the Company will notify the Underwriters promptly and prepare and file with the Commission, subject to Section 4.1 hereof, an appropriate
amendment or supplement in accordance with Section 10 of the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)   <U>Filing
of Final Prospectus</U>. The Company will file the final Prospectus (in form and substance reasonably satisfactory to the Representative)
with the Commission pursuant to the requirements of Rule 424.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)   <U>Exchange
Act Registration</U>. For a period of three years from the Execution Date (except in connection with a going private transaction that
is approved by a majority of disinterested members of the Board of Directors and stockholders), (i) the Company will use its reasonable
best efforts to maintain the registration of the Common Stock under the Exchange Act and (ii) the Company will not deregister the Common
Stock under the Exchange Act without the prior written consent of the Representative.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)   <U>Free
Writing Prospectuses</U>. The Company represents and agrees that it has not made and will not make any offer relating to the Securities
that would constitute an issuer free writing prospectus, as defined in Rule 433 of the rules and regulations under the Securities Act,
without the prior written consent of the Representative. Any such free writing prospectus consented to by the Representative is herein
referred to as a <B>&ldquo;</B><U>Permitted Free Writing Prospectus</U>.&rdquo; The Company represents that it will treat each Permitted
Free Writing Prospectus as an &ldquo;issuer free writing prospectus&rdquo; as defined in rule and regulations under the Securities Act,
and has complied and will comply with the applicable requirements of Rule 433 of the Securities Act, including timely Commission filing
where required, legending and record keeping.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.3   <U>Delivery
to the Underwriters of Prospectuses</U>. The Company will deliver to the Underwriters, without charge, from time to time during the period
when the Prospectus is required to be delivered under the Securities Act or the Exchange Act such number of copies of each Prospectus
as the Underwriters may reasonably request and, as soon as the Registration Statement or any amendment or supplement thereto becomes effective,
deliver to you two original executed Registration Statements, including exhibits, and all post-effective amendments thereto and copies
of all exhibits filed therewith or incorporated therein by reference and all original executed consents of certified experts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.4   <U>Effectiveness
and Events Requiring Notice to the Underwriters</U>. The Company will use its reasonable best efforts to cause the Registration Statement
to remain effective with a current prospectus until the later of nine (9) months from the Execution Date and the date on which the Warrants
are no longer outstanding, and will notify the Underwriters and holders of the Warrants promptly and confirm the notice in writing: (i)&nbsp;of
the effectiveness of the Registration Statement and any amendment thereto, provided that the filing of an amendment to the Registration
Statement on the SEC&rsquo;s EDGAR system, and the posting of the notice of effectiveness on EDGAR, shall be deemed to be such notification;
(ii)&nbsp;of the issuance by the Commission of any stop order or of the initiation, or the threatening, of any proceeding for that purpose;
(iii)&nbsp;of the issuance by any state securities commission of any proceedings for the suspension of the qualification of the Securities
for offering or sale in any jurisdiction or of the initiation, or the threatening, of any proceeding for that purpose; (iv)&nbsp;of the
mailing and delivery to the Commission for filing of any amendment or supplement to the Registration Statement or Prospectus, provided
that the filing of an amendment or supplement to the Registration Statement on the SEC&rsquo;s EDGAR system shall be deemed to be such
notification; (v)&nbsp;of the receipt of any comments or request for any additional information from the Commission with respect to the
Registration Statement; and (vi)&nbsp;of the happening of any event during the period described in this Section 4.4 that, in the judgment
of the Company, makes any statement of a material fact made in the Registration Statement or the Prospectus untrue or that requires the
making of any changes in the Registration Statement or the Prospectus in order to make the statements therein, in light of the circumstances
under which they were made, not misleading. If the Commission or any state securities commission shall enter a stop order or suspend such
qualification at any time, the Company will make every reasonable effort to obtain promptly the lifting of such order.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.5   <U>Review
of Financial Statements</U>. For a period of three(3) years from the Execution Date, the Company, at its expense, shall cause its regularly
engaged independent registered public accountants to review (but not audit) the Company&rsquo;s financial statements for each of the first
three fiscal quarters prior to the announcement of quarterly financial information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.6   <U>Expenses
of the Offering</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)   <U>General
Expenses Related to the Offering</U>. The Company hereby agrees to pay on each of the Closing Date and each Option Closing Date, if any,
to the extent not paid at the Closing Date, all expenses incident to the performance of the obligations of the Company under this Agreement,
including, but not limited to: (a) all filing fees and communication expenses relating to the registration of the Securities to be sold
in the Offering (including the Option Securities) with the Commission; (b) all FINRA Public Offering Filing System fees associated with
the review of the Offering by FINRA; all fees and expenses relating to the listing of such Closing Shares, Option Shares and Warrant Shares
on the Trading Market and such other stock exchanges as the Company and the Representative together determine; (c) all fees, expenses
and disbursements relating to the registration or qualification of such Securities under the &ldquo;blue sky&rdquo; securities laws of
such states and other foreign jurisdictions as the Representative may reasonably designate (including, without limitation, all filing
and registration fees, and the fees and expenses of Blue Sky counsel); (d) the costs of all mailing and printing of the underwriting documents
(including, without limitation, the Underwriting Agreement, any Blue Sky Surveys and, if appropriate, any Agreement Among Underwriters,
Selected Dealers&rsquo; Agreement, Underwriters&rsquo; Questionnaire and Power of Attorney), Registration Statements, Prospectuses and
all amendments, supplements and exhibits thereto and as many preliminary and final Prospectuses as the Representative may reasonably deem
necessary; (e) the costs and expenses of the Company&rsquo;s public relations firm; (f) the costs of preparing, printing and delivering
the Securities; (g) fees and expenses of the Transfer Agent for the Securities (including, without limitation, any fees required for same-day
processing of any instruction letter delivered by the Company); (h) stock transfer and/or stamp taxes, if any, payable upon the transfer
of securities from the Company to the Underwriters; (i) the fees and expenses of the Company&rsquo;s accountants; and (j) the fees and
expenses of the Company&rsquo;s legal counsel and other agents and representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)   <U>Expenses
of the Representative</U>. The Company further agrees that, in addition to the expenses payable pursuant to Section 4.6(a), on the Closing
Date and Option Closing Date, if applicable, it will (i) pay to the Representative a management fee equal to 1.0% of the gross proceeds
received by the Company from the sale of the Public Securities and (ii) reimburse the Representative for its reasonable and documented
out-of-pocket expenses related to the Offering in an amount up to $135,000 in the aggregate, which shall be paid by deduction from the
proceeds of the Offering contemplated herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.7   <U>Application
of Net Proceeds</U>. The Company will apply the net proceeds from the Offering received by it in a manner consistent with the application
described under the caption &ldquo;Use of Proceeds&rdquo; in the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.8   <U>Delivery
of Earnings Statements to Security Holders</U>. The Company will make generally available to its security holders as soon as practicable,
but not later than the first day of the fifteenth full calendar month following the Execution Date, an earnings statement (which need
not be certified by independent public or independent certified public accountants unless required by the Securities Act or the Rules
and Regulations under the Securities Act, but which shall satisfy the provisions of Rule 158(a) under Section 11(a) of the Securities
Act) covering a period of at least twelve consecutive months beginning after the Execution Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.9   <U>Stabilization</U>.
Neither the Company, nor, to its knowledge, any of its employees, directors or shareholders (without the consent of the Representative)
has taken or will take, directly or indirectly, any action designed to or that has constituted or that might reasonably be expected to
cause or result in, under the Exchange Act, or otherwise, stabilization or manipulation of the price of any security of the Company to
facilitate the sale or resale of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.10   <U>Internal
Controls</U>. The Company will maintain a system of internal accounting controls sufficient to provide reasonable assurances that: (i)&nbsp;transactions
are executed in accordance with management&rsquo;s general or specific authorization; (ii)&nbsp;transactions are recorded as necessary
in order to permit preparation of financial statements in accordance with GAAP and to maintain accountability for assets; (iii)&nbsp;access
to assets is permitted only in accordance with management&rsquo;s general or specific authorization; and (iv)&nbsp;the recorded accountability
for assets is compared with existing assets at reasonable intervals and appropriate action is taken with respect to any differences.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.11   <U>Accountants</U>.
The Company shall continue to retain an independent certified public accounting firm registered with the Public Company Accounting Oversight
Board for a period of at least three years after the Execution Date. The Underwriters acknowledge that the Company Auditor is acceptable
to the Underwriters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.12   <U>FINRA</U>.
The Company shall advise the Underwriters (who shall make an appropriate filing with FINRA) if it is aware that any 5% or greater shareholder
of the Company becomes an affiliate or associated person of an Underwriter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.13   <U>No
Fiduciary Duties</U>. The Company acknowledges and agrees that the Underwriters&rsquo; responsibility to the Company is solely contractual
and commercial in nature, based on arms-length negotiations and that neither the Underwriters nor their affiliates or any selected dealer
shall be deemed to be acting in a fiduciary capacity, or otherwise owes any fiduciary duty to the Company or any of its affiliates in
connection with the Offering and the other transactions contemplated by this Agreement. Notwithstanding anything in this Agreement to
the contrary, the Company acknowledges that the Underwriters may have financial interests in the success of the Offering that are not
limited to the difference between the price to the public and the purchase price paid to the Company by the Underwriters for the shares
and the Underwriters have no obligation to disclose, or account to the Company for, any of such additional financial interests. The Company
hereby waives and releases, to the fullest extent permitted by law, any claims that the Company may have against the Underwriters with
respect to any breach or alleged breach of fiduciary duty.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.14   <U>Warrant
Shares</U>. If all or any portion of a Warrant is exercised at a time when there is an effective registration statement to cover the issuance
of the Warrant Shares or if the Warrant is exercised via cashless exercise, the Warrant Shares issued pursuant to any such exercise shall
be issued free of all restrictive legends. If at any time following the date hereof the Registration Statement (or any subsequent registration
statement registering the sale or resale of the Warrant Shares) is not effective or is not otherwise available for the sale of the Warrant
Shares, the Company shall promptly notify the holders of the Warrants in writing that such registration statement is not then effective
and thereafter shall promptly notify such holders when the registration statement is effective again and available for the sale of the
Warrant Shares (it being understood and agreed that the foregoing shall not limit the ability of the Company to issue, or any holder thereof
to sell, any of the Warrant Shares in compliance with applicable federal and state securities laws).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.15   <U>Board
Composition and Board Designations</U>. The Company shall ensure that: (i)&nbsp;the qualifications of the persons serving as board members
and the overall composition of the Board of Directors comply with the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder
and with the listing requirements of the Trading Market and (ii)&nbsp;if applicable, at least one member of the Board of Directors qualifies
as a &ldquo;financial expert&rdquo; as such term is defined under the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.16   <U>Securities
Laws Disclosure; Publicity</U>. At the request of the Representative, by 9:00 a.m. (New York City time) on the date hereof, the Company
shall issue a press release disclosing the material terms of the Offering. The Company and the Representative shall consult with each
other in issuing any other press releases with respect to the Offering, and neither the Company nor any Underwriter shall issue any such
press release nor otherwise make any such public statement without the prior consent of the Company, with respect to any press release
of such Underwriter, or without the prior consent of such Underwriter, with respect to any press release of the Company, which consent
shall not unreasonably be withheld or delayed, except if such disclosure is required by law, in which case the disclosing party shall
promptly provide the other party with prior notice of such public statement or communication. The Company will not issue press releases
or engage in any other publicity, without the Representative&rsquo;s prior written consent, for a period ending on the earlier of (a)
the first business day following the 45th day following the Closing Date, or (b) the first business day following the final Option Closing
Date, other than normal and customary releases issued in the ordinary course of the Company&rsquo;s business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.17   <U>Shareholder
Rights Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any Underwriter
of the Securities is an &ldquo;Acquiring Person&rdquo; under any control share acquisition, business combination, poison pill (including
any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company,
or that any Underwriter of Securities could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving
Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.18   <U>Reservation
of Common Stock</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available at all
times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue Option
Shares pursuant to the Option and Warrant Shares pursuant to any exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.19   <U>Listing
of Common Stock</U>. The Company hereby agrees to use reasonable best efforts to maintain the listing or quotation of the Common Stock
on the Trading Market on which it is currently listed, and concurrently with the Closing, the Company shall apply to list or quote all
of the Closing Shares, Option Shares and Warrant Shares on such Trading Market and promptly secure the listing of all of the Closing Shares,
Option Shares and Warrant Shares on such Trading Market. The Company further agrees, if the Company applies to have the Common Stock traded
on any other Trading Market, it will then include in such application all of the Closing Shares, Option Shares and Warrant Shares, and
will take such other action as is necessary to cause all of the Closing Shares, Option Shares and Warrant Shares to be listed or quoted
on such other Trading Market as promptly as possible. The Company will then take all action reasonably necessary to continue the listing
and trading of its Common Stock on a Trading Market and will comply in all material respects with the Company&rsquo;s reporting, filing
and other obligations under the bylaws or rules of the Trading Market. The Company agrees to use reasonable best efforts to maintain the
eligibility of the Common Stock for electronic transfer through the Depository Trust Company or another established clearing corporation,
including, without limitation, by timely payment of fees to the Depository Trust Company or such other established clearing corporation
in connection with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.20   <U>Subsequent
Equity Sales</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)   From
the date hereof until ninety (90) days following the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any
agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or file any
registration statement or amendment or supplement thereto, other than the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)   From
the date hereof until one (1) year following the Closing Date, the Company shall be prohibited from effecting or entering into an agreement
to effect any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents (or a combination of units
thereof) involving a Variable Rate Transaction. &ldquo;<U>Variable Rate Transaction</U>&rdquo; means a transaction in which the Company
(i) issues or sells any debt or equity securities that are convertible into, exchangeable or exercisable for, or include the right to
receive, additional shares of Common Stock either (A) at a conversion price, exercise price or exchange rate or other price that is based
upon, and/or varies with, the trading prices of or quotations for the shares of Common Stock at any time after the initial issuance of
such debt or equity securities or (B) with a conversion, exercise or exchange price that is subject to being reset at some future date
after the initial issuance of such debt or equity security or upon the occurrence of specified or contingent events directly or indirectly
related to the business of the Company or the market for the Common Stock or (ii) enters into, or effects a transaction under, any agreement,
including, but not limited to, an equity line of credit or an &ldquo;at-the-market offering&rdquo;, whereby the Company may issue securities
at a future determined price regardless of whether shares pursuant to such agreement have actually been issued and regardless of whether
such agreement is subsequently canceled; <U>provided</U>, <U>however</U>, that, after ninety (90) days following the Closing Date, the
entry into and/or issuance of shares of Common Stock in an &ldquo;at the market&rdquo; offering with the Representative as sales agent
shall not be deemed a Variable Rate Transaction. Any Underwriter shall be entitled to obtain injunctive relief against the Company to
preclude any such issuance, which remedy shall be in addition to any right to collect damages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)   Notwithstanding
the foregoing, this Section 4.20 shall not apply in respect of an Exempt Issuance, except that no Variable Rate Transaction shall be an
Exempt Issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.21   <U>Capital
Changes</U>. Until the one (1) year anniversary of the Closing Date, the Company shall not undertake a reverse or forward stock split
or reclassification of the Common Stock without the prior written consent of the Representative other than a reverse stock split that
is required, in the good faith determination of the Board of Directors, to maintain the listing of the Common Stock on the Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.22   <U>Research
Independence</U>. The Company acknowledges that each Underwriter&rsquo;s research analysts and research departments, if any, are required
to be independent from their respective investment banking divisions and are subject to certain regulations and internal policies, and
that such Underwriter&rsquo;s research analysts may hold and make statements or investment recommendations and/or publish research reports
with respect to the Company and/or the offering that differ from the views of its investment bankers. The Company hereby waives and releases,
to the fullest extent permitted by law, any claims that the Company may have against such Underwriter with respect to any conflict of
interest that may arise from the fact that the views expressed by their independent research analysts and research departments may be
different from or inconsistent with the views or advice communicated to the Company by such Underwriter&rsquo;s investment banking divisions.
The Company acknowledges that the Representative is a full service securities firm and as such from time to time, subject to applicable
securities laws, may effect transactions for its own account or the account of its customers and hold long or short position in debt or
equity securities of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">ARTICLE V.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center; text-indent: 0in">DEFAULT BY UNDERWRITERS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">If
on the Closing Date or any Option Closing Date, if any, any Underwriter shall fail to purchase and pay for the portion of the Closing
Securities or Option Securities, as the case may be, which such Underwriter has agreed to purchase and pay for on such date (otherwise
than by reason of any default on the part of the Company), the Representative, or if the Representative is the defaulting Underwriter,
the non-defaulting Underwriters, shall use their reasonable efforts to procure within 36 hours thereafter one or more of the other Underwriters,
or any others, to purchase from the Company such amounts as may be agreed upon and upon the terms set forth herein, the Closing Securities
or Option Securities, as the case may be, which the defaulting Underwriter or Underwriters failed to purchase. If during such 36 hours
the Representative shall not have procured such other Underwriters, or any others, to purchase the Closing Securities or Option Securities,
as the case may be, agreed to be purchased by the defaulting Underwriter or Underwriters, then (a) if the aggregate number of Closing
Securities or Option Securities, as the case may be, with respect to which such default shall occur does not exceed 10% of the Closing
Securities or Option Securities, as the case may be, covered hereby, the other Underwriters shall be obligated, severally, in proportion
to the respective numbers of Closing Securities or Option Securities, as the case may be, which they are obligated to purchase hereunder,
to purchase the Closing Securities or Option Securities, as the case may be, which such defaulting Underwriter or Underwriters failed
to purchase, or (b) if the aggregate number of Closing Securities or Option Securities, as the case may be, with respect to which such
default shall occur exceeds 10% of the Closing Securities or Option Securities, as the case may be, covered hereby, the Company or the
Representative will have the right to terminate this Agreement without liability on the part of the non-defaulting Underwriters or of
the Company except to the extent provided in Article VI hereof. In the event of a default by any Underwriter or Underwriters, as set forth
in this Article V, the applicable Closing Date may be postponed for such period, not exceeding seven days, as the Representative, or if
the Representative is the defaulting Underwriter, the non-defaulting Underwriters, may determine in order that the required changes in
the Prospectus or in any other documents or arrangements may be effected. The term &ldquo;Underwriter&rdquo; includes any Person substituted
for a defaulting Underwriter. Any action taken under this Section shall not relieve any defaulting Underwriter from liability in respect
of any default of such Underwriter under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal"></FONT></P>

<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE VI.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INDEMNIFICATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.1   <U>Indemnification
of the Underwriters</U>. Subject to the conditions set forth below, the Company agrees to indemnify and hold harmless the Underwriters,
and each dealer selected by each Underwriter that participates in the offer and sale of the Securities (each a &ldquo;<U>Selected Dealer</U>&rdquo;)
and each of their respective directors, officers and employees and each Person, if any, who controls such Underwriter or any Selected
Dealer (&ldquo;<U>Controlling Person</U>&rdquo;) within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange
Act, against any and all loss, liability, claim, damage and expense whatsoever (including but not limited to any and all legal or other
expenses reasonably incurred in investigating, preparing or defending against any litigation, commenced or threatened, or any claim whatsoever,
whether arising out of any action between such Underwriter and the Company or between such Underwriter and any third party or otherwise)
to which they or any of them may become subject under the Securities Act, the Exchange Act or any other statute or at common law or otherwise
or under the laws of foreign countries, arising out of or based upon any untrue statement or alleged untrue statement of a material fact
contained in (i) any Preliminary Prospectus, the Registration Statement or the Prospectus (as from time to time each may be amended and
supplemented); (ii) any materials or information provided to investors by, or with the approval of, the Company in connection with the
marketing of the offering of the Securities, including any &ldquo;road show&rdquo; or investor presentations made to investors by the
Company (whether in person or electronically); or (iii) any application or other document or written communication (in this Article VI,
collectively called &ldquo;<U>application</U>&rdquo;) executed by the Company or based upon written information furnished by the Company
in any jurisdiction in order to qualify the Securities under the securities laws thereof or filed with the Commission, any state securities
commission or agency, Trading Market or any securities exchange; or the omission or alleged omission therefrom of a material fact required
to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading,
unless such statement or omission was made in reliance upon and in conformity with written information furnished to the Company with respect
to the applicable Underwriter by or on behalf of such Underwriter expressly for use in any Preliminary Prospectus, the Registration Statement
or Prospectus, or any amendment or supplement thereto, or in any application, as the case may be. With respect to any untrue statement
or omission or alleged untrue statement or omission made in the Preliminary Prospectus, the indemnity agreement contained in this Section
6.1 shall not inure to the benefit of an Underwriter to the extent that any loss, liability, claim, damage or expense of such Underwriter
results from the fact that a copy of the Prospectus was not given or sent to the Person asserting any such loss, liability, claim or damage
at or prior to the written confirmation of sale of the Securities to such Person as required by the Securities Act and the rules and regulations
thereunder, and if the untrue statement or omission has been corrected in the Prospectus, unless such failure to deliver the Prospectus
was a result of non-compliance by the Company with its obligations under this Agreement. The Company agrees promptly to notify each Underwriter
of the commencement of any litigation or proceedings against the Company or any of its officers, directors or Controlling Persons in connection
with the issue and sale of the Public Securities or in connection with the Registration Statement or Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.2   <U>Procedure</U>.
If any action is brought against an Underwriter, a Selected Dealer or a Controlling Person in respect of which indemnity may be sought
against the Company pursuant to Section 6.1, such Underwriter, such Selected Dealer or Controlling Person, as the case may be, shall promptly
notify the Company in writing of the institution of such action and the Company shall assume the defense of such action, including the
employment and fees of counsel (subject to the reasonable approval of such Underwriter or such Selected Dealer, as the case may be) and
payment of actual expenses. Such Underwriter, such Selected Dealer or Controlling Person shall have the right to employ its or their own
counsel in any such case, but the fees and expenses of such counsel shall be at the expense of such Underwriter, such Selected Dealer
or Controlling Person unless (i) the employment of such counsel at the expense of the Company shall have been authorized in writing by
the Company in connection with the defense of such action, or (ii) the Company shall not have employed counsel to have charge of the defense
of such action, or (iii) such indemnified party or parties shall have reasonably concluded that there may be defenses available to it
or them which are different from or additional to those available to the Company (in which case the Company shall not have the right to
direct the defense of such action on behalf of the indemnified party or parties), in any of which events the reasonable and documented
fees and expenses of not more than one additional firm of attorneys selected by such Underwriter (in addition to local counsel), Selected
Dealer and/or Controlling Person shall be borne by the Company. Notwithstanding anything to the contrary contained herein, if any Underwriter,
Selected Dealer or Controlling Person shall assume the defense of such action as provided above, the Company shall have the right to approve
in writing the terms of any settlement of such action which approval shall not be unreasonably withheld.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.3   <U>Indemnification
of the Company</U>. Each Underwriter severally and not jointly agrees to indemnify and hold harmless the Company, its directors, officers
and employees and agents who control the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange
Act against any and all loss, liability, claim, damage and expense described in the foregoing indemnity from the Company to such Underwriter,
as incurred, but only with respect to untrue statements or omissions, or alleged untrue statements or omissions made in any Preliminary
Prospectus, if any, the Registration Statement or Prospectus or any amendment or supplement thereto or in any application, in reliance
upon, and in strict conformity with, written information furnished to the Company with respect to such Underwriter by or on behalf of
such Underwriter expressly for use in such Preliminary Prospectus, if any, the Registration Statement or Prospectus or any amendment or
supplement thereto or in any such application. In case any action shall be brought against the Company or any other Person so indemnified
based on any Preliminary Prospectus, if any, the Registration Statement or Prospectus or any amendment or supplement thereto or any application,
and in respect of which indemnity may be sought against such Underwriter, such Underwriter shall have the rights and duties given to the
Company, and the Company and each other Person so indemnified shall have the rights and duties given to such Underwriter by the provisions
of this Article VI. Notwithstanding the provisions of this Section 6.3, no Underwriter shall be required to indemnify the Company for
any amount in excess of the underwriting discounts and commissions applicable to the Securities purchased by such Underwriter. The Underwriters&rsquo;
obligations in this Section 6.3 to indemnify the Company are several in proportion to their respective underwriting obligations and not
joint.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.4   <U>Contribution</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)   <U>Contribution
Rights</U>. In order to provide for just and equitable contribution under the Securities Act in any case in which (i) any Person entitled
to indemnification under this Article VI makes a claim for indemnification pursuant hereto but it is judicially determined (by the entry
of a final judgment or decree by a court of competent jurisdiction and the expiration of time to appeal or the denial of the last right
of appeal) that such indemnification may not be enforced in such case notwithstanding the fact that this Article VI provides for indemnification
in such case, or (ii) contribution under the Securities Act, the Exchange Act or otherwise may be required on the part of any such Person
in circumstances for which indemnification is provided under this Article VI, then, and in each such case, the Company and each Underwriter,
severally and not jointly, shall contribute to the aggregate losses, liabilities, claims, damages and expenses of the nature contemplated
by said indemnity agreement incurred by the Company and such Underwriter, as incurred, in such proportions that such Underwriter is responsible
for that portion represented by the percentage that the underwriting discount appearing on the cover page of the Prospectus bears to the
initial offering price appearing thereon and the Company is responsible for the balance; provided, that, no Person guilty of a fraudulent
misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any Person who was
not guilty of such fraudulent misrepresentation. For purposes of this Section, each director, officer and employee of such Underwriter
or the Company, as applicable, and each Person, if any, who controls such Underwriter or the Company, as applicable, within the meaning
of Section 15 of the Securities Act shall have the same rights to contribution as such Underwriter or the Company, as applicable. Notwithstanding
the provisions of this Section 6.4, no Underwriter shall be required to contribute any amount in excess of the underwriting discounts
and commissions applicable to the Securities purchased by such Underwriter. The Underwriters&rsquo; obligations in this Section 6.4 to contribute
are several in proportion to their respective underwriting obligations and not joint.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)   <U>Contribution
Procedure</U>. Within fifteen days after receipt by any party to this Agreement (or its representative) of notice of the commencement
of any action, suit or proceeding, such party will, if a claim for contribution in respect thereof is to be made against another party
(&ldquo;<U>contributing party</U>&rdquo;), notify the contributing party of the commencement thereof, but the failure to so notify the
contributing party will not relieve it from any liability which it may have to any other party other than for contribution hereunder.
In case any such action, suit or proceeding is brought against any party, and such party notifies a contributing party or its representative
of the commencement thereof within the aforesaid fifteen days, the contributing party will be entitled to participate therein with the
notifying party and any other contributing party similarly notified. Any such contributing party shall not be liable to any party seeking
contribution on account of any settlement of any claim, action or proceeding affected by such party seeking contribution without the written
consent of such contributing party. The contribution provisions contained in this Section 6.4 are intended to supersede, to the extent
permitted by law, any right to contribution under the Securities Act, the Exchange Act or otherwise available.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE VII.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>MISCELLANEOUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.1   <U>Termination</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)   <U>Termination
Right</U>. The Representative shall have the right to terminate this Agreement at any time prior to any Closing Date, (i)&nbsp;if any
domestic or international event or act or occurrence has materially disrupted, or in its opinion will in the immediate future materially
disrupt, general securities markets in the United States; or (ii)&nbsp;if trading on any Trading Market shall have been suspended or materially
limited, or minimum or maximum prices for trading shall have been fixed, or maximum ranges for prices for securities shall have been required
by FINRA or by order of the Commission or any other government authority having jurisdiction, or (iii)&nbsp;if the United States shall
have become involved in a new war or an increase in major hostilities, or (iv)&nbsp;if a banking moratorium has been declared by a New
York State or federal authority, or (v)&nbsp;if a moratorium on foreign exchange trading has been declared which materially adversely
impacts the United States securities markets, or (vi)&nbsp;if the Company shall have sustained a material loss by fire, flood, accident,
hurricane, earthquake, theft, sabotage or other calamity or malicious act which, whether or not such loss shall have been insured, will,
in the Representative&rsquo;s opinion, make it inadvisable to proceed with the delivery of the Securities, or (vii)&nbsp;if the Company
is in material breach of any of its representations, warranties or covenants hereunder, or (viii)&nbsp;if the Representative shall have
become aware after the date hereof of such a material adverse change in the conditions or prospects of the Company, or such adverse material
change in general market conditions as in the Representative&rsquo;s judgment would make it impracticable to proceed with the offering,
sale and/or delivery of the Securities or to enforce contracts made by the Underwriters for the sale of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)   <U>Expenses</U>.
In the event this Agreement shall be terminated pursuant to Section 7.1(a), within the time specified herein or any extensions thereof
pursuant to the terms herein, the Company shall be obligated to pay to the Representative its actual and accountable out of pocket expenses
related to the transactions contemplated herein then due and payable, including the fees and disbursements of EGS, in an aggregate amount
not to exceed $50,000 (<U>provided</U>, <U>however</U>, that such expense cap in no way limits or impairs the indemnification and contribution
provisions of this Agreement).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)   <U>Indemnification</U>.
Notwithstanding any contrary provision contained in this Agreement, any election hereunder or any termination of this Agreement, and whether
or not this Agreement is otherwise carried out, the provisions of Article VI shall not be in any way effected by such election or termination
or failure to carry out the terms of this Agreement or any part hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.2   <U>Entire
Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, the Prospectus and the Prospectus Supplement,
if any, contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior
agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such
documents, exhibits and schedules. Notwithstanding anything herein to the contrary, the Engagement Agreement, dated December 4, 2023 (&ldquo;<U>Engagement
Agreement</U>&rdquo;), by and between the Company and the Representative shall continue to be effective and the terms therein, including,
without limitation, Section 4(b) and Section 5 with respect to any future offerings, shall continue to survive and be enforceable by the
Representative in accordance with its terms, provided that, in the event of a conflict between the terms of the Engagement Agreement and
this Agreement, the terms of this Agreement shall prevail.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.3   <U>Notices</U>.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall
be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is delivered via e-mail
attachment at the email address set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City time) on a Trading
Day, (b) the next Trading Day after the time of transmission, if such notice or communication is delivered via e-mail attachment at the
e-mail address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York
City time) on any Trading Day, (c) the second (2<SUP>nd</SUP>) Trading Day following the date of mailing, if sent by U.S. nationally recognized
overnight courier service or (d) upon actual receipt by the party to whom such notice is required to be given. The address for such notices
and communications shall be as set forth on the signature pages attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.4   <U>Amendments;
Waivers</U>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in
the case of an amendment, by the Company and the Representative. No waiver of any default with respect to any provision, condition or
requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver
of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder
in any manner impair the exercise of any such right.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.5   <U>Headings</U>.
The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any
of the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.6   <U>Successors
and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.7   <U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed
by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts
of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective affiliates,
directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts
sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting
in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction
contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably
waives, and agrees not to assert in any Action or Proceeding, any claim that it is not personally subject to the jurisdiction of any such
court, that such Action or Proceeding is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives
personal service of process and consents to process being served in any such Action or Proceeding by mailing a copy thereof via registered
or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this
Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If either party shall commence an
Action or Proceeding to enforce any provisions of the Transaction Documents, then, in addition to the obligations of the Company under
Article VI, the prevailing party in such Action or Proceeding shall be reimbursed by the other party for its reasonable attorneys&rsquo;
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Action or Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.8   <U>Survival</U>.
The representations and warranties contained herein shall survive the Closing and the Option Closing, if any, and the delivery of the
Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.9   <U>Execution</U>.
This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that
the parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery of a &ldquo;.pdf&rdquo;
format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature
is executed) with the same force and effect as if such &ldquo;.pdf&rdquo; signature page were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.10   <U>Severability</U>.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force
and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts
to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,
covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining
terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.11   <U>Remedies</U>.
In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, the Underwriters
and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may
not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and hereby
agree to waive and not to assert in any Action for specific performance of any such obligation the defense that a remedy at law would
be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.12 <U>Saturdays, Sundays,
Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein
shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.13   <U>Construction</U>.
The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents
and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall
not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference to
share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse and forward stock splits,
stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.14   <B><U>WAIVER
OF JURY TRIAL</U>. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY ARISING OUT OF
OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT
PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVE FOREVER ANY RIGHT TO TRIAL BY JURY. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><I>(Signature Pages Follow)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">If the foregoing correctly sets
forth the understanding between the Underwriters and the Company, please so indicate in the space provided below for that purpose, whereupon
this letter shall constitute a binding agreement among the Company and the several Underwriters in accordance with its terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PERASO INC.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    James Sullivan</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp; </FONT></TD>
    <TD STYLE="width: 31%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">James Sullivan</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CFO</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for Notice:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Peraso Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2309 Bering Drive</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">San Jose, California 95131</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attention: James W. Sullivan, Chief Financial Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Copy to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">Mitchell Silberberg &amp; Knupp
LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">437 Madison Ave., 25th Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">New York, New York 10022</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">Email: bjb@msk.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">Attention: Blake Baron, Esq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Accepted on the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>Ladenburg Thalmann &amp;
Co. Inc., </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As the Representative of the several</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Underwriters listed on Schedule I</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By: Ladenburg Thalmann &amp; Co. Inc.,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid">/s/ Nicholas Stergis</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 31%"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nicholas Stergis</FONT></TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: </FONT></TD>
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Managing Director Investment Banking</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Address for Notice:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladenburg Thalmann &amp; Co. Inc.,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">640 Fifth Avenue, 4<SUP>th</SUP> Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, NY 10019</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>SCHEDULE I</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps">Schedule
of Underwriters</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Underwriters</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Closing<BR>
 Shares</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Pre-Funded<BR>
 Warrants</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Closing A<BR>
 Warrants</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Closing B<BR>
 Warrants</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Closing<BR>
 Purchase Price</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; text-align: left; padding-bottom: 1.5pt">Ladenburg Thalmann &amp; Co. Inc.</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">480,000</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">1,424,760</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">3,809,520</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">3,809,520</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">3,678,685.54</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">480,000</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">1,424,760</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">3,809,520</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">3,809,520</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">$</TD><TD STYLE="font-weight: bold; text-align: right">3,678,685.54</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">42</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ea193205ex10-2_perasoinc.htm
<DESCRIPTION>WARRANT AGENCY AGREEMENT, DATED FEBRUARY 8, 2024, BY AND BETWEEN THE COMPANY AND EQUINITI TRUST COMPANY, LLC
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.2</B></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">PERASO INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">EQUINITI <FONT STYLE="text-transform: uppercase">TRUST
COMPANY</FONT>, LLC as</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Warrant Agent</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Warrant Agency Agreement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Dated as of February 8, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><U>WARRANT AGENCY AGREEMENT</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WARRANT AGENCY AGREEMENT,
dated as of February 8, 2024 (&ldquo;<U>Agreement</U>&rdquo;), between Peraso Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;),
and Equiniti Trust Company, LLC (the &ldquo;<U>Warrant Agent</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">W I T N E S S E T H</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, pursuant to a registered
offering by the Company of 480,000 shares of common stock, par value $0.001 per share (the &ldquo;<U>Common Stock</U>&rdquo;), pre-funded
warrants to purchase 1,424,760 shares of Common Stock at an exercise price of $0.001 (the &ldquo;<U>Pre-Funded Warrants</U>&rdquo;), Series
A Common Stock purchase warrants to purchase 3,809,520 shares of Common Stock at an exercise price of $2.25 (the &ldquo;<U>Series A Warrants</U>&rdquo;)
and Series B Common Stock purchase warrants to purchase 3,809,520 shares of Common Stock at an exercise price of $2.25 (the &ldquo;<U>Series
B Warrants</U>&rdquo; and together with the Pre-Funded Warrants and Series A Warrants, the &ldquo;<U>Warrants</U>&rdquo; and the shares
of Common Stock underlying the Warrants, the &ldquo;<U>Warrant Shares</U>&rdquo;) (the &ldquo;<U>Offering</U>&rdquo;); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Company granted
an over-allotment option to purchase up to 285,714 additional shares of Common Stock, Series A Warrants to purchase up to 571,428 shares
of Common Stock and/or Series B Warrants to purchase up to 571,428 shares of Common Stock (the &ldquo;<U>Over-Allotment Option</U>&rdquo;)
to the underwriters in the Offering (for the avoidance of doubt, the defined term &ldquo;Warrants&rdquo; include any Warrants issued as
part of the Over-Allotment Option);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, upon the terms and
subject to the conditions hereinafter set forth and pursuant to an effective registration statement on Form S-1, as amended (File No.
333-276247) (the &ldquo;<U>Registration Statement</U>&rdquo;), and the terms and conditions of the Warrant Certificate (as defined below),
the Company wishes to issue the Warrants in book entry form entitling the respective holders of the Warrants (the &ldquo;<U>Holders</U>,&rdquo;
which term shall include a Holder&rsquo;s transferees, successors and assigns and &ldquo;Holder&rdquo; shall include, if the Warrants
are held in &ldquo;street name,&rdquo; a Participant (as defined below) or a designee appointed by such Participant); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Common Stock
(or Pre-Funded Warrants) and Warrants to be issued in connection with the Offering shall be immediately separable and will be issued separately,
but will be purchased together in the Offering; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Company wishes
the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing so to act, in connection with the issuance, registration,
transfer, exchange, exercise and replacement of the Warrants and, in the Warrant Agent&rsquo;s capacity as the Company&rsquo;s transfer
agent, the delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, in consideration
of the premises and the mutual agreements herein set forth, the parties hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1. <U>Certain Definitions</U>.
For purposes of this Agreement, all capitalized terms not herein defined shall have the meanings hereby indicated:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) &ldquo;<U>Affiliate</U>&rdquo;
has the meaning ascribed to it in Rule 12b-2 under the Securities Exchange Act of 1934, as amended (the &ldquo;<U>Exchange Act</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) &ldquo;<U>Business Day</U>&rdquo;
means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day on which the Nasdaq
Stock Market is authorized or required by law or other governmental action to close.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) &ldquo;<U>Close of Business</U>&rdquo;
on any given date means 5:00 p.m., New York City time, on such date; <U>provided</U>, <U>however</U>, that if such date is not a Business
Day it means 5:00 p.m., New York City time, on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) &ldquo;<U>Person</U>&rdquo;
means an individual, corporation, association, partnership, limited liability company, joint venture, trust, unincorporated organization,
government or political subdivision thereof or governmental agency or other entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 26.55pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) &ldquo;<U>Warrant Certificate</U>&rdquo;
means a certificate in substantially the form attached as <U>Exhibit 1-A </U>hereto (as it relates to the Pre-Funded Warrants), <U>Exhibit
1-B</U> hereto (as it relates to the Series A Warrants) and <U>Exhibit 1-C</U> hereto (as it relates to the Series B Warrants), representing
such number of Warrant Shares as is indicated therein, provided that any reference to the delivery of a Warrant Certificate in this Agreement
shall include delivery of a Definitive Certificate or a Global Warrant (each as defined below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 26.55pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All other capitalized terms
used but not otherwise defined herein shall have the meaning ascribed to such terms in the Warrant Certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 2. <U>Appointment
of Warrant Agent</U>. The Company hereby appoints the Warrant Agent to act as agent for the Company in accordance with the terms and conditions
hereof, and the Warrant Agent hereby accepts such appointment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3. <U>Global Warrants</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) The Warrants shall be
registered securities and shall be evidenced by a global warrant (the &ldquo;<U>Global Warrants</U>&rdquo;), in the form of the Warrant
Certificate, which shall be deposited with the Warrant Agent and registered in the name of Cede &amp; Co., a nominee of The Depository
Trust Company (the &ldquo;<U>DTC</U>&rdquo;), or as otherwise directed by the DTC. Ownership of beneficial interests in the Warrants shall
be shown on, and the transfer of such ownership shall be effected through, records maintained by (i) the DTC or its nominee for each Global
Warrant or (ii) institutions that have accounts with the DTC (such institution, with respect to a Warrant in its account, a &ldquo;<U>Participant</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 26.55pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) If the DTC subsequently
ceases to make its book-entry settlement system available for the Warrants, the Company may instruct the Warrant Agent regarding other
arrangements for book-entry settlement. In the event that the Warrants are not eligible for, or it is no longer necessary to have the
Warrants available in, book-entry form, the Warrant Agent shall provide written instructions to the DTC to deliver to the Warrant Agent
for cancellation of each Global Warrant, and the Company shall instruct the Warrant Agent to deliver to each Holder a Warrant Certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 26.55pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) A Holder has the right
to elect at any time or from time to time a Warrant Exchange (as defined below) pursuant to a Warrant Certificate Request Notice (as defined
below). Upon written notice by a Holder to the Company and the Warrant Agent for the exchange of some or all of such Holder&rsquo;s Global
Warrants for a separate certificate in the form attached hereto as <U>Exhibit 1-A</U>, <U>Exhibit 1-B</U>, or <U>Exhibit 1-C</U> as the
case may be (such separate certificate, a &ldquo;<U>Definitive Certificate</U>&rdquo;) evidencing the same number of Warrants, which request
shall be in the form attached hereto as <U>Exhibit 2</U> (a &ldquo;<U>Warrant Certificate Request Notice</U>&rdquo; and the date of delivery
of such Warrant Certificate Request Notice by the Holder, the &ldquo;<U>Warrant Certificate Request Notice Date</U>&rdquo; and the surrender
by the Holder to the Warrant Agent of a number of Global Warrants for the same number of Warrants evidenced by a Warrant Certificate,
a &ldquo;<U>Warrant Exchange</U>&rdquo;), the Company and the Warrant Agent shall promptly effect the Warrant Exchange and the Company
shall promptly issue and deliver to the Holder a Definitive Certificate for such number of Warrants in the name set forth in the Warrant
Certificate Request Notice. Such Definitive Certificate shall be dated the Initial Exercise Date of the Warrants, shall be manually executed
by an authorized signatory of the Company, shall be in the form attached hereto as <U>Exhibit 1-A</U>, <U>Exhibit 1-B</U> or <U>Exhibit
1-C</U>, as the case may be, and shall be reasonably acceptable in all respects to such Holder. In connection with a Warrant Exchange,
the Company agrees to deliver the Definitive Certificate to the Holder within ten (10) Business Days of the Warrant Certificate Request
Notice pursuant to the delivery instructions in the Warrant Certificate Request Notice (&ldquo;<U>Warrant Certificate Delivery Date</U>&rdquo;).
If the Company fails for any reason to deliver to the Holder the Definitive Certificate subject to the Warrant Certificate Request Notice
by the Warrant Certificate Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for
each $1,000 of Warrant Shares evidenced by such Definitive Certificate (based on the VWAP (as defined in the Warrants) of the Common Stock
on the Warrant Certificate Request Notice Date), $10 per Business Day for each Business Day after such Warrant Certificate Delivery Date
until such Definitive Certificate is delivered or, prior to delivery of such Warrant Certificate, the Holder rescinds such Warrant Exchange.
The Company covenants and agrees that, upon the date of delivery of the Warrant Certificate Request Notice, the Holder shall be deemed
to be the holder of the Definitive Certificate and, notwithstanding anything to the contrary set forth herein, the Definitive Certificate
shall be deemed for all purposes to contain all of the terms and conditions of the Warrants evidenced by such Warrant Certificate and
the terms of this Agreement, other than Sections 3(c), 3(d) and 9 herein, shall not apply to the Warrants evidenced by the Definitive
Certificate. Notwithstanding anything herein to the contrary, the Company shall act as warrant agent with respect to any Definitive Certificate
requested and issued pursuant to this section. Notwithstanding anything to the contrary contained in this Agreement, in the event of inconsistency
between any provision in this Agreement and any provision in a Definitive Certificate, as it may from time to time be amended, the terms
of such Definitive Certificate shall control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 26.55pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 26.55pt"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 26.55pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) A Holder of a Definitive
Certificate (pursuant to a Warrant Exchange or otherwise) has the right to elect at any time or from time to time a Global Warrants Exchange
(as defined below) pursuant to a Global Warrants Request Notice (as defined below). Upon written notice by a Holder to the Company for
the exchange of some or all of such Holder&rsquo;s Warrants evidenced by a Definitive Certificate for a beneficial interest in Global
Warrants held in book-entry form through the DTC evidencing the same number of Warrants, which request shall be in the form attached hereto
as <U>Exhibit 3</U> (a &ldquo;<U>Global Warrants Request Notice</U>&rdquo; and the date of delivery of such Global Warrants Request Notice
by the Holder, the &ldquo;<U>Global Warrants Request Notice Date</U>&rdquo; and the surrender upon delivery by the Holder of the Warrants
evidenced by Definitive Certificates for the same number of Warrants evidenced by a beneficial interest in Global Warrants held in book-entry
form through the DTC, a &ldquo;<U>Global Warrants Exchange</U>&rdquo;), the Company shall promptly effect the Global Warrants Exchange
and shall promptly direct the Warrant Agent to issue and deliver to the Holder Global Warrants for such number of Warrants in the Global
Warrants Request Notice, which beneficial interest in such Global Warrants shall be delivered by the DTC&rsquo;s Deposit or Withdrawal
at Custodian system to the Holder pursuant to the instructions in the Global Warrants Request Notice. In connection with a Global Warrants
Exchange, the Company shall direct the Warrant Agent to deliver the beneficial interest in such Global Warrants to the Holder within ten
(10) Business Days of the Global Warrants Request Notice pursuant to the delivery instructions in the Global Warrant Request Notice (&ldquo;<U>Global
Warrants Delivery Date</U>&rdquo;). If the Company fails for any reason to deliver to the Holder Global Warrants subject to the Global
Warrants Request Notice by the Global Warrants Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and
not as a penalty, for each $1,000 of Warrant Shares evidenced by such Global Warrants (based on the VWAP (as defined in the Warrants)
of the Common Stock on the Global Warrants Request Notice Date), $10 per Business Day for each Business Day after such Global Warrants
Delivery Date until such Global Warrants are delivered or, prior to delivery of such Global Warrants, the Holder rescinds such Global
Warrants Exchange. The Company covenants and agrees that, upon the date of delivery of the Global Warrants Request Notice, the Holder
shall be deemed to be the beneficial holder of such Global Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 4. <U>Form of Warrant
Certificates</U>. The Warrant Certificate, together with the form of election to purchase Common Stock (&ldquo;<U>Notice of Exercise</U>&rdquo;)
and the form of assignment to be printed on the reverse thereof, shall be substantially in the form of <U>Exhibit 1-A</U>, <U>Exhibit
1-B</U> or <U>Exhibit 1-C</U>, as the case may be, hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 5. <U>Countersignature
and Registration</U>. The Global Warrant shall be executed on behalf of the Company by its Chief Executive Officer, Chief Financial Officer
or Vice President, by facsimile signature, and have affixed thereto the Company&rsquo;s seal or a facsimile thereof which shall be attested
by the Secretary or an Assistant Secretary of the Company, by facsimile signature. The Global Warrant shall be countersigned by the Warrant
Agent by electronic or facsimile signature and shall not be valid for any purpose unless so countersigned. In case any officer of the
Company who shall have signed any of the Global Warrant shall cease to be such officer of the Company before countersignature by the Warrant
Agent and issuance and delivery by the Company, such Global Warrant, nevertheless, may be countersigned by the Warrant Agent, issued and
delivered with the same force and effect as though the person who signed such Global Warrant had not ceased to be such officer of the
Company; and any Global Warrant may be signed on behalf of the Company by any person who, at the actual date of the execution of such
Global Warrant, shall be a proper officer of the Company to sign such Global Warrant, although at the date of the execution of this Agreement
any such person was not such an officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Warrant Agent will keep
or cause to be kept, at one of its offices, or at the office of one of its agents, books for registration and transfer of the Global Warrants
issued hereunder. Such books shall show the names and addresses of the respective Holders of the Global Warrant, the number of warrants
evidenced on the face of each of such Global Warrant and the date of each of such Global Warrant. The Warrant Agent will create a special
account for the issuance of Global Warrants. The Company will keep or cause to be kept at one of its offices, books for the registration
and transfer of any Definitive Certificates issued hereunder and the Warrant Agent shall not have any obligation to keep books and records
with respect to any Definitive Warrants. Such Company books shall show the names and addresses of the respective Holders of the Definitive
Certificates, the number of warrants evidenced on the face of each such Definitive Certificate and the date of each such Definitive Certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 6. <U>Transfer, Split
Up, Combination and Exchange of Warrant Certificates; Mutilated, Destroyed, Lost or Stolen Warrant Certificates</U>. With respect to the
Global Warrant, subject to the provisions of the Warrant Certificate and the last sentence of this first paragraph of Section 6 and subject
to applicable law, rules or regulations, or any &ldquo;stop transfer&rdquo; instructions the Company may give to the Warrant Agent, at
any time after the closing date of the Offering, and at or prior to the Close of Business on the Termination Date (as such term is defined
in the Warrant Certificate), any Global Warrant or Global Warrants may be transferred, split up, combined or exchanged for another Global
Warrant or Global Warrants, entitling the Holder to purchase a like number of shares of Common Stock as the Global Warrant or Global Warrants
surrendered then entitled such Holder to purchase. Any Holder desiring to transfer, split up, combine or exchange any Global Warrant shall
make such request in writing delivered to the Warrant Agent, and shall surrender the Global Warrant to be transferred, split up, combined
or exchanged at the principal office of the Warrant Agent. Any requested transfer of Warrants, whether in book-entry form or certificate
form, shall be accompanied by reasonable evidence of authority of the party making such request that may be required by the Warrant Agent.
Thereupon the Warrant Agent shall, subject to the last sentence of this first paragraph of Section 6, countersign and deliver to the Person
entitled thereto a Global Warrant or Global Warrants, as the case may be, as so requested. The Company may require payment from the Holder
of a sum sufficient to cover any tax or governmental charge that may be imposed in connection with any transfer, split up, combination
or exchange of Global Warrants. The Company shall compensate the Warrant Agent per the fee schedule mutually agreed upon by the parties
hereto and provided separately on the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon receipt by the Warrant
Agent of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of a Warrant Certificate, which evidence
shall include an affidavit of loss, or in the case of mutilated certificates, the certificate or portion thereof remaining, and, in case
of loss, theft or destruction, of indemnity in customary form and amount (but, with respect to any Definitive Certificates, shall not
include the posting of any bond by the Holder), and satisfaction of any other reasonable requirements established by Section 8-405 of
the Uniform Commercial Code as in effect in the State of Delaware, and reimbursement to the Company and the Warrant Agent of all reasonable
expenses incidental thereto, and upon surrender to the Warrant Agent and cancellation of the Warrant Certificate if mutilated, the Company
will make and deliver a new Warrant Certificate of like tenor to the Warrant Agent for delivery to the Holder in lieu of the Warrant Certificate
so lost, stolen, destroyed or mutilated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 7. <U>Exercise of
Warrants; Exercise Price; Termination Date</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) The Warrants shall be
exercisable commencing on the Initial Exercise Date. The Warrants shall cease to be exercisable as set forth in the Warrant Certificate.
Subject to the foregoing and to Section 7(b) below, the Holder of a Warrant may exercise the Warrant in whole or in part pursuant to Section
2 of the Warrant Certificate. Subject to Section 7(b) below, payment of the Exercise Price (unless exercised via a cashless exercise)
may be made, at the option of the Holder, by wire transfer or by certified or official bank check in United States dollars, to the Warrant
Agent at the principal office of the Warrant Agent or to the office of one of its agents as may be designated by the Warrant Agent from
time to time. In the case of the Holder of a Global Warrant, the Holder shall deliver the executed Notice of Exercise and the payment
of the Exercise Price as described herein. Notwithstanding any other provision in this Agreement, a holder whose interest in a Global
Warrant is a beneficial interest in a Global Warrant held in book-entry form through the DTC (or another established clearing corporation
performing similar functions), shall effect exercises by delivering to the DTC (or such other clearing corporation, as applicable) the
appropriate instruction form for exercise, complying with the procedures to effect exercise that are required by the DTC (or such other
clearing corporation, as applicable). The Company acknowledges that the bank accounts maintained by the Warrant Agent in connection with
the services provided under this Agreement will be in its name and that the Warrant Agent may receive investment earnings in connection
with the investment at Warrant Agent&rsquo;s risk and for its benefit of funds held in those accounts from time to time. Neither the Company
nor the Holders will receive interest on any deposits or Exercise Price. No ink-original Notice of Exercise shall be required, nor shall
any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. The Company hereby acknowledges
and agrees that, with respect to a holder whose interest in a Global Warrant is a beneficial interest in a Global Warrant held in book-entry
form through the DTC (or another established clearing corporation performing similar functions), upon delivery of irrevocable instructions
to such holder&rsquo;s Participant to exercise such warrants, that solely for purposes of Regulation SHO that such holder shall be deemed
to have exercised such warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) Upon receipt of a Notice
of Exercise for a Cashless Exercise, the Company will promptly calculate and transmit to the Warrant Agent the number of Warrant Shares
issuable in connection with such Cashless Exercise and deliver a copy of the Notice of Exercise to the Warrant Agent, which shall issue
such number of Warrant Shares in connection with such Cashless Exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) Upon the exercise of the
Warrant Certificate pursuant to the terms of Section 2 of the Warrant Certificate, the Warrant Agent shall cause the Warrant Shares underlying
such Warrant Certificate or Global Warrant to be delivered to or upon the order of the Holder of such Warrant Certificate or Global Warrant,
registered in such name or names as may be designated by such Holder, no later than the Warrant Share Delivery Date (as such term is defined
in the Warrant Certificate). If the Company is then a participant in the DWAC system of the DTC and either (A) there is an effective registration
statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by Holder or (B) the Warrant is being exercised
via Cashless Exercise, then the certificates for Warrant Shares shall be transmitted by the Warrant Agent to the Holder by crediting the
account of the Holder&rsquo;s broker with the DTC through its DWAC system. For the avoidance of doubt, if the Company becomes obligated
to pay any amounts to any Holders pursuant to Section 2(d)(i) or 2(d)(iv) of the Warrant Certificate, such obligation shall be solely
that of the Company and not that of the Warrant Agent. Notwithstanding anything else to the contrary in this Agreement, except in the
case of a Cashless Exercise, if any Holder fails to duly deliver payment to the Warrant Agent of an amount equal to the aggregate Exercise
Price of the Warrant Shares to be purchased upon exercise of such Holder&rsquo;s Warrant as set forth in Section 7(a) hereof by the Warrant
Share Delivery Date, the Warrant Agent will not obligated to deliver such Warrant Shares (via DWAC or otherwise) until following receipt
of such payment, and the applicable Warrant Share Delivery Date shall be deemed extended by one day for each day (or part thereof) until
such payment is delivered to the Warrant Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 26.55pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) The Warrant Agent shall
deposit all funds received by it in payment of the Exercise Price for all Warrants in the account of the Company maintained with the Warrant
Agent for such purpose (or to such other account as directed by the Company in writing) and shall advise the Company via email at the
end of each day on which notices of exercise are received or funds for the exercise of any Warrant are received of the amount so deposited
to its account.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 8. <U>Cancellation
and Destruction of Warrant Certificates</U>. All Warrant Certificates surrendered for the purpose of exercise, transfer, split up, combination
or exchange shall, if surrendered to the Company or to any of its agents, be delivered to the Warrant Agent for cancellation or in canceled
form, or, if surrendered to the Warrant Agent, shall be canceled by it, and no Warrant Certificate shall be issued in lieu thereof except
as expressly permitted by any of the provisions of this Agreement. The Company shall deliver to the Warrant Agent for cancellation and
retirement, and the Warrant Agent shall so cancel and retire, any other Warrant Certificate purchased or acquired by the Company otherwise
than upon the exercise thereof. The Warrant Agent shall deliver all canceled Warrant Certificates to the Company, or shall, at the written
request of the Company, destroy such canceled Warrant Certificates, and in such case shall deliver a certificate of destruction thereof
to the Company, subject to any applicable law, rule or regulation requiring the Warrant Agent to retain such canceled certificates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 9. <U>Certain Representations;
Reservation and Availability of Common Stock or Cash</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) This Agreement has been
duly authorized, executed and delivered by the Company and, assuming due authorization, execution and delivery hereof by the Warrant Agent,
constitutes a valid and legally binding obligation of the Company enforceable against the Company in accordance with its terms, and the
Warrants have been duly authorized, executed and issued by the Company and, assuming due authentication thereof by the Warrant Agent pursuant
hereto and payment therefor by the Holders as provided in the Registration Statement, constitute valid and legally binding obligations
of the Company enforceable against the Company in accordance with their terms and entitled to the benefits hereof; in each case except
as enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium and other similar laws relating to or affecting
creditors&rsquo; rights generally or by general equitable principles (regardless of whether such enforceability is considered in a proceeding
in equity or at law).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) As of the date hereof,
the authorized capital stock of the Company consists of (i) 120,000,000 shares of Common Stock, of which approximately <FONT STYLE="background-color: white">723,838
shares of </FONT>Common Stock are issued and outstanding, and 9,043,800 shares of Common Stock are reserved for issuance upon exercise
of the Warrants, and (ii) 20,000,000 shares of preferred stock, none of which are issued and outstanding . Except as disclosed in the
Registration Statement, there are no other outstanding obligations, warrants, options or other rights to subscribe for or purchase from
the Company any class of capital stock of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) The Company covenants
and agrees that it will cause to be reserved and kept available out of its authorized and unissued Common Stock or its authorized and
issued Common Stock held in its treasury, free from preemptive rights, the number of shares of Common Stock that will be sufficient to
permit the exercise in full of all outstanding Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) The Warrant Agent will
create a special account for the issuance of Common Stock upon the exercise of Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) The Company further covenants
and agrees that it will pay when due and payable any and all federal and state transfer taxes and charges which may be payable in respect
of the original issuance or delivery of the Warrant Certificates or certificates evidencing Common Stock upon exercise of the Warrants.
The Company shall not, however, be required to pay any tax or governmental charge which may be payable in respect of any transfer involved
in the transfer or delivery of Warrant Certificates or the issuance or delivery of certificates for shares of Common Stock in a name other
than that of the Holder of the Warrant Certificate evidencing Warrants surrendered for exercise or to issue or deliver any certificate
for shares of Common Stock upon the exercise of any Warrants until any such tax or governmental charge shall have been paid (any such
tax or governmental charge being payable by the Holder of such Warrant Certificate at the time of surrender) or until it has been established
to the Company&rsquo;s reasonable satisfaction that no such tax or governmental charge is due.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 10. <U>Common Stock
Record Date</U>. Each Person in whose name any certificate for shares of Common Stock is issued (or to whose broker&rsquo;s account is
credited shares of Common Stock through the DWAC system) upon the exercise of Warrants shall for all purposes be deemed to have become
the holder of record for the Common Stock represented thereby on, and such certificate shall be dated, the date on which submission of
the Notice of Exercise was made, provided that the Warrant Certificate evidencing such Warrant is duly surrendered (but only if required
herein) and payment of the Exercise Price (and any applicable transfer taxes) is received on or prior to the Warrant Share Delivery Date;
<U>provided</U>, <U>however</U>, that if the date of submission of the Notice of Exercise is a date upon which the Common Stock transfer
books of the Company are closed, such Person shall be deemed to have become the record holder of such shares on, and such certificate
shall be dated, the next succeeding day on which the Common Stock transfer books of the Company are open.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 11. <U>Adjustment
of Exercise Price, Number of Common Stock or Number of the Company Warrants</U>. The Exercise Price, the number of shares covered by each
Warrant and the number of Warrants outstanding are subject to adjustment from time to time as provided in Section 3 of the Warrant Certificate.
In the event that at any time, as a result of an adjustment made pursuant to Section 3 of the Warrant Certificate, the Holder of any Warrant
thereafter exercised shall become entitled to receive any shares of capital stock of the Company other than Common Stock, thereafter the
number of such other shares so receivable upon exercise of any Warrant shall be subject to adjustment from time to time in a manner and
on terms as nearly equivalent as practicable to the provisions with respect to the shares contained in Section 3 of the Warrant Certificate
and the provisions of Sections 7, 11 and 12 of this Agreement with respect to the Common Stock shall apply on like terms to any such other
shares. All Warrants originally issued by the Company subsequent to any adjustment made to the Exercise Price pursuant to the Warrant
Certificate shall evidence the right to purchase, at the adjusted Exercise Price, the number of shares of Common Stock purchasable from
time to time hereunder upon exercise of the Warrants, all subject to further adjustment as provided herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 12. <U>Certification
of Adjusted Exercise Price or Number of Shares of Common Stock</U>. Whenever the Exercise Price or the number of shares of Common Stock
issuable upon the exercise of each Warrant is adjusted as provided in Section 11 or 13, the Company shall (a) promptly prepare a certificate
setting forth the Exercise Price of each Warrant as so adjusted, and a brief statement of the facts accounting for such adjustment, (b)
promptly file with the Warrant Agent and with each transfer agent for the Common Stock a copy of such certificate and (c) instruct the
Warrant Agent to send a brief summary thereof to each Holder of a Warrant Certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 13. <U>Fractional
Shares of Common Stock</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) The Company shall not
issue fractions of Warrants or distribute Warrant Certificates which evidence fractional Warrants. Whenever any fractional Warrant would
otherwise be required to be issued or distributed, the actual issuance or distribution shall reflect a rounding of such fraction to the
nearest whole Warrant (rounded up).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) The Company shall not
issue fractions of shares of Common Stock upon exercise of Warrants or distribute stock certificates which evidence fractional shares
of Common Stock. Whenever any fraction of a share of Common Stock would otherwise be required to be issued or distributed, the actual
issuance or distribution in respect thereof shall be made in accordance with Section 2(d)(v) of the Warrant Certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 14. <U>Conditions
of the Warrant Agent&rsquo;s Obligations</U>. The Warrant Agent accepts its obligations herein set forth upon the terms and conditions
hereof, including the following to all of which the Company agrees and to all of which the rights hereunder of the Holders from time to
time of the Warrant Certificates shall be subject:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify"><I>Compensation and Indemnification</I>. The Company agrees promptly to pay the Warrant Agent the compensation
detailed on the fee schedule mutually agreed upon by the parties hereto and provided separately on the date hereof for all services rendered
by the Warrant Agent and to reimburse the Warrant Agent for reasonable out-of-pocket expenses (including reasonable counsel fees) incurred
without gross negligence or willful misconduct by the Warrant Agent in connection with the services rendered hereunder by the Warrant
Agent. The Company also agrees to indemnify the Warrant Agent for, and to hold it harmless against, any loss, liability or expense incurred
without gross negligence or willful misconduct on the part of the Warrant Agent, arising out of or in connection with its acting as Warrant
Agent hereunder, including the reasonable costs and expenses of defending against any claim of such liability. The Warrant Agent shall
be under no obligation to institute or defend any action, suit, or legal proceeding in connection herewith or to take any other action
likely to involve the Warrant Agent in expense, unless first indemnified to the Warrant Agent&rsquo;s satisfaction. The indemnities provided
by this paragraph shall survive the resignation or discharge of the Warrant Agent or the termination of this Agreement. Anything in this
Agreement to the contrary notwithstanding, in no event shall the Warrant Agent be liable under or in connection with the Agreement for
indirect, special, incidental, punitive or consequential losses or damages of any kind whatsoever, including but not limited to lost profits,
whether or not foreseeable, even if the Warrant Agent has been advised of the possibility thereof and regardless of the form of action
in which such damages are sought, and the Warrant Agent&rsquo;s aggregate liability to the Company, or any of the Company&rsquo;s representatives
or agents, under this Section 14(a) or under any other term or provision of this Agreement, whether in contract, tort, or otherwise, is
expressly limited to, and shall not exceed in any circumstances, one (1) year&rsquo;s fees received by the Warrant Agent as fees and charges
under this Agreement, but not including reimbursable expenses previously reimbursed to the Warrant Agent by the Company hereunder.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify"><I>Agent for the Company</I>. In acting under this Agreement and in connection with the Warrant Certificates,
the Warrant Agent is acting solely as agent of the Company and does not assume any obligations or relationship of agency or trust for
or with any of the Holders of Warrant Certificates or beneficial owners of Warrants.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(c)</TD><TD STYLE="text-align: justify"><I>Counsel</I>. The Warrant Agent may consult with counsel satisfactory to it, which may include counsel
for the Company, and the written advice of such counsel shall be full and complete authorization and protection in respect of any action
taken, suffered or omitted by it hereunder in good faith and in accordance with the advice of such counsel.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(d)</TD><TD STYLE="text-align: justify"><I>Documents</I>. The Warrant Agent shall be protected and shall incur no liability for or in respect
of any action taken or omitted by it in reliance upon any Warrant Certificate, notice, direction, consent, certificate, affidavit, statement
or other paper or document reasonably believed by it to be genuine and to have been presented or signed by the proper parties.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(e)</TD><TD STYLE="text-align: justify"><I>Certain Transactions</I>. The Warrant Agent, and its officers, directors and employees, may become
the owner of, or acquire any interest in, Warrants, with the same rights that it or they would have if it were not the Warrant Agent hereunder,
and, to the extent permitted by applicable law, it or they may engage or be interested in any financial or other transaction with the
Company and may act on, or as depositary, trustee or agent for, any committee or body of Holders of Warrant Securities or other obligations
of the Company as freely as if it were not the Warrant Agent hereunder. Nothing in this Agreement shall be deemed to prevent the Warrant
Agent from acting as trustee under any indenture to which the Company is a party.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(f)</TD><TD STYLE="text-align: justify"><I>No Liability for Interest</I>. Unless otherwise agreed with the Company, the Warrant Agent shall have
no liability for interest on any monies at any time received by it pursuant to any of the provisions of this Agreement or of the Warrant
Certificates.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(g)</TD><TD STYLE="text-align: justify"><I>No Liability for Invalidity</I>. The Warrant Agent shall have no liability with respect to any invalidity
of this Agreement or the Warrant Certificates (except as to the Warrant Agent&rsquo;s countersignature thereon).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(h)</TD><TD STYLE="text-align: justify"><I>No Responsibility for Representations</I>. The Warrant Agent shall not be responsible for any of the
recitals or representations herein or in the Warrant Certificate (except as to the Warrant Agent&rsquo;s countersignature thereon), all
of which are made solely by the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(i)</TD><TD STYLE="text-align: justify"><I>No Implied Obligations</I>. The Warrant Agent shall be obligated to perform only such duties as are
herein and in the Warrant Certificates specifically set forth and no implied duties or obligations shall be read into this Agreement or
the Warrant Certificates against the Warrant Agent. The Warrant Agent shall not be under any obligation to take any action hereunder which
may tend to involve it in any expense or liability, the payment of which within a reasonable time is not, in its reasonable opinion, assured
to it. The Warrant Agent shall not be accountable or under any duty or responsibility for the use by the Company of any of the Warrant
Certificates authenticated by the Warrant Agent and delivered by it to the Company pursuant to this Agreement or for the application by
the Company of the proceeds of the Warrant Certificate. The Warrant Agent shall have no duty or responsibility in case of any default
by the Company in the performance of its covenants or agreements contained herein or in the Warrant Certificates or in the case of the
receipt of any written demand from a Holder of a Warrant Certificate with respect to such default, including, without limiting the generality
of the foregoing, any duty or responsibility to initiate or attempt to initiate any proceedings at law.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 15. <U>Purchase or
Consolidation or Change of Name of Warrant Agent</U>. Any corporation into which the Warrant Agent or any successor Warrant Agent may
be merged or with which it may be consolidated, or any corporation resulting from any merger or consolidation to which the Warrant Agent
or any successor Warrant Agent shall be party, or any corporation succeeding to the corporate trust business of the Warrant Agent or any
successor Warrant Agent, shall be the successor to the Warrant Agent under this Agreement without the execution or filing of any paper
or any further act on the part of any of the parties hereto, provided that such corporation would be eligible for appointment as a successor
Warrant Agent under the provisions of Section 17. In case at the time such successor Warrant Agent shall succeed to the agency created
by this Agreement any of the Warrant Certificates shall have been countersigned but not delivered, any such successor Warrant Agent may
adopt the countersignature of the predecessor Warrant Agent and deliver such Warrant Certificates so countersigned; and in case at that
time any of the Warrant Certificates shall not have been countersigned, any successor Warrant Agent may countersign such Warrant Certificates
either in the name of the predecessor Warrant Agent or in the name of the successor Warrant Agent; and in all such cases such Warrant
Certificates shall have the full force provided in the Warrant Certificates and in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In case at any time the name
of the Warrant Agent shall be changed and at such time any of the Warrant Certificates shall have been countersigned but not delivered,
the Warrant Agent may adopt the countersignature under its prior name and deliver such Warrant Certificates so countersigned; and in case
at that time any of the Warrant Certificates shall not have been countersigned, the Warrant Agent may countersign such Warrant Certificates
either in its prior name or in its changed name; and in all such cases such Warrant Certificates shall have the full force provided in
the Warrant Certificates and in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 16. <U>Duties of
Warrant Agent</U>. The Warrant Agent undertakes the duties and obligations imposed by this Agreement upon the following terms and conditions,
by all of which the Company, by its acceptance hereof, shall be bound:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) The Warrant Agent may
consult with legal counsel reasonably acceptable to the Company (who may be legal counsel for the Company), and the opinion of such counsel
shall be full and complete authorization and protection to the Warrant Agent as to any action taken or omitted by it in good faith and
in accordance with such opinion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 26.55pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) Whenever in the performance
of its duties under this Agreement the Warrant Agent shall deem it necessary or desirable that any fact or matter be proved or established
by the Company prior to taking or suffering any action hereunder, such fact or matter (unless other evidence in respect thereof be herein
specifically prescribed) may be deemed to be conclusively proved and established by a certificate signed by the Chief Executive Officer,
Chief Financial Officer or Vice President of the Company; and such certificate shall be full authentication to the Warrant Agent for any
action taken or suffered in good faith by it under the provisions of this Agreement in reliance upon such certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) Subject to the limitation
set forth in Section 14, the Warrant Agent shall be liable hereunder only for its own gross negligence or willful misconduct, or for a
breach by it of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) The Warrant Agent shall
not be liable for or by reason of any of the statements of fact or recitals contained in this Agreement or in the Warrant Certificate
(except its countersignature thereof) by the Company or be required to verify the same, but all such statements and recitals are and shall
be deemed to have been made by the Company only.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) The Warrant Agent shall
not be under any responsibility in respect of the validity of this Agreement or the execution and delivery hereof (except the due execution
hereof by the Warrant Agent) or in respect of the validity or execution of any Warrant Certificate (except its countersignature thereof);
nor shall it be responsible for any breach by the Company of any covenant or condition contained in this Agreement or in any Warrant Certificate;
nor shall it be responsible for the adjustment of the Exercise Price or the making of any change in the number of shares of Common Stock
required under the provisions of Section 11 or 13 or responsible for the manner, method or amount of any such change or the ascertaining
of the existence of facts that would require any such adjustment or change (except with respect to the exercise of Warrants evidenced
by the Warrant Certificates after actual notice of any adjustment of the Exercise Price); nor shall it by any act hereunder be deemed
to make any representation or warranty as to the authorization or reservation of any shares of Common Stock to be issued pursuant to this
Agreement or any Warrant Certificate or as to whether any shares of Common Stock will, when issued, be duly authorized, validly issued,
fully paid and nonassessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f) Each party hereto agrees
that it will perform, execute, acknowledge and deliver or cause to be performed, executed, acknowledged and delivered all such further
and other acts, instruments and assurances as may reasonably be required by the other party hereto for the carrying out or performing
by any party of the provisions of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g) The Warrant Agent is
hereby authorized to accept instructions with respect to the performance of its duties hereunder from the Chief Executive Officer, Chief
Financial Officer or Vice President of the Company, and to apply to such officers for advice or instructions in connection with its duties,
and it shall not be liable and shall be indemnified and held harmless for any action taken or suffered to be taken by it in good faith
in accordance with instructions of any such officer, provided Warrant Agent carries out such instructions without gross negligence or
willful misconduct.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h) The Warrant Agent and
any shareholder, director, officer or employee of the Warrant Agent may buy, sell or deal in any of the Warrants or other securities of
the Company or become pecuniarily interested in any transaction in which the Company may be interested, or contract with or lend money
to the Company or otherwise act as fully and freely as though it were not Warrant Agent under this Agreement. Nothing herein shall preclude
the Warrant Agent from acting in any other capacity for the Company or for any other legal entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) The Warrant Agent may
execute and exercise any of the rights or powers hereby vested in it or perform any duty hereunder either itself or by or through its
attorney or agents, and the Warrant Agent shall not be answerable or accountable for any act, default, neglect or misconduct of any such
attorney or agents or for any loss to the Company resulting from any such act, default, neglect or misconduct, provided reasonable care
was exercised in the selection and continued employment thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 17. <U>Change of
Warrant Agent</U>. The Warrant Agent may resign and be discharged from its duties under this Agreement upon 30 days&rsquo; notice in writing
sent to the Company and to each transfer agent of the Common Stock and to the Holders of the Warrant Certificates. The Company may remove
the Warrant Agent or any successor Warrant Agent upon 30 days&rsquo; notice in writing, sent to the Warrant Agent or successor Warrant
Agent, as the case may be, and to each transfer agent of the Common Stock, and to the Holders of the Warrant Certificates. If the Warrant
Agent shall resign or be removed or shall otherwise become incapable of acting, the Company shall appoint a successor to the Warrant Agent.
If the Company shall fail to make such appointment within a period of 30 days after such removal or after it has been notified in writing
of such resignation or incapacity by the resigning or incapacitated Warrant Agent or by the Holder of a Warrant Certificate (who shall,
with such notice, submit his Warrant Certificate for inspection by the Company), then the Holder of any Warrant Certificate may apply
to any court of competent jurisdiction for the appointment of a new Warrant Agent, provided that, for purposes of this Agreement, the
Company shall be deemed to be the Warrant Agent until a new warrant agent is appointed. Any successor Warrant Agent, whether appointed
by the Company or by such a court, shall be a corporation organized and doing business under the laws of the United States or of a state
thereof, in good standing, which is authorized under such laws to exercise corporate trust powers and is subject to supervision or examination
by federal or state authority and which has at the time of its appointment as Warrant Agent a combined capital and surplus of at least
$50,000,000. After appointment, the successor Warrant Agent shall be vested with the same powers, rights, duties and responsibilities
as if it had been originally named as Warrant Agent without further act or deed; but the predecessor Warrant Agent shall deliver and transfer
to the successor Warrant Agent any property at the time held by it hereunder, and execute and deliver any further assurance, conveyance,
act or deed necessary for the purpose. Not later than the effective date of any such appointment, the Company shall file notice thereof
in writing with the predecessor Warrant Agent and each transfer agent of the Common Stock, and mail a notice thereof in writing to the
Holders of the Warrant Certificates. However, failure to give any notice provided for in this Section 17, or any defect therein, shall
not affect the legality or validity of the resignation or removal of the Warrant Agent or the appointment of the successor Warrant Agent,
as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 18. <U>Issuance of
New Warrant Certificates</U>. Notwithstanding any of the provisions of this Agreement or of the Warrants to the contrary, the Company
may, at its option, issue new Warrant Certificates evidencing Warrants in such form as may be approved by its Board of Directors to reflect
any adjustment or change in the Exercise Price per share and the number or kind or class of shares of stock or other securities or property
purchasable under the several Warrant Certificates made in accordance with the provisions of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 19. <U>Notices</U>.
Notices or demands authorized by this Agreement to be given or made (i) by the Warrant Agent or by the Holder of any Warrant Certificate
to or on the Company, (ii) subject to the provisions of Section 17, by the Company or by the Holder of any Warrant Certificate to or on
the Warrant Agent or (iii) by the Company or the Warrant Agent to the Holder of any Warrant Certificate shall be deemed given (a) on the
date delivered, if delivered personally, (b) on the first Business Day following the deposit thereof with Federal Express or another recognized
overnight courier, if sent by Federal Express or another recognized overnight courier, (c) on the fourth Business Day following the mailing
thereof with postage prepaid, if mailed by registered or certified mail (return receipt requested), and (d) the date of transmission,
if such notice or communication is delivered via facsimile or email attachment at or prior to 5:30 p.m. (New York City time) on a Business
Day and (e) the next Business Day after the date of transmission, if such notice or communication is delivered via facsimile or email
attachment on a day that is not a Business Day or later than 5:30 p.m. (New York City time) on any Business Day, in each case to the parties
at the following addresses (or at such other address for a party as shall be specified by like notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify"><B>If to the Company, to</B>:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 58.95pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: 0.5in">Peraso Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: 0.5in">2309 Bering Drive</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: 0.5in">San Jose, CA 95131</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.25pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify"><B>If to the Warrant Agent, to</B>:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 58.95pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: 0.5in">Equiniti Trust Company, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: 0.5in">1110 Centre Pointe Curve, Suite 101</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: 0.5in">Mendota Heights, MN 55120-4101</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: 0.5in">Attention: Corporate Actions</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For any notice delivered by email to be deemed
given or made, such notice must be followed by notice sent by overnight courier service to be delivered on the next business day following
such email, unless the recipient of such email has acknowledged via return email receipt of such email.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) If to the Holder of any
Warrant Certificate to the address of such Holder as shown on the registry books of the Company. Any notice required to be delivered by
the Company to the Holder of any Warrant may be given by the Warrant Agent on behalf of the Company. Notwithstanding any other provision
of this Agreement, where this Agreement provides for notice of any event to a Holder of any Warrant, such notice shall be sufficiently
given if given to the DTC (or its designee) pursuant to the procedures of the DTC or its designee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 20. <U>Supplements
and Amendments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) The Company and the Warrant
Agent may from time to time supplement or amend this Agreement without the approval of any Holders of Global Warrants in order to add
to the covenants and agreements of the Company for the benefit of the Holders of the Global Warrants or to surrender any rights or power
reserved to or conferred upon the Company in this Agreement, provided that such addition or surrender shall not adversely affect the interests
of the Holders of the Global Warrants or Warrant Certificates in any material respect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) In addition to the foregoing,
with the consent of Holders of Warrants entitled, upon exercise thereof, to receive not less than a majority of the shares of Common Stock
issuable under Warrants which are not beneficially owned by Affiliates of the Company, the Company and the Warrant Agent may modify this
Agreement for the purpose of adding any provisions to or changing in any manner or eliminating any of the provisions of this Agreement
or modifying in any manner the rights of the Holders of the Global Warrants; <U>provided</U>, <U>however</U>, that no modification of
the terms (including but not limited to the adjustments described in Section 11) upon which the Warrants are exercisable or the rights
of holders of Warrants to receive liquidated damages or other payments in cash from the Company or reducing the percentage required for
consent to modification of this Agreement may be made without the consent of the Holder of each outstanding Warrant Certificate affected
thereby; <U>provided</U>, <U>further</U>, <U>however</U>, that no amendment hereunder shall affect any terms of any Warrant Certificate
issued in a Warrant Exchange. As a condition precedent to the Warrant Agent&rsquo;s execution of any amendment, the Company shall deliver
to the Warrant Agent a certificate from a duly authorized officer of the Company that states that the proposed amendment complies with
the terms of this Section 20.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 21. <U>Successors</U>.
All covenants and provisions of this Agreement by or for the benefit of the Company or the Warrant Agent shall bind and inure to the benefit
of their respective successors and assigns hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 22. <U>Benefits of
this Agreement</U>. Nothing in this Agreement shall be construed to give any Person other than the Company, the Holders of Warrant Certificates
and the Warrant Agent any legal or equitable right, remedy or claim under this Agreement. This Agreement shall be for the sole and exclusive
benefit of the Company, the Warrant Agent and the Holders of the Warrant Certificates. Notwithstanding anything to the contrary contained
herein, to the extent any provision of a Warrant Certificate conflicts with any provision of this Agreement, the provisions of the Warrant
Certificate shall govern and be controlling.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 23. <U>Governing
Law</U>. This Agreement and each Warrant Certificate and Global Warrant issued hereunder shall be governed by, and construed in accordance
with, the laws of the State of New York, without giving effect to the conflicts of law principles thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 24. <U>Counterparts</U>.
This Agreement may be executed in two or more counterparts, each one of which shall be an original, with the same effect as if the signatures
thereto and hereto were upon the same instrument, and may be delivered by electronic delivery of a portable document format (PDF) file
(including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic
Signatures and Records Act or other applicable law, e.g., www.docusign.com).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 25. <U>Captions</U>.
The captions of the sections of this Agreement have been inserted for convenience only and shall not control or affect the meaning or
construction of any of the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 26. <U>Information</U>.
The Company agrees to promptly provide to the Holders of the Warrants any information it provides to the holders of the shares of Common
Stock, except to the extent any such information is publicly available on the EDGAR system (or any successor thereof) of the Securities
and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">[<I>Signature page to follow</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
hereto have caused this Agreement to be duly executed as of the day and year first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PERASO INC.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ James Sullivan</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="width: 31%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">James Sullivan</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CFO</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EQUINITI TRUST COMPANY, LLC</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Michael Legregin</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael Legregin</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Senior Vice President</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Exhibit 1-A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Form of Pre-Funded Warrant Certificate</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>PRE-FUNDED COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>PERASO INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%">Warrant Shares: 1,424,760</TD>
    <TD STYLE="text-align: right; width: 50%">Initial Exercise Date: February 8, 2024</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">CUSIP: 71360T 127</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ISIN: US71360T1271</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">THIS PRE-FUNDED COMMON STOCK
PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, CEDE &amp; CO. or its assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) until this Warrant is exercised in full (the &ldquo;<U>Termination Date</U>&rdquo;)
but not thereafter, to subscribe for and purchase from Peraso Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to 1,424,760
shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of Common Stock. The purchase price of one share
of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued
and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee (&ldquo;<U>DTC</U>&rdquo;)
shall initially be the sole registered holder of this Warrant, subject to a Holder&rsquo;s right to elect to receive a Warrant in certificated
form pursuant to the terms of the Warrant Agency Agreement, in which case this sentence shall not apply.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 1</U>. <U>Definitions</U>.
In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated in this Section 1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Bid Price</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading
Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York
City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in
good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the fees
and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized
or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;&nbsp;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally
are open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration
Statement</U>&rdquo; means the Company&rsquo;s registration statement on Form S-1 (File No. 333-276247).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed
or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the Common Stock is traded on a Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange, OTCQB or OTCQX (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transfer
Agent</U>&rdquo; means Equiniti Trust Company, LLC, the current transfer agent of the Company, with a mailing address of 1110 Centre Pointe
Curve, Suite 101, Mendota Heights, MN 55120-4101, Attn: Corporate Actions, and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Underwriting
Agreement</U>&rdquo; means the underwriting agreement, dated as of February 6, 2024, among the Company and Ladenburg Thalmann &amp; Co.
Inc. as representative of the underwriters named therein, as amended, modified or supplemented from time to time in accordance with its
terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted
average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock
is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market
(or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrant
Agency Agreement</U>&rdquo; means that certain warrant agency agreement, dated on or about the Initial Exercise Date, between the Company
and the Warrant Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrant
Agent</U>&rdquo; means the Transfer Agent and any successor warrant agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrants</U>&rdquo;
means this Warrant and other Pre-Funded Common Stock purchase warrants issued by the Company pursuant to the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 2</U>. <U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted
by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;). Within
the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section
2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the shares specified
in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless the cashless exercise
procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall
be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding
anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder
has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall
surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise
is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares
available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal
to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant
Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Business
Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of
the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available
for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">Notwithstanding
the foregoing in this Section 2(a), a holder whose interest in this Warrant is a beneficial interest in certificate(s) representing this
Warrant held in book-entry form through DTC (or another established clearing corporation performing similar functions), shall effect exercises
made pursuant to this Section 2(a) by delivering to DTC (or such other clearing corporation, as applicable) the appropriate instruction
form for exercise, complying with the procedures to effect exercise that are required by DTC (or such other clearing corporation, as applicable),
subject to a Holder&rsquo;s right to elect to receive a Warrant in certificated form pursuant to the terms of the Warrant Agency Agreement,
in which case this sentence shall not apply.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Exercise
Price</U>. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.001 per Warrant Share, was pre-funded
to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise
price of $0.001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The
Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance
or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining
unpaid exercise price per share of Common Stock under this Warrant shall be $0.001, subject to adjustment hereunder (the &ldquo;<U>Exercise
Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Cashless
Exercise</U>. This Warrant may also be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which
the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 95.25pt; text-align: justify; text-indent: -20.25pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD>
    <TD STYLE="text-align: left; width: 0.25in">(A)</TD><TD STYLE="text-align: center; width: 0.15in">= </TD><TD STYLE="text-align: justify">as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice
of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading
Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading
hours&rdquo; (as defined in Rule 600(b)(68) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, or the
Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg as of the time of the Holder&rsquo;s execution
of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day
and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading hours&rdquo;
on a Trading Day) pursuant to Section 2(a) hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 75pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD>
    <TD STYLE="width: 0.25in">(B)</TD><TD STYLE="width: 0.15in; text-align: center">=</TD><TD STYLE="text-align: justify"> the Exercise Price of this Warrant, as adjusted hereunder;
and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 1in">&nbsp;</TD>
<TD STYLE="width: 0.25in">(X)</TD><TD STYLE="width: 0.15in; text-align: center">=</TD><TD STYLE="text-align: justify"> the number of Warrant Shares that would be issuable upon
exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a
cashless exercise.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">If Warrant Shares
are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act,
the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not to take any position
contrary to this Section 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"> d) <U>Mechanics of Exercise</U>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -9pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"> i. <U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by book entry of a certificate, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. Notwithstanding anything herein to the contrary, the Company shall not be responsible for the payment of liquidated damages resulting from the failure to issue or deliver Warrant Shares if such failure is caused solely by any action or inaction of the Holder. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise. Notwithstanding the foregoing, with respect to any Notice(s) of Exercise delivered on or prior to 12:00 p.m. (New York City time) on the Initial Exercise Date, which may be delivered at any time after the time of execution of the Underwriting Agreement, the Company agrees to deliver the Warrant Shares subject to such notice(s) by 4:00 p.m. (New York City time) on the Initial Exercise Date and the Initial Exercise Date shall be the Warrant Share Delivery Date for purposes hereunder, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received by such Warrant Share Delivery Date.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii. <U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights
of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be
identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iii. <U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iv. <U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date (other than any such failure that is solely due to
any action or inaction by the Holder with respect to such exercise), and if after such date the Holder is required by its broker to purchase
(in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common Stock to deliver
in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;),
then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s total purchase price (including
brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number
of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price
at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the
portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall
be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely
complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase
price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving
rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay
the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the
Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue
any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or
injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock upon exercise of the Warrant as
required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">v. <U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">vi. <U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>, <U>however</U>,
that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition
thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent
fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing
corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">vii. <U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting
as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&nbsp; For purposes of the foregoing sentence,
the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties.&nbsp; Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial
ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder,
it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section
13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the
extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation
to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is
exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s
determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates
and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation.
To ensure compliance with this restriction, each Holder shall be deemed to represent to the Company each time it delivers a Notice of
Exercise that such Notice of Exercise has not violated the restrictions set forth in this paragraph, and the Company shall have no obligation
to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall
be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes
of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding
shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the
case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent
setting forth the number of shares of Common Stock outstanding.&nbsp; Upon the written or oral request of a Holder, the Company shall
within one Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.&nbsp; In any
case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities
of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number
of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% (or, upon
election by a Holder prior to the issuance of any Warrants, 9.99%) of the number of shares of the Common Stock outstanding immediately
after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company,
may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation
in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares
of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any
increase in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to
the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with
the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended
Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such
limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 3</U>. <U>Certain
Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common
Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the
numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective
date in the case of a subdivision, combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Reserved</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells
any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any
class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms
applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number
of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including
without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance
or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are
to be determined for the grant, issue or sale of such Purchase Rights (provided, however, that, to the extent that the Holder&rsquo;s
right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder
shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as
a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until
such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Pro
Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution
of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including,
without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after
the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent
that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise
of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation)
immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the
record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>, <U>however</U>,
that, to the extent that the Holder's right to participate in any such Distribution would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership
of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance
for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation). To the extent that this Warrant has not been partially or completely exercised at the time of such Distribution, such portion
of the Distribution shall be held in abeyance for the benefit of the Holder until the Holder has exercised this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions
effects any merger or consolidation of the Company with or into another Person, (ii) the Company or any Subsidiary, directly or indirectly,
effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one
or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company
or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other
securities, cash or property and has been accepted by the holders of greater than 50% of the outstanding Common Stock or greater than
50% of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more related transactions
effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which
the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly,
in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without
limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby
such other Person or group acquires greater than 50% of the outstanding shares of Common Stock or greater than 50% of the voting power
of the common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this
Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately
prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e)
on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if
it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result
of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately
prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes
of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration
based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the
Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any
different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property
to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives
upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor entity in a Fundamental
Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations
of the Company under this Warrant in accordance with the provisions of this Section 3(e) pursuant to written agreements in form and substance
reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and
shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by
a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares
of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon
exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and
with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative
value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number
of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately
prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder.
Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the term &ldquo;Company&rdquo; under this
Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction, each and every provision of this Warrant
and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead to each of the Company and the Successor
Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor Entities, jointly and severally with the Company,
may exercise every right and power of the Company prior thereto and the Successor Entity or Successor Entities shall assume all of the
obligations of the Company prior thereto under this Warrant and the other Transaction Documents with the same effect as if the Company
and such Successor Entity or Successor Entities, jointly and severally, had been named as the Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits
of the provisions of this Section 3(e) regardless of (i) whether the Company has sufficient authorized shares of Common Stock for the
issuance of Warrant Shares and/or (ii) whether a Fundamental Transaction occurs prior to the Initial Exercise Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f) <U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g) <U>Notice
to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i. <U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii. <U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall
authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock
of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of
all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall
appear upon the Warrant Register of the Company, at least 10 calendar days prior to the applicable record or effective date hereinafter
specified, a notice (unless such information is filed with the Commission, in which case a notice shall not be required) stating (x) the
date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is
not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption,
rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share
exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record
shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification,
consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in
the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that
any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries,
the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain
entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering
such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 4</U>. <U>Transfer
of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Transferability</U>.
Subject to compliance with any applicable securities laws, this Warrant and all rights hereunder (including, without limitation, any registration
rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated
agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its
agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if
required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable,
and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing
the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary,
the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full,
in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers
an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised
by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>New
Warrants</U>. If this Warrant is not held in global form through DTC (or any successor depositary), this Warrant may be divided or combined
with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names
and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section
4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or
Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers
or exchanges shall be dated the initial issuance date of this Warrant and shall be identical with this Warrant except as to the number
of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Warrant
Register</U>. The Warrant Agent shall register this Warrant, upon records to be maintained by the Warrant Agent for that purpose (the
&ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company and the Warrant Agent may
deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution
to the Holder, and for all other purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5</U>. <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>No
Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set
forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to
Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required
to net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Authorized
Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number
of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further
covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the
necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action
as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation,
or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares
which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented
by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any
transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior
to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and
legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts
to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary
to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by and
construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of
law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Warrant (whether brought against a party hereto or their respective affiliates, directors, officers, shareholders,
partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York.
Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough
of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed
herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally
subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding.
Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding
by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address
in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient service of process and
notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted
by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant, the prevailing party in
such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys&rsquo; fees and other costs and
expenses incurred with the investigation, preparation and prosecution of such action or proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f) <U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g) <U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of this
Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages
to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but
not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts
due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">h) <U>Notices</U>.
Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any Notice
of Exercise, shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight courier service, addressed
to the Company, at 2309 Bering Drive, San Jose, CA 95131, Attention: James W. Sullivan, email address: jsullivan@perasoinc.com, or such
other email address or address as the Company may specify for such purposes by notice to the Holders. Any and all notices or other communications
or deliveries to be provided by the Company hereunder shall be in writing and delivered personally, by e-mail, or sent by a nationally
recognized overnight courier service addressed to each Holder at the e-mail address or address of such Holder appearing on the books of
the Company. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest of (i) the
time of transmission, if such notice or communication is delivered via e-mail at the e-mail address set forth in this Section prior to
5:30 p.m. (New York City time) on any date, (ii) the next Trading Day after the time of transmission, if such notice or communication
is delivered via e-mail at the e-mail address set forth in this Section on a day that is not a Trading Day or later than 5:30 p.m. (New
York City time) on any Trading Day, (iii) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized
overnight courier service, or (iv) upon actual receipt by the party to whom such notice is required to be given. To the extent that any
notice provided hereunder constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries, the Company
shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">i) <U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">j) <U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">k) <U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">l) <U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand, and
the Holder or the beneficial owner of this Warrant, on the other hand</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">m) <U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">n) <U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">o) <U>Warrant
Agency Agreement.</U> If this Warrant is held in global form through DTC (or any successor depositary), this Warrant is issued subject
to the Warrant Agency Agreement. To the extent any provision of this Warrant conflicts with the express provisions of the Warrant Agency
Agreement, the provisions of this Warrant shall govern and be controlling.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I></I></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>PERASO INC.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 4%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 31%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">To: <B>PERASO
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(1) The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2) Payment
shall take the form of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&#9744; in lawful money
of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&#9744; if permitted,
the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise
this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in
subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(3) Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Investing Entity: _________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Investing
Entity</I>: __________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: ____________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: _____________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: ________________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ASSIGNMENT FORM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><I>(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">FOR VALUE RECEIVED, the foregoing
Warrant and all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 40%">______________________________________</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Address:</FONT></TD>
    <TD>______________________________________</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Phone Number:</FONT></TD>
    <TD STYLE="text-align: justify">______________________________________</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Email Address:</TD>
    <TD STYLE="text-align: justify">______________________________________</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Dated: _______________ __, ______</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Holder&rsquo;s Signature:_______________________</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Holder&rsquo;s Address:_________________________</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>


<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Exhibit 1-B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Form of Series A Warrant Certificate</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SERIES A COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PERASO INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Warrant Shares: 4,380,948</FONT></TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Initial Exercise Date: February 8, 2024</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">CUSIP: 71360T 119</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">ISIN: US71360T1198</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">THIS SERIES A COMMON STOCK PURCHASE
WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, CEDE &amp; CO. or its assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00 p.m. (New York City time) on February 8, 2029
the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Peraso Inc., a Delaware corporation
(the &ldquo;<U>Company</U>&rdquo;), up to 4,380,948 shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;)
of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in
Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository
Trust Company or its nominee (&ldquo;<U>DTC</U>&rdquo;) shall initially be the sole registered holder of this Warrant, subject to a Holder&rsquo;s
right to elect to receive a Warrant in certificated form pursuant to the terms of the Warrant Agency Agreement, in which case this sentence
shall not apply.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 1</U>. <U>Definitions</U>.
In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated in this Section 1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Bid Price</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading
Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York
City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in
good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the fees
and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 34; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized
or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;&nbsp;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally
are open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration
Statement</U>&rdquo; means the Company&rsquo;s registration statement on Form S-1 (File No. 333-276247).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed
or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the Common Stock is traded on a Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange, OTCQB or OTCQX (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transfer
Agent</U>&rdquo; means Equiniti Trust Company, LLC, the current transfer agent of the Company, with a mailing address of 1110 Centre Pointe
Curve, Suite 101, Mendota Heights, MN 55120-4101, Attn: Corporate Actions, and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Underwriting
Agreement</U>&rdquo; means the underwriting agreement, dated as of February 6, 2024, among the Company and Ladenburg Thalmann &amp; Co.
Inc. as representative of the underwriters named therein, as amended, modified or supplemented from time to time in accordance with its
terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted
average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock
is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market
(or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrant
Agency Agreement</U>&rdquo; means that certain warrant agency agreement, dated on or about the Initial Exercise Date, between the Company
and the Warrant Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrant
Agent</U>&rdquo; means the Transfer Agent and any successor warrant agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrants</U>&rdquo;
means this Warrant and other Series A Common Stock purchase warrants issued by the Company pursuant to the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 2</U>. <U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)<FONT STYLE="font-size: 10pt">
</FONT><U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any
time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed
PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;).
Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the
shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless the
cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice
of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise
be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to
the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in
which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which
the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the
total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable
hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing
the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise
within one (1) Business Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and
agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number
of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">Notwithstanding
the foregoing in this Section 2(a), a holder whose interest in this Warrant is a beneficial interest in certificate(s) representing this
Warrant held in book-entry form through DTC (or another established clearing corporation performing similar functions), shall effect exercises
made pursuant to this Section 2(a) by delivering to DTC (or such other clearing corporation, as applicable) the appropriate instruction
form for exercise, complying with the procedures to effect exercise that are required by DTC (or such other clearing corporation, as applicable),
subject to a Holder&rsquo;s right to elect to receive a Warrant in certificated form pursuant to the terms of the Warrant Agency Agreement,
in which case this sentence shall not apply.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)<FONT STYLE="font-size: 10pt">
</FONT><U>Exercise Price</U>. The exercise price per share of Common Stock under this Warrant shall be $2.25, subject to adjustment hereunder
(the &ldquo;<U>Exercise Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)<FONT STYLE="font-size: 10pt">
</FONT><U>Cashless Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus
contained therein is not available for the issuance of the Warrant Shares to the Holder, then this Warrant may also be exercised, in whole
or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant
Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">(A)</TD><TD STYLE="text-align: justify">= as applicable: (i) the VWAP on the Trading Day immediately
preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section
2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior
to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b)(68) of Regulation NMS promulgated under the federal
securities laws) on such Trading Day, or the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg as
of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular
trading hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close
of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">(B)</TD><TD STYLE="text-align: justify">= the Exercise Price of this Warrant, as adjusted hereunder;
and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">(X)</TD><TD STYLE="text-align: justify">= the number of Warrant Shares that would be issuable upon exercise
of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless
exercise.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">If Warrant Shares
are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act,
the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not to take any position
contrary to this Section 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"> d) <U>Mechanics of Exercise</U>.</P>



<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"> i. <U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by book entry of a certificate, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. Notwithstanding anything herein to the contrary, the Company shall not be responsible for the payment of liquidated damages resulting from the failure to issue or deliver Warrant Shares if such failure is caused solely by any action or inaction of the Holder. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise</P>



<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">ii.</TD><TD STYLE="text-align: justify"><U>Delivery of New Warrants Upon Exercise</U>. If this Warrant
shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender of this Warrant, at the time of delivery
of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares
called for by this Warrant, which new Warrant shall in all other respects be identical with this Warrant.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">iii.</TD><TD STYLE="text-align: justify"><U>Rescission Rights</U>. If the Company fails to cause the
Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i) by the Warrant Share Delivery Date, then the
Holder will have the right to rescind such exercise.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">iv.</TD><TD STYLE="text-align: justify"><U>Compensation for Buy-In on Failure to Timely Deliver Warrant
Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if the Company fails to cause the Transfer Agent to
transmit to the Holder the Warrant Shares in accordance with the provisions of Section 2(d)(i) above pursuant to an exercise on or before
the Warrant Share Delivery Date (other than any such failure that is solely due to any action or inaction by the Holder with respect
to such exercise), and if after such date the Holder is required by its broker to purchase (in an open market transaction or otherwise)
or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of
the Warrant Shares which the Holder anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall
(A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s total purchase price (including brokerage commissions,
if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that
the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell order
giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant
and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded)
or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its exercise
and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover
a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase obligation
of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder
shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the
Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue any other remedies available
to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect
to the Company&rsquo;s failure to timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms
hereof.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">v.</TD><TD STYLE="text-align: justify"><U>No Fractional Shares or Scrip</U>. No fractional shares
or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As to any fraction of a share which the Holder
would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect
of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round up to the next whole share.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">vi.</TD><TD STYLE="text-align: justify"><U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares
shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such
Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant Shares shall be issued in the name of
the Holder or in such name or names as may be directed by the Holder; <U>provided</U>, <U>however</U>, that, in the event that Warrant
Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied
by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition thereto, the payment of
a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent fees required for
same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing corporation
performing similar functions) required for same-day electronic delivery of the Warrant Shares.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">vii.</TD><TD STYLE="text-align: justify"><U>Closing of Books</U>. The Company will not close its stockholder
books or records in any manner which prevents the timely exercise of this Warrant, pursuant to the terms hereof.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)<FONT STYLE="font-size: 10pt">
</FONT><U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have
the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such
issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and
any other Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution
Parties</U>&rdquo;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&nbsp; For purposes of
the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties
shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is
being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised
portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion
of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock
Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the
Holder or any of its Affiliates or Attribution Parties.&nbsp; Except as set forth in the preceding sentence, for purposes of this Section
2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance
with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith.
To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in
relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant
is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s
determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates
and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation.
To ensure compliance with this restriction, each Holder shall be deemed to represent to the Company each time it delivers a Notice of
Exercise that such Notice of Exercise has not violated the restrictions set forth in this paragraph, and the Company shall have no obligation
to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall
be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes
of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding
shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the
case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent
setting forth the number of shares of Common Stock outstanding.&nbsp; Upon the written or oral request of a Holder, the Company shall
within one Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.&nbsp; In any
case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities
of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number
of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% (or, upon
election by a Holder prior to the issuance of any Warrants, 9.99%) of the number of shares of the Common Stock outstanding immediately
after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company,
may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation
in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares
of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any
increase in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to
the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with
the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended
Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such
limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 3</U>. <U>Certain
Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)<FONT STYLE="font-size: 10pt">
</FONT><U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or
otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable
in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise
of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way
of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares
of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction
of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before
such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the
number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this
Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record
date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after
the effective date in the case of a subdivision, combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)<FONT STYLE="font-size: 10pt">
</FONT><U>Reserved</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)<FONT STYLE="font-size: 10pt">
</FONT><U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants,
issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had
held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise
hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for
the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares
of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, that, to the extent that
the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation,
then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of
Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the
Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)<FONT STYLE="font-size: 10pt">
</FONT><U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend
or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend,
spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the
beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation). To the extent that this Warrant has not been partially or completely exercised at the
time of such Distribution, such portion of the Distribution shall be held in abeyance for the benefit of the Holder until the Holder has
exercised this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"> e) <U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related
transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company or any Subsidiary,
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or
substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender
offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are
permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of
greater than 50% of the outstanding Common Stock or greater than 50% of the voting power of the common equity of the Company, (iv)
the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or
recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted
into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related
transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a
reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such
other Person or group acquires greater than 50% of the outstanding shares of Common Stock or greater than 50% of the voting power of
the common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this
Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise
immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation
in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or
of the Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate
Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock
for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section
2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be
appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect
of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate
Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If
holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction,
then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant
following such Fundamental Transaction. Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, other
than in clause (i) above in connection with a merger or consolidation of the Company with any Subsidiary or Affiliate whereby the
stockholders of the Company do not own at least (x) 50.1% of the outstanding shares of Common Stock and (y) 50.1% of the voting
power of the surviving entity immediately after such merger or consolidation, the Company or any Successor Entity (as defined below)
shall, at the Holder&rsquo;s option, exercisable at any time concurrently with, or within 30 days after, the consummation of the
Fundamental Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction), purchase this
Warrant from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of the
remaining unexercised portion of this Warrant on the date of the consummation of such Fundamental Transaction; <U>provided</U>, <U>however</U>,
that, if the Fundamental Transaction is not within the Company&rsquo;s control, including not approved by the Company&rsquo;s Board
of Directors, the Holder shall only be entitled to receive from the Company or any Successor Entity the same type or form of
consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that is being
offered and paid to the holders of Common Stock of the Company in connection with the Fundamental Transaction, whether that
consideration be in the form of cash, stock or any combination thereof, or whether the holders of Common Stock are given the choice
to receive from among alternative forms of consideration in connection with the Fundamental Transaction; <U>provided</U>, <U>further</U>,
that if holders of Common Stock of the Company are not offered or paid any consideration in such Fundamental Transaction <FONT STYLE="background-color: white">and
the Company remains the Successor Entity following such Fundamental Transaction</FONT>, such holders of Common Stock will be deemed
to have received common stock of the Successor Entity in such Fundamental Transaction. &ldquo;<U>Black Scholes Value</U>&rdquo;
means the value of this Warrant based on the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on
Bloomberg, L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) determined as of the day of consummation of the applicable Fundamental Transaction
for pricing purposes and reflecting (i) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the
remaining term of this Warrant as of such date of request, (ii) an expected volatility equal to the remaining term of this Warrant
obtained from the HVT function on Bloomberg as of the Trading Day immediately prior to the public announcement of the applicable
Fundamental Transaction or, if the Fundamental Transaction is not publicly announced, the date the Fundamental Transaction is
consummated, (iii) the underlying price per share used in such calculation shall be the greater of (A) the sum of the price per
share being offered in cash, if any, plus the per share value of any non-cash consideration, if any, being offered in such
Fundamental Transaction and (B) the greater of (x) the last weighted average price of the Common Stock immediately prior to the
public announcement of such Fundamental Transaction and (y) the last weighted average price of the Common Stock immediately prior to
the consummation of such Fundamental Transaction, (iv) a zero cost of borrow and (v) a 360 day annualization factor. The payment of
the Black Scholes Value will be made by wire transfer of immediately available funds (or such other consideration) within the later
of (i) five Business Days of the Holder&rsquo;s election and (ii) the date of consummation of the Fundamental Transaction. The
Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the
&ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant in accordance
with the provisions of this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder
and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the
Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument
substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital
stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon
exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction,
and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the
relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock,
such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this
Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and
substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the term
&ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction,
each and every provision of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer
instead to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or
Successor Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto and the
Successor Entity or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and the
other Transaction Documents with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and
severally, had been named as the Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits
of the provisions of this Section 3(e) regardless of (i) whether the Company has sufficient authorized shares of Common Stock for the
issuance of Warrant Shares and/or (ii) whether a Fundamental Transaction occurs prior to the Initial Exercise Date.</P>



<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 43; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f) <FONT STYLE="font-size: 10pt"> </FONT><U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For
purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the
sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g)<FONT STYLE="font-size: 10pt">
</FONT><U>Notice to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.25in; text-align: left">i.</TD><TD STYLE="text-align: justify"><U>Adjustment to Exercise Price</U>. Whenever the Exercise Price
is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by email a notice setting forth
the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement
of the facts requiring such adjustment.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.25in; text-align: left">ii.</TD><TD STYLE="text-align: justify"><U>Notice to Allow Exercise by Holder</U>. If (A) the Company
shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B) the Company shall declare a special nonrecurring
cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize the granting to all holders of the Common Stock
rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders
of the Company shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the
Company (or any of its Subsidiaries) is a party, any sale or transfer of all or substantially all of its assets, or any compulsory share
exchange whereby the Common Stock is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary
or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be
delivered by email to the Holder at its last email address as it shall appear upon the Warrant Register of the Company, at least 10 calendar
days prior to the applicable record or effective date hereinafter specified, a notice (unless such information is filed with the Commission,
in which case a notice shall not be required) stating (x) the date on which a record is to be taken for the purpose of such dividend,
distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock
of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which
such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date
as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock
for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange;
provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the
corporate action required to be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains,
material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice
with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period
commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly
set forth herein.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">h)<FONT STYLE="font-size: 10pt">
</FONT><U>Voluntary Adjustment By Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time
during the term of this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by
the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 44; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 4</U>. <U>Transfer
of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)<FONT STYLE="font-size: 10pt">
</FONT><U>Transferability</U>. Subject to compliance with any applicable securities laws, this Warrant and all rights hereunder (including,
without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office
of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly
executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer.
Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the
assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue
to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding
anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder
has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days
of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned
in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)<FONT STYLE="font-size: 10pt">
</FONT><U>New Warrants</U>. If this Warrant is not held in global form through DTC (or any successor depositary), this Warrant may be
divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice
specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject
to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and
deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All
Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and shall be identical with this Warrant
except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)<FONT STYLE="font-size: 10pt">
</FONT><U>Warrant Register</U>. The Warrant Agent shall register this Warrant, upon records to be maintained by the Warrant Agent for
that purpose (the &ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company and the
Warrant Agent may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof
or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 45; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5</U>. <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)<FONT STYLE="font-size: 10pt">
</FONT><U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly
set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant
to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i), Section 2(d)(iv) and Section 3(e) herein, in no event shall the
Company be required to net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)<FONT STYLE="font-size: 10pt">
</FONT><U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)<FONT STYLE="font-size: 10pt">
</FONT><U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right
required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding
Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 46; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)<FONT STYLE="font-size: 10pt">
</FONT><U>Authorized Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number
of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further
covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the
necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action
as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation,
or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares
which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented
by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any
transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior
to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and
legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts
to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary
to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 47; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)<FONT STYLE="font-size: 10pt">
</FONT><U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall
be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles
of conflicts of law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the
transactions contemplated by this Warrant (whether brought against a party hereto or their respective affiliates, directors, officers,
shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City
of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of
New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated
hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that
it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient
venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any
such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery)
to such party at the address in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient
service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any
other manner permitted by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant,
the prevailing party in such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys&rsquo; fees
and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f)  <U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g)<FONT STYLE="font-size: 10pt"> </FONT><U>
Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other
provision of this Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results
in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs
and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by
the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies
hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">h)<FONT STYLE="font-size: 10pt">
</FONT><U>Notices</U>. Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without
limitation, any Notice of Exercise, shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight
courier service, addressed to the Company, at 2309 Bering Drive, San Jose, CA 95131, Attention: James W. Sullivan, email address: jsullivan@perasoinc.com,
or such other email address or address as the Company may specify for such purposes by notice to the Holders. Any and all notices or other
communications or deliveries to be provided by the Company hereunder shall be in writing and delivered personally, by e-mail, or sent
by a nationally recognized overnight courier service addressed to each Holder at the e-mail address or address of such Holder appearing
on the books of the Company. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest
of (i) the time of transmission, if such notice or communication is delivered via e-mail at the e-mail address set forth in this Section
prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading Day after the time of transmission, if such notice or communication
is delivered via e-mail at the e-mail address set forth in this Section on a day that is not a Trading Day or later than 5:30 p.m. (New
York City time) on any Trading Day, (iii) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized
overnight courier service, or (iv) upon actual receipt by the party to whom such notice is required to be given. To the extent that any
notice provided hereunder constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries, the Company
shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 48; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">i) <FONT STYLE="font-size: 10pt"> </FONT><U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase
Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder
for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or
by creditors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">j) <FONT STYLE="font-size: 10pt"> </FONT><U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to
specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation
for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the
defense in any action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">k)<FONT STYLE="font-size: 10pt">
</FONT><U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby
shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted
assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and
shall be enforceable by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">l) <FONT STYLE="font-size: 10pt"> </FONT><U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand, and the Holder or the beneficial owner of this Warrant, on the other hand. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">m) <FONT STYLE="font-size: 10pt"> </FONT><U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable
law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be
ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">n) <FONT STYLE="font-size: 10pt"> </FONT><U>
Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">o) <U>Warrant Agency
Agreement.</U> If this Warrant is held in global form through DTC (or any successor depositary), this Warrant is issued subject to the
Warrant Agency Agreement. To the extent any provision of this Warrant conflicts with the express provisions of the Warrant Agency Agreement,
the provisions of this Warrant shall govern and be controlling.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I><BR STYLE="clear: both"></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I></I></P>

<!-- Field: Page; Sequence: 49; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>PERASO INC.</B></FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 36%">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    </TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 50; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="text-transform: uppercase">To:</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase"><B>PERASO INC.</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(1)<FONT STYLE="font-size: 10pt">
</FONT>The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant
(only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes,
if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2) Payment shall take
the form of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&#9744; in lawful money
of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&#9744; if permitted,
the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise
this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in
subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(3)<FONT STYLE="font-size: 10pt">
 </FONT>Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Investing Entity: ________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Investing
Entity</I>: _________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: ___________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: ____________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: ________________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 51 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>ASSIGNMENT FORM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><I>(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">FOR VALUE RECEIVED, the foregoing
Warrant and all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 40%">______________________________________</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Address:</FONT></TD>
    <TD>______________________________________</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Phone Number:</FONT></TD>
    <TD STYLE="text-align: justify">______________________________________</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Email Address:</TD>
    <TD STYLE="text-align: justify">______________________________________</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Dated: _______________ __, ______</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Holder&rsquo;s Signature:_______________________</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Holder&rsquo;s Address:_________________________</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 52 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Exhibit 1-C</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Form of Series B Warrant Certificate</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SERIES B COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>PERASO INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%">Warrant Shares: 4,380,948</TD>
  <TD STYLE="text-align: right; width: 50%">Initial Exercise Date: February 8, 2024</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">CUSIP: 71360T 135</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ISIN: US71360T1354</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">THIS SERIES B COMMON STOCK PURCHASE
WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, CEDE &amp; CO. or its assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00 p.m. (New York City time) on August 8, 2024 the
&ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Peraso Inc., a Delaware corporation (the
&ldquo;<U>Company</U>&rdquo;), up to 4,380,948 shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of
Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section
2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust
Company or its nominee (&ldquo;<U>DTC</U>&rdquo;) shall initially be the sole registered holder of this Warrant, subject to a Holder&rsquo;s
right to elect to receive a Warrant in certificated form pursuant to the terms of the Warrant Agency Agreement, in which case this sentence
shall not apply.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 1</U>. <U>Definitions</U>.
In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated in this Section 1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Bid Price</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading
Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York
City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in
good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the fees
and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 53; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized
or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;&nbsp;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally
are open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration
Statement</U>&rdquo; means the Company&rsquo;s registration statement on Form S-1 (File No. 333-276247).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed
or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the Common Stock is traded on a Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange, OTCQB or OTCQX (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 54; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transfer
Agent</U>&rdquo; means Equiniti Trust Company, LLC, the current transfer agent of the Company, with a mailing address of 1110 Centre Pointe
Curve, Suite 101, Mendota Heights, MN 55120-4101, Attn: Corporate Actions, and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Underwriting
Agreement</U>&rdquo; means the underwriting agreement, dated as of February 6, 2024, among the Company and Ladenburg Thalmann &amp; Co.
Inc. as representative of the underwriters named therein, as amended, modified or supplemented from time to time in accordance with its
terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted
average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock
is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market
(or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrant
Agency Agreement</U>&rdquo; means that certain warrant agency agreement, dated on or about the Initial Exercise Date, between the Company
and the Warrant Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrant
Agent</U>&rdquo; means the Transfer Agent and any successor warrant agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrants</U>&rdquo;
means this Warrant and other Series B Common Stock purchase warrants issued by the Company pursuant to the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 55; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 2</U>. <U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted
by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;). Within
the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section
2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the shares specified
in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless the cashless exercise
procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall
be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding
anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder
has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall
surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise
is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares
available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal
to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant
Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Business
Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of
the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available
for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">Notwithstanding
the foregoing in this Section 2(a), a holder whose interest in this Warrant is a beneficial interest in certificate(s) representing this
Warrant held in book-entry form through DTC (or another established clearing corporation performing similar functions), shall effect exercises
made pursuant to this Section 2(a) by delivering to DTC (or such other clearing corporation, as applicable) the appropriate instruction
form for exercise, complying with the procedures to effect exercise that are required by DTC (or such other clearing corporation, as applicable),
subject to a Holder&rsquo;s right to elect to receive a Warrant in certificated form pursuant to the terms of the Warrant Agency Agreement,
in which case this sentence shall not apply.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Exercise
Price</U>. The exercise price per share of Common Stock under this Warrant shall be $2.25, subject to adjustment hereunder (the &ldquo;<U>Exercise
Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 56; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Cashless
Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus contained
therein is not available for the issuance of the Warrant Shares to the Holder, then this Warrant may also be exercised, in whole or in
part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant
Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 95.25pt; text-align: justify; text-indent: -20.25pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
<TD STYLE="width: 0.25in">(A)</TD><TD STYLE="text-align: center; width: 0.15in">=</TD><TD STYLE="text-align: justify"> as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice
of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading
Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading
hours&rdquo; (as defined in Rule 600(b)(68) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, or the
Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg as of the time of the Holder&rsquo;s execution
of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day
and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading hours&rdquo;
on a Trading Day) pursuant to Section 2(a) hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 75pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD>
    <TD STYLE="width: 0.25in">(B)</TD><TD STYLE="width: 0.15in; text-align: center">=</TD><TD STYLE="text-align: justify"> the Exercise Price of this Warrant, as adjusted hereunder;
and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD>
    <TD STYLE="width: 0.25in">(X)</TD><TD STYLE="width: 0.15in; text-align: center">=</TD><TD STYLE="text-align: justify"> the number of Warrant Shares that would be issuable upon
exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a
cashless exercise.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">If Warrant Shares
are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act,
the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not to take any position
contrary to this Section 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 57; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"> d) <U>Mechanics of Exercise</U>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -9pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"> i. <U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by book entry of a certificate, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. Notwithstanding anything herein to the contrary, the Company shall not be responsible for the payment of liquidated damages resulting from the failure to issue or deliver Warrant Shares if such failure is caused solely by any action or inaction of the Holder. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii. <U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights
of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be
identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iii. <U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 58; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iv. <U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date (other than any such failure that is solely due to
any action or inaction by the Holder with respect to such exercise), and if after such date the Holder is required by its broker to purchase
(in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common Stock to deliver
in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;),
then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s total purchase price (including
brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number
of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price
at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the
portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall
be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely
complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase
price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving
rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay
the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the
Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue
any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or
injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock upon exercise of the Warrant as
required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">v. <U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">vi. <U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>, <U>however</U>,
that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition
thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent
fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing
corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">vii. <U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 59; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting
as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&nbsp; For purposes of the foregoing sentence,
the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties.&nbsp; Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial
ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder,
it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section
13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the
extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation
to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is
exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s
determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates
and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation.
To ensure compliance with this restriction, each Holder shall be deemed to represent to the Company each time it delivers a Notice of
Exercise that such Notice of Exercise has not violated the restrictions set forth in this paragraph, and the Company shall have no obligation
to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall
be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes
of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding
shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the
case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent
setting forth the number of shares of Common Stock outstanding.&nbsp; Upon the written or oral request of a Holder, the Company shall
within one Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.&nbsp; In any
case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities
of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number
of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% (or, upon
election by a Holder prior to the issuance of any Warrants, 9.99%) of the number of shares of the Common Stock outstanding immediately
after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company,
may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation
in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares
of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any
increase in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to
the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with
the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended
Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such
limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 60; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 3</U>. <U>Certain
Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common
Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the
numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective
date in the case of a subdivision, combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Reserved</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells
any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any
class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms
applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number
of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including
without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance
or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are
to be determined for the grant, issue or sale of such Purchase Rights (provided, however, that, to the extent that the Holder&rsquo;s
right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder
shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as
a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until
such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Pro
Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall
declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock,
by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property
or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction)
(a &ldquo;<U>Distribution</U>&rdquo;), at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled
to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number
of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including
without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution,
or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation
in such Distribution (<U>provided</U>, <U>however</U>, that, to the extent that the Holder's right to participate in any such Distribution
would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such
Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent)
and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto
would not result in the Holder exceeding the Beneficial Ownership Limitation). To the extent that this Warrant has not been partially
or completely exercised at the time of such Distribution, such portion of the Distribution shall be held in abeyance for the benefit of
the Holder until the Holder has exercised this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"></P>

<!-- Field: Page; Sequence: 61; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"> e) <U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related
transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company or any Subsidiary,
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or
substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender
offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are
permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of
greater than 50% of the outstanding Common Stock or greater than 50% of the voting power of the common equity of the Company, (iv)
the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or
recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted
into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related
transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a
reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such
other Person or group acquires greater than 50% of the outstanding shares of Common Stock or greater than 50% of the voting power of
the common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this
Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise
immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation
in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or
of the Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate
Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock
for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section
2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be
appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect
of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate
Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If
holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction,
then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant
following such Fundamental Transaction. Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, other
than in clause (i) above in connection with a merger or consolidation of the Company with any Subsidiary or Affiliate whereby the
stockholders of the Company do not own at least (x) 50.1% of the outstanding shares of Common Stock and (y) 50.1% of the voting
power of the surviving entity immediately after such merger or consolidation, the Company or any Successor Entity (as defined below)
shall, at the Holder&rsquo;s option, exercisable at any time concurrently with, or within 30 days after, the consummation of the
Fundamental Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction), purchase this
Warrant from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of the
remaining unexercised portion of this Warrant on the date of the consummation of such Fundamental Transaction; <U>provided</U>, <U>however</U>,
that, if the Fundamental Transaction is not within the Company's control, including not approved by the Company's Board of
Directors, the Holder shall only be entitled to receive from the Company or any Successor Entity the same type or form of
consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that is being
offered and paid to the holders of Common Stock of the Company in connection with the Fundamental Transaction, whether that
consideration be in the form of cash, stock or any combination thereof, or whether the holders of Common Stock are given the choice
to receive from among alternative forms of consideration in connection with the Fundamental Transaction; <U>provided</U>, <U>further</U>,
that if holders of Common Stock of the Company are not offered or paid any consideration in such Fundamental Transaction <FONT STYLE="background-color: white">and
the Company remains the Successor Entity following such Fundamental Transaction</FONT>, such holders of Common Stock will be deemed
to have received common stock of the Successor Entity in such Fundamental Transaction. &ldquo;<U>Black Scholes Value</U>&rdquo;
means the value of this Warrant based on the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on
Bloomberg, L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) determined as of the day of consummation of the applicable Fundamental Transaction
for pricing purposes and reflecting (i) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the
remaining term of this Warrant as of such date of request, (ii) an expected volatility equal to the remaining term of this Warrant
obtained from the HVT function on Bloomberg as of the Trading Day immediately prior to the public announcement of the applicable
Fundamental Transaction or, if the Fundamental Transaction is not publicly announced, the date the Fundamental Transaction is
consummated, (iii) the underlying price per share used in such calculation shall be the greater of (A) the sum of the price per
share being offered in cash, if any, plus the per share value of any non-cash consideration, if any, being offered in such
Fundamental Transaction and (B) the greater of (x) the last weighted average price of the Common Stock immediately prior to the
public announcement of such Fundamental Transaction and (y) the last weighted average price of the Common Stock immediately prior to
the consummation of such Fundamental Transaction, (iv) a zero cost of borrow and (v) a 360 day annualization factor. The payment of
the Black Scholes Value will be made by wire transfer of immediately available funds (or such other consideration) within the later
of (i) five Business Days of the Holder&rsquo;s election and (ii) the date of consummation of the Fundamental Transaction. The
Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the
&ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant in accordance
with the provisions of this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder
and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the
Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument
substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital
stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon
exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction,
and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the
relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock,
such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this
Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and
substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the term
&ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction,
each and every provision of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer
instead to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or
Successor Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto and the
Successor Entity or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and the
other Transaction Documents with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and
severally, had been named as the Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits
of the provisions of this Section 3(e) regardless of (i) whether the Company has sufficient authorized shares of Common Stock for the
issuance of Warrant Shares and/or (ii) whether a Fundamental Transaction occurs prior to the Initial Exercise Date.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 62; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f) <U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g) <U>Notice
to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i. <U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii. <U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall
authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock
of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of
all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall
appear upon the Warrant Register of the Company, at least 10 calendar days prior to the applicable record or effective date hereinafter
specified, a notice (unless such information is filed with the Commission, in which case a notice shall not be required) stating (x) the
date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is
not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption,
rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share
exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record
shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification,
consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in
the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that
any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries,
the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain
entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering
such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 63; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">h) <U>Voluntary
Adjustment By Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time during the term of
this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the board of directors
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 4</U>. <U>Transfer
of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Transferability</U>.
Subject to compliance with any applicable securities laws, this Warrant and all rights hereunder (including, without limitation, any registration
rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated
agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its
agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if
required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable,
and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing
the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary,
the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full,
in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers
an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised
by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>New
Warrants</U>. If this Warrant is not held in global form through DTC (or any successor depositary), this Warrant may be divided or combined
with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names
and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section
4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or
Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers
or exchanges shall be dated the initial issuance date of this Warrant and shall be identical with this Warrant except as to the number
of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Warrant
Register</U>. The Warrant Agent shall register this Warrant, upon records to be maintained by the Warrant Agent for that purpose (the
&ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company and the Warrant Agent may
deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution
to the Holder, and for all other purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 64; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5</U>. <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>No
Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set
forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to
Section 2(c) or to receive cash payments pursuant to Section 2(d)(i), Section 2(d)(iv) and Section 3(e) herein, in no event shall the
Company be required to net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Authorized
Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number
of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further
covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the
necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action
as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation,
or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares
which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented
by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any
transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 65; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior
to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and
legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts
to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary
to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by and
construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of
law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Warrant (whether brought against a party hereto or their respective affiliates, directors, officers, shareholders,
partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York.
Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough
of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed
herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally
subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding.
Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding
by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address
in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient service of process and
notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted
by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant, the prevailing party in
such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys&rsquo; fees and other costs and
expenses incurred with the investigation, preparation and prosecution of such action or proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 66; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f) <U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g) <U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of this
Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages
to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but
not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts
due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">h) <U>Notices</U>.
Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any Notice
of Exercise, shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight courier service, addressed
to the Company, at 2309 Bering Drive, San Jose, CA 95131, Attention: James W. Sullivan, email address: jsullivan@perasoinc.com, or such
other email address or address as the Company may specify for such purposes by notice to the Holders. Any and all notices or other communications
or deliveries to be provided by the Company hereunder shall be in writing and delivered personally, by e-mail, or sent by a nationally
recognized overnight courier service addressed to each Holder at the e-mail address or address of such Holder appearing on the books of
the Company. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest of (i) the
time of transmission, if such notice or communication is delivered via e-mail at the e-mail address set forth in this Section prior to
5:30 p.m. (New York City time) on any date, (ii) the next Trading Day after the time of transmission, if such notice or communication
is delivered via e-mail at the e-mail address set forth in this Section on a day that is not a Trading Day or later than 5:30 p.m. (New
York City time) on any Trading Day, (iii) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized
overnight courier service, or (iv) upon actual receipt by the party to whom such notice is required to be given. To the extent that any
notice provided hereunder constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries, the Company
shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">i) <U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">j) <U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 67; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">k) <U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">l) <U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand, and the Holder or the beneficial owner of this Warrant, on the other hand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">m) <U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">n) <U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">o) <U>Warrant
Agency Agreement.</U> If this Warrant is held in global form through DTC (or any successor depositary), this Warrant is issued subject
to the Warrant Agency Agreement. To the extent any provision of this Warrant conflicts with the express provisions of the Warrant Agency
Agreement, the provisions of this Warrant shall govern and be controlling.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I></I></P>

<!-- Field: Page; Sequence: 68; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>PERASO INC.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 4%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 31%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 69; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">1-C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">To: <B>PERASO
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(1) The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2) Payment
shall take the form of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&#9744; in lawful money
of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&#9744; if permitted,
the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise
this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in
subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(3) Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Investing Entity: _________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Investing
Entity</I>: __________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: ____________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: _____________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: ________________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 70 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>ASSIGNMENT FORM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><I>(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">FOR VALUE RECEIVED, the foregoing
Warrant and all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 40%">______________________________________</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Address:</FONT></TD>
    <TD>______________________________________</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Phone Number:</FONT></TD>
    <TD STYLE="text-align: justify">______________________________________</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Email Address:</TD>
    <TD STYLE="text-align: justify">______________________________________</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Dated: _______________ __, ______</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Holder&rsquo;s Signature:_______________________</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Holder&rsquo;s Address:_________________________</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"><B>&nbsp;</B></P>



<!-- Field: Page; Sequence: 71 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Exhibit 2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Form of Warrant Certificate Request Notice</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">WARRANT CERTIFICATE REQUEST NOTICE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">To: Equiniti Trust Company, LLC, as Warrant
Agent for Peraso Inc. (the &ldquo;Company&rdquo;)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">The undersigned Holder of [Pre-Funded Warrants,
Series A Warrants and/or Series B Warrants] (&ldquo;<U>Warrants</U>&rdquo;) in the form of Global Warrants issued by the Company hereby
elects to receive a Warrant Certificate evidencing the Warrants held by the Holder as specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in"></TD><TD STYLE="text-align: justify; width: 0.25in">1.</TD><TD STYLE="text-align: justify; padding-right: 0.5in">Name of Holder of Warrants in form of Global Warrants: _____________________________</TD></TR></TABLE>

<P STYLE="margin: 0pt; text-align: justify; text-indent: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in"></TD><TD STYLE="text-align: justify; width: 0.25in">2.</TD><TD STYLE="text-align: justify; padding-right: 0.5in">Name of Holder in Warrant Certificate (if different from name of Holder of Warrants in form of Global
Warrants): ________________________________</TD></TR></TABLE>

<P STYLE="margin: 0pt; text-align: justify; text-indent: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in"></TD><TD STYLE="text-align: justify; width: 0.25in">3.</TD><TD STYLE="text-align: justify; padding-right: 0.5in">Number of Warrants in name of Holder in form of Global Warrants: ___________________</TD></TR></TABLE>

<P STYLE="margin: 0pt; text-align: justify; text-indent: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in"></TD><TD STYLE="text-align: justify; width: 0.25in">4.</TD><TD STYLE="text-align: justify; padding-right: 0.5in">Number of Warrants for which Warrant Certificate shall be issued: __________________</TD></TR></TABLE>

<P STYLE="margin: 0pt; text-align: justify; text-indent: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in"></TD><TD STYLE="text-align: justify; width: 0.25in">5.</TD><TD STYLE="text-align: justify; padding-right: 0.5in">Number of Warrants in name of Holder in form of Global Warrants after issuance of
Warrant Certificate, if any: ___________</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in"></TD><TD STYLE="text-align: justify; width: 0.25in">6.</TD><TD STYLE="text-align: justify">Warrant Certificate shall be delivered to the following address:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">The undersigned hereby acknowledges and agrees
that, in connection with this Warrant Exchange and the issuance of the Warrant Certificate, the Holder is deemed to have surrendered the
number of Warrants in form of Global Warrants in the name of the Holder equal to the number of Warrants evidenced by the Warrant Certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0.5in 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in"><FONT STYLE="text-transform: uppercase">[SIGNATURE OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in">Name of Investing Entity: ____________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in"><I>Signature of Authorized Signatory of Investing Entity</I>: ______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in">Name of Authorized Signatory: ________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in">Title of Authorized Signatory: _________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in">Date: _______________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 72 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Exhibit 3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Form of Global Warrant Request Notice</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">GLOBAL WARRANT REQUEST NOTICE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify">To: Equiniti Trust Company, LLC, as Warrant
Agent for Peraso Inc. (the &ldquo;Company&rdquo;)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">The undersigned Holder of [Pre-Funded Warrants,
Series A Warrants and/or Series B Warrants] (&ldquo;<U>Warrants</U>&rdquo;) in the form of Warrants Certificates issued by the Company
hereby elects to receive a Global Warrant evidencing the Warrants held by the Holder as specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in"></TD><TD STYLE="text-align: justify; width: 0.25in">1.</TD><TD STYLE="text-align: justify; padding-right: 0.5in">Name of Holder of Warrants in form of Warrant Certificates: _____________________________</TD></TR></TABLE>

<P STYLE="margin: 0pt; text-align: justify; text-indent: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in"></TD><TD STYLE="text-align: justify; width: 0.25in">2.</TD><TD STYLE="text-align: justify; padding-right: 0.5in">Name of Holder in Global Warrant (if different from name of Holder of Warrants in form of Warrant Certificates):
________________________________</TD></TR></TABLE>

<P STYLE="margin: 0pt; text-align: justify; text-indent: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in"></TD><TD STYLE="text-align: justify; width: 0.25in">3.</TD><TD STYLE="text-align: justify; padding-right: 0.5in">Number of Warrants in name of Holder in form of Warrant Certificates: ___________________</TD></TR></TABLE>

<P STYLE="margin: 0pt; text-align: justify; text-indent: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in"></TD><TD STYLE="text-align: justify; width: 0.25in">4.</TD><TD STYLE="text-align: justify; padding-right: 0.5in">Number of Warrants for which Global Warrant shall be issued: __________________</TD></TR></TABLE>

<P STYLE="margin: 0pt; text-align: justify; text-indent: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in"></TD><TD STYLE="text-align: justify; width: 0.25in">5.</TD><TD STYLE="text-align: justify; padding-right: 0.5in">Number of Warrants in name of Holder in form of Warrant Certificates after issuance
of Global Warrant, if any: ___________</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in"></TD><TD STYLE="text-align: justify; width: 0.25in">6.</TD><TD STYLE="text-align: justify">Global Warrant shall be delivered to the following address:</TD></TR></TABLE>

<P STYLE="text-align: justify; text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">The undersigned hereby acknowledges and agrees
that, in connection with this Global Warrant Exchange and the issuance of the Global Warrant, the Holder is deemed to have surrendered
the number of Warrants in form of Warrant Certificates in the name of the Holder equal to the number of Warrants evidenced by the Global
Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in"><FONT STYLE="text-transform: uppercase">[SIGNATURE OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in">Name of Investing Entity: ____________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in"><I>Signature of Authorized Signatory of Investing Entity</I>: ______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in">Name of Authorized Signatory: ________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in">Title of Authorized Signatory: _________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in">Date: _______________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: center"><B></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 73; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>ea193205ex99-1_perasoinc.htm
<DESCRIPTION>PRESS RELEASE OF PERASO INC., DATED FEBRUARY 6, 2024
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Exhibit 99.1</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><IMG SRC="ex99-1_001.jpg" ALT=""></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Peraso Announces Pricing of $4 Million Underwritten
Public Offering</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>SAN JOSE, Calif., February 6, 2024 &ndash;
</B>Peraso Inc. (NASDAQ: PRSO) (&ldquo;Peraso&rdquo; or the &ldquo;Company&rdquo;), a leader in mmWave technology, today announced the
pricing of its underwritten public offering of 480,000 shares of common stock, pre-funded warrants to purchase up to 1,424,760 shares
of common stock, Series A warrants to purchase up to 3,809,520 shares of common stock and Series B warrants to purchase up to 3,809,520
shares of common stock (the &ldquo;Offering&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ladenburg Thalmann &amp; Co. Inc. is acting as
the sole book-running manager for the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each share of common stock and each pre-funded
warrant is being sold together with one Series A warrant to purchase two shares of common stock and one Series B warrant to purchase two
shares of common stock. The Series A warrants have an exercise price of $2.25 per share, are exercisable immediately upon issuance, and
will expire five years following the date of issuance. The Series B warrants have an exercise price of $2.25 per share, are exercisable
immediately upon issuance, and will expire six months following the date of issuance. The pre-funded warrants will be immediately exercisable
at a nominal exercise price of $0.001 per share and may be exercised at any time until all of the pre-funded warrants are exercised in
full. The warrants are fixed priced and do not contain any price based anti-dilution or variable pricing features. The combined public
offering price of each share of common stock, together with the accompanying Series A warrant and Series B warrant, is $2.10, less underwriting
discounts and commissions. The combined public offering price of pre-funded warrant, together with the accompanying Series A warrant and
Series B warrant, is $2.099, less underwriting discounts and commissions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Offering is expected to close on or about
February 8, 2024, subject to the satisfaction of customary closing conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, the Company has granted the underwriter
a 45-day option to purchase up to an additional 285,714 shares of common stock, Series A warrants to purchase up to an additional 571,428
shares of common stock and/or Series B warrants to purchase up to an additional 571,428 shares of common stock at the public offering
price, less underwriting discounts and commissions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The gross proceeds from the Offering to the Company,
before deducting underwriting discounts and commissions and other Offering expenses and excluding any proceeds that may be received upon
the exercise of the warrants and the exercise of the underwriter&rsquo;s option to purchase additional shares of common stock, Series
A warrants and/or Series B warrants, are expected to be approximately $4 million. Peraso currently intends to use the net proceeds of
the Offering to fund operations and for working capital and other general corporate purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The securities described above are being offered
pursuant to Peraso&rsquo;s registration statement on Form S-1 (File No. 333-276247) previously filed with and subsequently declared effective
by the Securities and Exchange Commission (the &ldquo;SEC&rdquo;) on February 6, 2024. The securities may be offered only by means of
a prospectus which forms part of the effective registration statement. A preliminary prospectus describing the terms of the Offering has
been filed with the SEC and is available on the SEC&rsquo;s website located at http://www.sec.gov. A final prospectus relating to this
Offering will be filed by the Company with the SEC. Electronic copies of the final prospectus relating to the Offering, when available,
may also be obtained by contacting Ladenburg Thalmann &amp; Co. Inc., Prospectus Department, 640 Fifth Avenue, 4th Floor, New York, New
York 10019 or by email at prospectus@ladenburg.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>This press release shall not constitute an
offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities
in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under
the securities laws of such state or jurisdiction.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This press release contains forward-looking statements
within the meaning of The Private Securities Litigation Reform Act of 1995. The Company may, in some cases, use terms such as &ldquo;predicts,&rdquo;
&ldquo;believes,&rdquo; &ldquo;potential,&rdquo; &ldquo;proposed,&rdquo; &ldquo;continue,&rdquo; &ldquo;estimates,&rdquo; &ldquo;anticipates,&rdquo;
&ldquo;expects,&rdquo; &ldquo;plans,&rdquo; &ldquo;intends,&rdquo; &ldquo;may,&rdquo; &ldquo;could,&rdquo; &ldquo;might,&rdquo; &ldquo;will,&rdquo;
&ldquo;should&rdquo; or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements.
Forward-looking statements may include, without limitation, statements regarding the Company&rsquo;s expectations with respect to market
conditions, the timing and completion of the Offering and the intended use of net proceeds from the Offering. Such statements are based
on information available to the Company as of the date of this press release and are subject to numerous important factors, risks and
uncertainties that may cause actual events or results to differ materially from the Company&rsquo;s current expectations, including market
conditions, risks associated with the cash requirements of Peraso&rsquo;s business and other risks detailed from time to time in the Company&rsquo;s
filings with the SEC, and represent views only as of the date they are made and should not be relied upon as representing views as of
any subsequent date. The Company does not assume any obligation to update any forward-looking statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Peraso Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Peraso Inc. (NASDAQ: PRSO) is a pioneer in high
performance 60 GHz unlicensed and 5G mmWave wireless technology, offering chipsets, antenna modules, software and IP. Peraso supports
a variety of applications, including fixed wireless access, immersive video and factory automation. In addition, Peraso&rsquo;s solutions
for data and telecom networks focus on Accelerating Data Intelligence and Multi-Access Edge Computing, providing end-to-end solutions
from the edge to the centralized core and into the cloud. For additional information, please visit www.perasoinc.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Company Contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Jim Sullivan, CFO</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Peraso Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">P: 408-418-7500</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">E: jsullivan@perasoinc.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Investor Relations Contacts:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Shelton Group</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Brett L. Perry | Leanne K. Sievers</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">P: 214-272-0070| 949-224-3874</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">E: sheltonir@sheltongroup.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>5
<FILENAME>ea193205ex99-2_perasoinc.htm
<DESCRIPTION>PRESS RELEASE OF PERASO INC., DATED FEBRUARY 8, 2024
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.2</B></P>



<P STYLE="text-align: right; margin: 0"><IMG SRC="ex99-2_001.jpg" ALT=""></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Peraso Announces Closing of $4.172 Million
Underwritten Public <BR>
Offering, Including Partial Exercise of Overallotment Option</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>SAN JOSE, Calif., February 8, 2024 &ndash;
</B>Peraso Inc. (NASDAQ: PRSO) (&ldquo;Peraso&rdquo; or the &ldquo;Company&rdquo;), a leader in mmWave technology, today announced the
closing of its previously announced underwritten public offering of common stock, pre-funded warrants, Series A warrants and Series B
warrants for gross proceeds of approximately $4.172 million, prior to deducting underwriting discounts and commissions and offering expenses.
The offering proceeds include partial exercise of the underwriter&rsquo;s over-allotment option to purchase additional shares of common
stock, Series A warrants and Series B warrants (the &ldquo;Offering&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ladenburg Thalmann &amp; Co. Inc. acted as the
sole book-running manager for the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Offering consisted of a total of 562,500 shares
of common stock, pre-funded warrants to purchase up to 1,424,760 shares of common stock, Series A warrants to purchase up to 3,974,520
shares of common stock and Series B warrants to purchase up to 3,974,520 shares of common stock. The securities issued at closing included
82,500 shares of common stock, Series A warrants to purchase up to 165,000 shares of common stock and Series B warrants to purchase up
to 165,000 shares of common stock, which securities were issued upon the partial exercise of the underwriter&rsquo;s over-allotment option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each share of common stock and each pre-funded
warrant was sold together with two Series A warrants to purchase one share of common stock each and two Series B warrants to purchase
one share of common stock each. The Series A warrants have an exercise price of $2.25 per share, are exercisable immediately upon issuance,
and expire five years following the date of issuance. The Series B warrants have an exercise price of $2.25 per share, are exercisable
immediately upon issuance, and expire six months following the date of issuance. The pre-funded warrants are immediately exercisable at
a nominal exercise price of $0.001 per share and may be exercised at any time until all of the pre-funded warrants are exercised in full.
The warrants are fixed priced and do not contain any price based anti-dilution or variable pricing features. The combined public offering
price of each share of common stock, together with the accompanying Series A warrants and Series B warrants, was $2.10, less underwriting
discounts and commissions. The combined public offering price of each pre-funded warrant, together with the accompanying Series A warrants
and Series B warrants, was $2.099, less underwriting discounts and commissions. Peraso currently intends to use the net proceeds of the
Offering to fund operations and for working capital and other general corporate purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The securities described above were offered pursuant
to Peraso&rsquo;s registration statement on Form S-1 (File No. 333-276247) previously filed with and subsequently declared effective by
the Securities and Exchange Commission (the &ldquo;SEC&rdquo;) on February 6, 2024. A final prospectus describing the terms of the Offering
has been filed with the SEC and is available on the SEC&rsquo;s website located at http://www.sec.gov. Electronic copies of the final
prospectus relating to the Offering may also be obtained by contacting Ladenburg Thalmann &amp; Co. Inc., Prospectus Department, 640 Fifth
Avenue, 4th Floor, New York, New York 10019 or by email at prospectus@ladenburg.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>This press release shall not constitute an
offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities
in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under
the securities laws of such state or jurisdiction.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This press release contains forward-looking statements
within the meaning of The Private Securities Litigation Reform Act of 1995. The Company may, in some cases, use terms such as &ldquo;predicts,&rdquo;
&ldquo;believes,&rdquo; &ldquo;potential,&rdquo; &ldquo;proposed,&rdquo; &ldquo;continue,&rdquo; &ldquo;estimates,&rdquo; &ldquo;anticipates,&rdquo;
&ldquo;expects,&rdquo; &ldquo;plans,&rdquo; &ldquo;intends,&rdquo; &ldquo;may,&rdquo; &ldquo;could,&rdquo; &ldquo;might,&rdquo; &ldquo;will,&rdquo;
&ldquo;should&rdquo; or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements.
Forward-looking statements may include, without limitation, statements regarding the Company&rsquo;s expectations with respect to the
intended use of net proceeds from the Offering. Such statements are based on information available to the Company as of the date of this
press release and are subject to numerous important factors, risks and uncertainties that may cause actual events or results to differ
materially from the Company&rsquo;s current expectations, including market conditions, risks associated with the cash requirements of
Peraso&rsquo;s business and other risks detailed from time to time in the Company&rsquo;s filings with the SEC, and represent views only
as of the date they are made and should not be relied upon as representing views as of any subsequent date. The Company does not assume
any obligation to update any forward-looking statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Peraso Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Peraso Inc. (NASDAQ: PRSO) is a pioneer in high
performance 60 GHz unlicensed and 5G mmWave wireless technology, offering chipsets, antenna modules, software and IP. Peraso supports
a variety of applications, including fixed wireless access, immersive video and factory automation. In addition, Peraso&rsquo;s solutions
for data and telecom networks focus on Accelerating Data Intelligence and Multi-Access Edge Computing, providing end-to-end solutions
from the edge to the centralized core and into the cloud. For additional information, please visit www.perasoinc.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Company Contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Jim Sullivan, CFO</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Peraso Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">P: 408-418-7500</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">E: jsullivan@perasoinc.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Investor Relations Contacts:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Shelton Group</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Brett L. Perry | Leanne K. Sievers</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">P: 214-272-0070| 949-224-3874</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">E: sheltonir@sheltongroup.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !# .\# 2(  A$! Q$!_\0
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M3?\ H!KY/4E6#*2"#D$=J6%5XM#QSM.+_K<^POL]K_SQA_[Y%'V>U_YXP_\
M?(KY(%_>_P#/U/\ ]_#5[2KV\.KV8-U.09TS^\/]X4?5'_,'U]7^$^L    !
M@#H!7'?%+_DGVH_6/_T-:[&N.^*7_)/M1^L?_H:UR4OXD?4[J_\ "EZ,\>^&
MZJ_CW2U90P+MD$9_@:OHW[+;_P#/"+_O@5\HV%]=:;>1W=G,T-Q'RDB=1QBM
MT>/?%7_0;NOS'^%>G7P\JLDTSQL+BX48.,E<[CXQZ9IUL-/O((HHKR5F5P@
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(T45D;I6/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>ex99-2_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-2_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  V .\# 2(  A$! Q$!_\0
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M_P"#L+4G+;?V*M/5<G&?CA=,0.< X^&"Y(& 2  3S@=*M1_\'7.J.>?V+=.
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M*67C:+X:ZEJ^H/X7A^'4^BR:L-3\-ZSX?6$:G)XJU%;41'5OM1;[)(6, B&
MY8?TH445U9]Q'G'$V*I8W.L6L7B:&'CA:514*%#EH1J3JJ')AZ=.#M.I.7,T
MY:VO9)+BX6X/X>X+P-?+>&\"\OP>)Q<L=6I/$XK%.>)G2I4)5/:8NK6J1O2H
MTX\D9*'NWMS-M_B)_P %,_\ @C9H'_!0+XK>#?C!HOQ2M?A+XJT7PB/!_BF6
M7PE-XE3Q39:??W%[X?NV,6NZ/]EN]+2_OK)V9)_M-HUHA9/LJAO2/^"7W_!-
M+QM_P3IF^*6DW'QXM/BCX%^),&@WP\,Q^"Y_#CZ-XLT.2ZMUUZWNY?$&KJZW
M^CWC:=?6RPQ-/]CTV0RXLPC%%=]3C?B:KP]'A6MF"JY%"E3HPP=7"82I*%.C
MB'B:*AB947BHNE6;=*2J\U.+=.+5-\IY-+PSX+H<7SX[H91*AQ14KUL34S&A
MC\PI0J5L1A5@L1*I@H8A8*:Q&'48UX2H.%6<8UIQ=5*H9G_!3+_@F+X\_P""
MAWBCX=SM\?[3X;> OAQH^HQ:5X-;P7<^(1=>)=;ND?5_$EU=Q^(-*0W$UA9Z
M7IMK#Y#BVM[24HVZ\GW8W_!-;_@D#X;_ &!?B+XS^*FL_$FW^+'C+6_#:>%/
M#%XGA5O#D/A72[NZCO/$$T0EUC5Y+B^U=K33[3S%:%;>R@GB <W<F"BM8\><
M4T^')<)4LR5'(94)8:>"HX/!TI3HSK_6:L)XF%!8J;K5O>KRE6<ZR]RI)T_<
M,)^%? M7C*/']?)I8CBN&)AC*>9XG,,QKQI8BGA?J5"=+!5<3+ TUAL,W#"P
MAAU##R;J4HQJOG/V?J"ZM;:]MKBRO((;JTNX)K6ZMKB-98+BVN(VBG@GB<,D
ML,T3M')&ZE71F5@02***^03:::;33333:::::::LTTTFFFFFDTTTFOT)I---
M)IIIII-----------IIIIIM---I_S+^/O^#=+2]>\>>+O$'@S]H>W\*>%-9\
M2ZOJWASPS=_#^74[GP]I%_?S7=CHSZA!XFT^&\&E02I90W"V=OYL,$;R1B0N
MQ_>[]EOX2^,O@3\"/A[\(/'/CV+XEZO\/M''AJS\8)I=QI$NH>']/FDC\/6M
MW:7.H:I*;G2=(^RZ4UP;M_M$5G%(RJY;)17V?$7B%Q;Q9EV#ROB#,XYCA,!5
MIUL(JF!P-.O2JT\.L+S_ %NCAZ>)FZE!*-?GJ25>252JI5$I+\UX.\(?#_@#
M.,QSWA'(YY-F&;4*N&Q[HYGFE;"5Z%7&/'^R^H8G%UL%3C1Q4I3POLJ,'A8R
M=*@X4FZ;^;/VQO\ @F+^S5^V7<2>)O%VDWW@CXH"U2UC^)?@K[+::O?10JJ6
MT/B?3;B&33?$L-M&OE037*6VK0Q!((-6BMHU@K\8?$O_  ;P?$VUU"8^$OVA
MO =_I!N)/LS>(?#/B'2-0CMV=O*6:+3FUVWEF6/'F.D\2,^2J*I !17L<,>+
MWB%PIA*6793Q!4>7T4H8?!9CAL+FM#"P5VH87Z["5;#TD_AHTL3[&%VH4::?
M*?.\<?1W\(/$#,*V<\0\(T8YOB).IB\RR;'8[(<5CJCLG5QSRRI##XRM))<^
M(KX/ZS4LG5Q%624CW;X+?\&^OA+1M4MM2^.WQLO_ !9I]M-'*WAGX?:(?#\5
M[&(R)+:[\1:Q-?WB1&4A_,L=(M+DIA4G@8%V_??X5?";X=?!'P/H_P .?A9X
M3TKP;X.T*-DL-'TJ$HC32D-<WU]<RM+>:EJ=Y(/-O=2U">YOKN3YIYWPN"BO
M'XL\0^,N-W2CQ+GF)QV'H3]K0P%.%'!Y=1JV<?:PP&#A1P[K*+<56K+$5HQ<
MHPJ4U*2E]#X?^#OAMX7JO+@KA;!95C,53]CBLUJSQ&99SB:',I^PJYKF-7$X
MR.'<XQG+#8=X/#SG&,ZE&K*$'#T6O)?C/\#/A5^T'X+O/ /Q=\':7XP\.71:
M6"*^C:._TF],;1QZIH>J6[1:AH^IPACY=Y8W$,C+F&;S;=Y(7**^4PF,Q>7X
MK#X[ 8K$8+&X6K"OAL7A*U7#8G#UJ;YH5:->C.G5I5(O:4)IZM/FC*49??YC
MEV7YO@<7E>;8'!YGEN/H5,+CLOS#"T,;@L9AJT>6K0Q.%Q-*M0KTIQTE"I3D
MKJ,HN$X0J4_PS^*__!!?2KK5+F_^"WQK?1]*EDGEAT#X@Z')?S6BLV8;=/$&
M@O#Y\<294R2: DKG:68L&9_*O#?_  0@^*ES=A?$'QQ^'MA81RQ^9+H^C>)-
M7NFCW#>J6UY;Z'%N9%<*QNP%8J2& ()17[=@OI(>+^#P7U6/$F&Q'LH1A#%8
MW(\HQ6.M\"E/%3H4G5J)6_>5:$YN2YI<TKM_RYF?T*_HZ9CFGUZ?!.-P:K5)
MUJF RSBGB+ 97S7YW"G@:>+Q"H46VTZ-#%TZ:B^2')%)1_6/]E?_ ()D?L[_
M +,.H67BR&SO/B5\1[!_-L?&/C*"V>'1)PTA6X\-^'H0^G:7=QK(4BU.X?4M
M7A50+?4(0T@?]&***_)>(N)^(>+<RGF_$N<8[.<QG%0^L8ZLZGLJ2DY1H8:C
M%4\/A,/&4FXX?"X?#T4VY<DIMU'_ $+P;P+P?X>9+2X>X)X<RKAG)Z4W5^IY
F7AHT?;UY1C">*QN(G*MC,PQE2,8QJ8O'XS%XB44H*I3IJ-*/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>prso-20240206.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.21a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 8qI5s7xRiXgen8uOYHxcWaKEGcP9zp5yGZlBvGd1HalqfykmtZ194C1AhdV24RIL -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:PRSO="http://perasoinc.com/20240206" elementFormDefault="qualified" targetNamespace="http://perasoinc.com/20240206">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://perasoinc.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="prso-20240206_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="prso-20240206_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>prso-20240206_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.21a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>prso-20240206_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.21a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://perasoinc.com/role/Cover" xlink:href="prso-20240206.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://perasoinc.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139858261530448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Feb. 06, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb.  06,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-32929<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">PERASO INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000890394<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">77-0291941<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2309 Bering Dr.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Jose<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">95131<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">408<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">418-7500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PRSO<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M<F]P<R]A<' N>&UL4$L! A0#%     @ !$A)6,^Z:>SN    *P(  !$
M         ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ !$A)
M6)E<G",0!@  G"<  !,              ( !S $  'AL+W1H96UE+W1H96UE
M,2YX;6Q02P$"% ,4    "  $2$E8,:X?TD$$  !P$   &
M@($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ !$A)
M6)^@&_"Q @  X@P   T              ( !A P  'AL+W-T>6QE<RYX;6Q0
M2P$"% ,4    "  $2$E8EXJ[',     3 @  "P              @ %@#P
M7W)E;',O+G)E;'-02P$"% ,4    "  $2$E8JL0B%C,!   B @  #P
M        @ %)$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ !$A)6"0>
MFZ*M    ^ $  !H              ( !J1$  'AL+U]R96QS+W=O<FMB;V]K
M+GAM;"YR96QS4$L! A0#%     @ !$A)6&60>9(9 0  SP,  !,
M     ( !CA(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @
&V!,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea193205-8k_perasoinc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://perasoinc.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ea193205-8k_perasoinc.htm">ea193205-8k_perasoinc.htm</File>
    <File>prso-20240206.xsd</File>
    <File>prso-20240206_lab.xml</File>
    <File>prso-20240206_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea193205-8k_perasoinc.htm": {
   "nsprefix": "PRSO",
   "nsuri": "http://perasoinc.com/20240206",
   "dts": {
    "inline": {
     "local": [
      "ea193205-8k_perasoinc.htm"
     ]
    },
    "schema": {
     "local": [
      "prso-20240206.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "prso-20240206_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "prso-20240206_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://perasoinc.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2024-02-06",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea193205-8k_perasoinc.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-02-06",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea193205-8k_perasoinc.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001213900-24-011840-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-24-011840-xbrl.zip
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MQ,^RR"H!BV+M;+8OZ0KF=$34VB5#;Q5T1,BT;GY&O6DV4OITD4 -BIJKHJS
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M)!7:HM[. LLQ[07P1AM&_OU^9?3X#]\E=QL!BG#"/&*F4T1<!B8X;8,^VLG
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M"4R'S-629. :3L@BHU8=J/.7E3OVE&[,46<C/Z8S]X1#T(S>S#B\R.[0W"[
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M:T_'* K2@/KT;]ER]2QYB7E+?/!+$W<G%]GSHBAA%]E>TO;2S4O &D;%1*1
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M(%O8%4$*\HL52XB/7/B]S*&V3061@E2WU90:%]LB$$;+UTC?$R9-]*647A?
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M+\!*T46.HX)KJ64R=<?%B?%?]I4[#8,L73F.G++6)LF$7+9]7'YEQ&A_;Z>
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MIF)0>%_Q//#@9(P&3\CK-V_/3P^3=SY>U)>U?G_*3OI3<G[7XW-\46YRNKX
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M\>5]VVR3KZ(I-R/G*3Z4EMUYA5#JAQ$!14_0()!5:RFJ--'+EYRC<D"N.!;
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M-T>H SC6BHS^Q.2EUE :3"=OUQS[!?CD:"_999S/>U.BA&CO65,J12U4MA"
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MW7JZ^3+;)=6&O::Z*I?X[--BG/T3;;#7[FVX61E71?;RV9.G3Y8YZ5-.M_W
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M>R-<HSYP7%<8)H/7%NC$(Q'*T')POP0]OJ&H6OD'N!B$$L6E6]F$&&*@"K3
M>X"0/[';MFB:4-%@!.XA7RIG@M$T>>@&-6!4U2NP'M11%D."%*G8L:T+@?""
MDFD30U3ZIT@$M2/T0AN<Z>2D)-<G%"!\ ,X3G!E[1X?[0;YI*_[OI2HWV>KV
M$ LB>('Q,QSBZ9UQVQ7-([U]I&+V#\:CIX% 9'.PX>1$HE CKDK"]%(--#QS
M$>#S^I=PVNW:-PC5BBB!XBH<&^-@BO:<A&]1_7M3\1Z;%<OB3+QPRD%BN'I=
MKHI%!_L!WGP\(@OO;T=4G=$/U08JLMVRN?<FA%*39.5__7[R(C!H(K=TW^Q-
M@\6K=Q8"G!I0N7\[.J1*$2N<WM\,/A70[=#Y%DSZ> 3>8K78^L)5JW)"F1@,
M7E=U8\3G*MMRGN96LF"BP7*8M>'5NJ5!;FVX;UJ#;^/*'72#@Z=CL,CQT;[#
M=I6)#<9EHB;@7LW(OIUPP):AMWK?@2DBG!N(':H2S(B00P?O@(KES*"CNZ9@
M-TX.'$T'#-_:6$X\-M[%N#<4K80XAYH"%&J?#L4T>_B\OM"G)HZ@WOZ>"704
MQ\AA;5:9A ?;[#;X#SG\[XQ3+S^ZE^47HDVZ7B^N(ET2#2J<F>!(/L"53,^X
MQ-ZCB4]I& D7:V2.P\:], M</K0\8N%BM@O>4E"NX4D <]7RK&P9<BPDLJ2J
M4<+YKJSS#^N!R=)5BZ&\U?0*_2&N?,1QDR-.&='>?7A?Q=<,V5.D<1'*@8JG
MY^:!? K&*O?BYPWMK882O7.]^'H<;/?L71 CMV_ (2$XY/;7"0[YU(7:X$A<
MU"C*.X<>U5XZZ.,<0X5H8))@/PQ 96\3?XJ=97W >'1M("K^Z7 0*ON3,2BR
M3/]$N&G(M=_B"Q>I/ IJ_%[H2NMTHFBO9D9<\/9/Q8)V<D['H] [O=V/!6U?
MFUWB0&YNM]\J"M#$,:!K9.3:^ \;LVY,83"HCLNH@N5.+_9;AX.VBD6V12HH
M.M\3BS"D.+3[AB-*P[&CX9WLHP[N=YQ63,?]KXLII>)KUX22>ILH=C=X$PS,
M=5(,C>6O[I=/D3I-((E8U!>_@V4Y:XI+' <HQH>@I^M9!4:YY*S"EXS#%:DH
MQ7;A'@C51#\:CUS,)K'.VY;)AG+>9N*&XCN@\0<#/-=LX[>*[41HJN&P3D]H
MAF,ZV5\*Z?1$*XSC7".\*G;Q7=Y/_&8\2@9PLK>-W\2C?<O C2NP"LK8ZUWV
MQ5\+VO2V3S#-F0G8Q*/ I.^NH9KHMUO"-#WA</&: )WU5\(UVZ?3CJT?#_&A
M&J,B?-0F];)?!D))@5AW"(CU1 !"J>1%Z[%TZ0A=CW1$X49D9,=,%"&O@]=F
M(OSP,\UR]#E8[,VYIGPIRGY"Y"E4RRW2TF"M24MKRT@\M_0A\#B"2&U/:G@
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M*A5/.:YA=#CV<@+5OI\K?YV)*4BXV :K;6$9AK\G3?TFM%7&HSVN$*:N9$(
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M?'.]T.C=F]!H(C1Z]'6&1C\/L?:$<W<<X9R22=NPP@U+C"&<TPD"@5\(@.D
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M",[Y1$AB#%*+?-RAA Q2N5'UWO\&MFD[=.;(-D88NYO.  \IZ$!7<, [W+:
MP\V,]=<_+DXX^Y1+^SC@@A'_:7;Q=8)L2<S 0"L8LNVZP-564T*W:*D\+45!
MWP%W,2N79-[,2E=Q'PDXY %-FQ0@R2[X+(:J6\(V0W1@>KV6@Z9\C%99(B L
M+4+7LV 96*!3GS(#Z4>TE_@+F)AB"&>G$+*:0Q>QKXI]@Y>[K[;LA.,7? :3
M83)K')<#%&0+<WI/$BQL5J"?[/(,98DU39CC8N+,/=U"@4.43RR?$3+*MG.
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MUXID^*?GJTE=6Q\0F%Z;W+[[5"8 1M;&WTCXQ[_8-)V -,CA(/Q.ZQW_S3^
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M%*AZLJ+[#OV 5+LTL'4RW7*+!W!6ZV9=LQM !I#Z8&!RD5MOM>:26?$C /O
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MBOOD1A&3'P5AQY;T;UGW +-8'C JN-*XP+P84(, ?;59HC7J$#S>V]V_B9^
MI _+X'OD(0#UA/*EG?7'[.FR"PW7,15^)Z -!N54.J%K-EE+.+5IC]=0EWO.
M#<?*4NLXVHR!3G!P2V'ZT7/E#L2#/>BF85'C6)8,>:'N[?5[G0:>\_G@SI8*
M%\ SUM;;632$13LN/HBU3I8&\UG%2Z=D/D^6S1Y)1];*Q35'VHK)6<R"G8V
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M6B%33RT\1P4=$9/);"E@1G1J3)NUM&P-P.#\P$Q6N73U /C*"^)F@&+U>;D
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M/<C#$J0-9B.=8F^J"/LA8'%]4]VZ+-BY+.BIX^D:ASZN9]&S>5$UQYPIV1)
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M4^VQYDO G[H5N[,XFP'!_6!1*CME<6UJP"26C(:@O)Q>MFXQ$1^I^QU,*FS
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M^3EK *&!*LD MA3[)<7AW<YL;H 5#"[YB@.-J>Y@ CQ6J!PF.V0E.KX&6XY
M-T Z7F-HV,VL.;'XW.F"L'XP$F_&YL:\A*@YX*C'O'20 1GYTKB3';:RF\T$
M/:GD)L(5QKBS(] ^,B/F@A&2[^#ZXEE*_)FKREJ/-61E*4F9BZJ>!7K69-!G
MQ3MJO2S(E)Q\%5;(I(K)%$\B5FBM!NCX>88SB*--EYIZA8\[\^MM;H11=GK+
MT3O3E)R[D)"D95*I@"(FT2]\Z6,P+]8+8@O!DO9!BX/2 UDWB)E#GMV?ZIQ
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MC@+ YT43,F7&9<C(I8]Y0L+;"O(-;UDP&_I]6OJ$6+@B#!+CP0EL2&-+%[+
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MCTU"M A7A:3[,P2Z:Y5?QW%Q6+[_KIO?O07D>30-U'Q6"E?_L1.ICGH30@A
MI"4[*!!&C<T-@?35^.>H^N%:YMAH;\7"E6C[2P55FW/O;-NN>+@<X#7.BI3+
M[CM%HG7F[W@N_A?L.@6UJD;<5$@H%M)TILU]N4JN0:.<@F-<>.M..CQPCK\X
M*T&;P(NX>=67)9IKA"9LM_W.<GVBFS:2 +74?%":5> 6H;-> C$RA+,6[O[*
MVHJX2:1=!ULALI,[FQMF+YAWH&J:\J*>4#YH<716=:W/$?/0H1K@I7[?6>39
MDQI7'(WEGXOY*50+^/)ST,!3K@,6 PCZD"XZ2Y5*:M5P1D@<1%K4>'@EJ_Q
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MY1\" E<27EMWK<^HBZ'NX;3X?XW!B580N] J%B)!I=0J6\" 57P%WXK:K9$
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M/<D,<)-^8>I_<DJ_3/TO4$L#!!0    (  1(25A,?(PS+0,  .8+   1
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M!/V/X-BP1TQ!,?BF$6BXJ9HZ_@%02P,$%     @ !$A)6/T< OO]"@  @(8
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M K#9A,(0!42%W1F 12E&N1I)N1<P[D2RP6*_2**>J:(M=(L&9+3)AJD*" [
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M U!+ 0(4 Q0    (  1(25A5NAY&V1L  +ZF   9              "  0
M  !E83$Y,S(P-2TX:U]P97)A<V]I;F,N:'1M4$L! A0#%     @ !$A)6"N!
M_9)PIP  =J,# !L              ( !$!P  &5A,3DS,C U97@Q+3%?<&5R
M87-O:6YC+FAT;5!+ 0(4 Q0    (  1(25@Q1P]WV"0! '.;!@ <
M      "  ;G#  !E83$Y,S(P-65X,3 M,E]P97)A<V]I;F,N:'1M4$L! A0#
M%     @ !$A)6&Z45I(_#   5R\  !P              ( !R^@! &5A,3DS
M,C U97@Y.2TQ7W!E<F%S;VEN8RYH=&U02P$"% ,4    "  $2$E8YW3_DMD+
M  "@*@  '               @ %$]0$ 96$Q.3,R,#5E>#DY+3)?<&5R87-O
M:6YC+FAT;5!+ 0(4 Q0    (  1(25A,?(PS+0,  .8+   1
M  "  5<! @!P<G-O+3(P,C0P,C V+GAS9%!+ 0(4 Q0    (  1(25C]' +[
M_0H  ("&   5              "  ;,$ @!P<G-O+3(P,C0P,C V7VQA8BYX
M;6Q02P$"% ,4    "  $2$E8JS]="5D'  #75P  %0              @ 'C
M#P( <')S;RTR,#(T,#(P-E]P<F4N>&UL4$L%!@     (  @ ,P(  &\7 @
!  $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>ea193205-8k_perasoinc_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="prso-20240206.xsd" xlink:type="simple"/>
    <context id="AsOf2024-02-06">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000890394</identifier>
        </entity>
        <period>
            <startDate>2024-02-06</startDate>
            <endDate>2024-02-06</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2024-02-06" id="ixv-344">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2024-02-06" id="ixv-345">0000890394</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2024-02-06" id="ixv-365">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2024-02-06" id="ixv-366">2024-02-06</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2024-02-06" id="ixv-367">PERASO INC.</dei:EntityRegistrantName>
    <dei:EntityFileNumber contextRef="AsOf2024-02-06" id="ixv-368">000-32929</dei:EntityFileNumber>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2024-02-06" id="ixv-369">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2024-02-06" id="ixv-370">77-0291941</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2024-02-06" id="ixv-371">2309 Bering Dr.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2024-02-06" id="ixv-372">San Jose</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2024-02-06" id="ixv-373">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2024-02-06" id="ixv-374">95131</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2024-02-06" id="ixv-375">408</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2024-02-06" id="ixv-376">418-7500</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2024-02-06" id="ixv-377">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2024-02-06" id="ixv-378">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2024-02-06" id="ixv-379">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2024-02-06" id="ixv-380">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2024-02-06" id="ixv-381">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2024-02-06" id="ixv-382">PRSO</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2024-02-06" id="ixv-383">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2024-02-06" id="ixv-384">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
